|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
[ochratoxin A co-treated with Citrinin] results in increased expression of ACTA2 mRNA; [ochratoxin A co-treated with Citrinin] results in increased expression of ACTA2 protein |
CTD |
PMID:29673704 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
Citrinin results in increased expression of ATF3 mRNA |
CTD |
PMID:21844328 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf4 |
activating transcription factor 4 |
increases expression |
ISO |
Citrinin results in increased expression of ATF4 mRNA |
CTD |
PMID:21844328 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atg5 |
autophagy related 5 |
increases expression |
ISO |
Citrinin results in increased expression of ATG5 mRNA |
CTD |
PMID:22771370 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Bag3 |
BAG cochaperone 3 |
increases expression multiple interactions |
ISO |
Citrinin results in increased expression of BAG3 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of BAG3 mRNA; [Citrinin co-treated with ochratoxin A] results in increased expression of BAG3 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression multiple interactions |
ISO |
Citrinin results in increased expression of BAK1 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of BAK1 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression affects expression |
ISO |
Citrinin results in increased expression of BAX protein Citrinin affects the expression of BAX protein |
CTD |
PMID:21622943 PMID:22771370 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression affects expression |
ISO |
Citrinin results in decreased expression of BCL2 protein Citrinin affects the expression of BCL2 protein |
CTD |
PMID:21622943 PMID:22771370 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l12 |
Bcl2 like 12 |
increases expression multiple interactions |
ISO |
Citrinin results in increased expression of BCL2L12 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of BCL2L12 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:95,472,272...95,480,991
Ensembl chr 1:95,472,272...95,480,991
|
|
G |
Becn1 |
beclin 1 |
increases expression |
ISO |
Citrinin results in increased expression of BECN1 mRNA |
CTD |
PMID:22771370 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Casp2 |
caspase 2 |
decreases expression multiple interactions |
ISO |
Citrinin results in decreased expression of CASP2 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CASP2 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions increases expression |
ISO EXP |
Citrinin results in increased activity of CASP3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Citrinin results in increased activity of CASP3 protein]; Citrinin inhibits the reaction [ochratoxin A results in increased activity of CASP3 protein]; pyrazolanthrone inhibits the reaction [Citrinin results in increased activity of CASP3 protein] [Citrinin results in increased activity of CASP3 protein] which results in increased activity of PAK2 protein; Citrinin results in increased activity of CASP3 protein Citrinin results in increased expression of CASP3 protein modified form |
CTD |
PMID:18767140 PMID:19361540 PMID:21622943 PMID:22564900 PMID:29673704 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases activity increases expression |
ISO EXP |
Citrinin results in increased activity of CASP9 protein Citrinin results in increased expression of CASP9 protein modified form |
CTD |
PMID:21622943 PMID:22564900 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases activity |
ISO |
Citrinin results in increased activity of CAT protein |
CTD |
PMID:21622943 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccna2 |
cyclin A2 |
increases expression |
EXP |
Citrinin results in increased expression of CCNA2 mRNA |
CTD |
PMID:23856526 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression decreases expression multiple interactions |
EXP ISO |
Citrinin results in increased expression of CCNB1 mRNA Citrinin results in decreased expression of CCNB1 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CCNB1 mRNA |
CTD |
PMID:23856526 PMID:30428381 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccne1 |
cyclin E1 |
increases expression multiple interactions decreases expression |
EXP ISO |
Citrinin results in increased expression of CCNE1 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CCNE1 mRNA Citrinin results in decreased expression of CCNE1 mRNA |
CTD |
PMID:23856526 PMID:30428381 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccng1 |
cyclin G1 |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CCNG1 mRNA; [Citrinin co-treated with ochratoxin A] results in decreased expression of CCNG1 protein |
CTD |
PMID:30428381 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Cdc23 |
cell division cycle 23 |
decreases expression multiple interactions |
ISO |
Citrinin results in decreased expression of CDC23 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC23 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr18:26,236,891...26,260,611
Ensembl chr18:26,236,890...26,291,163
|
|
G |
Cdc25a |
cell division cycle 25A |
multiple interactions decreases expression increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC25A mRNA Citrinin results in decreased expression of CDC25A mRNA Citrinin results in increased expression of CDC25A mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
|
|
G |
Cdc25c |
cell division cycle 25C |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC25C mRNA Citrinin results in decreased expression of CDC25C mRNA |
CTD |
PMID:30428381 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdc26 |
cell division cycle 26 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC26 mRNA Citrinin results in decreased expression of CDC26 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 5:75,844,852...75,859,830
|
|
G |
Cdc34 |
cell division cycle 34, ubiqiutin conjugating enzyme |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC34 mRNA Citrinin results in decreased expression of CDC34 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 7:10,017,588...10,023,586
Ensembl chr 7:10,017,588...10,023,186
|
|
G |
Cdc6 |
cell division cycle 6 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC6 mRNA Citrinin results in decreased expression of CDC6 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
|
|
G |
Cdc7 |
cell division cycle 7 |
decreases expression multiple interactions |
ISO |
Citrinin results in decreased expression of CDC7 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC7 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr14:2,804,660...2,824,796
Ensembl chr14:2,804,661...2,824,778
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDH1 mRNA; [ochratoxin A co-treated with Citrinin] results in decreased expression of CDH1 protein |
CTD |
PMID:29673704 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression multiple interactions |
ISO |
Citrinin results in decreased expression of CDK1 protein modified form [Citrinin co-treated with ochratoxin A] results in decreased expression of CDK1 mRNA |
CTD |
PMID:20929984 PMID:30428381 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk10 |
cyclin-dependent kinase 10 |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDK10 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
Citrinin results in increased expression of CDKN1A protein |
CTD |
PMID:20929984 PMID:21622943 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
decreases expression multiple interactions |
ISO |
Citrinin results in decreased expression of CDKN1B mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CDKN1B mRNA; [Citrinin co-treated with ochratoxin A] results in increased expression of CDKN1B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of COL3A1 mRNA; [Citrinin co-treated with ochratoxin A] results in increased expression of and results in increased secretion of COL3A1 protein |
CTD |
PMID:29673704 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Cycs |
cytochrome c, somatic |
affects localization |
ISO |
Citrinin affects the localization of CYCS protein |
CTD |
PMID:21622943 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
decreases expression |
EXP |
Citrinin results in decreased expression of CYP11A1 protein |
CTD |
PMID:22564900 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
Citrinin results in increased expression of DDIT3 mRNA |
CTD |
PMID:21844328 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
E2f1 |
E2F transcription factor 1 |
increases expression |
EXP |
Citrinin results in increased expression of E2F1 mRNA |
CTD |
PMID:23856526 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
Egr1 |
early growth response 1 |
increases expression multiple interactions |
ISO |
Citrinin results in increased expression of EGR1 mRNA; Citrinin results in increased expression of EGR1 protein U 0126 inhibits the reaction [Citrinin results in increased expression of EGR1 protein] |
CTD |
PMID:19361540 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
ISO |
Citrinin results in increased expression of FOS mRNA; Citrinin results in increased expression of FOS protein U 0126 inhibits the reaction [Citrinin results in increased expression of FOS protein] |
CTD |
PMID:19361540 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
increases expression multiple interactions |
ISO |
Citrinin results in increased expression of GADD45B mRNA U 0126 inhibits the reaction [Citrinin results in increased expression of GADD45B mRNA] |
CTD |
PMID:19361540 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Hgf |
hepatocyte growth factor |
increases expression |
EXP |
Citrinin results in increased expression of HGF mRNA |
CTD |
PMID:23856526 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
Citrinin results in increased expression of HMOX1; Citrinin results in increased expression of HMOX1 mRNA |
CTD |
PMID:26260164 PMID:36460223 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression |
EXP |
Citrinin results in decreased expression of HSD3B1 protein |
CTD |
PMID:22564900 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Ifng |
interferon gamma |
decreases expression increases expression decreases secretion |
ISO |
Citrinin results in decreased expression of IFNG mRNA Citrinin results in increased expression of IFNG protein Citrinin results in decreased secretion of IFNG protein |
CTD |
PMID:12112629 PMID:22771370 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
Citrinin inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 mRNA]; Citrinin inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 protein]; Citrinin inhibits the reaction [Poly I-C results in increased expression of IL10 mRNA]; Citrinin inhibits the reaction [Poly I-C results in increased expression of IL10 protein]; Citrinin inhibits the reaction [Zymosan results in increased expression of IL10 mRNA]; Citrinin inhibits the reaction [Zymosan results in increased expression of IL10 protein] |
CTD |
PMID:22771370 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases expression |
ISO |
Citrinin inhibits the reaction [Poly I-C results in increased expression of IL1B mRNA]; Citrinin inhibits the reaction [Zymosan results in increased expression of IL1B mRNA] Citrinin results in decreased expression of IL1B mRNA |
CTD |
PMID:22771370 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Citrinin results in increased expression of JUN mRNA; Citrinin results in increased expression of JUN protein |
CTD |
PMID:19361540 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Citrinin results in increased expression of JUNB mRNA |
CTD |
PMID:19361540 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Lcn2 |
lipocalin 2 |
increases expression |
EXP |
Citrinin results in increased expression of LCN2 mRNA |
CTD |
PMID:23856526 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation multiple interactions |
ISO EXP |
Citrinin results in increased phosphorylation of MAPK1 protein Citrinin promotes the reaction [ochratoxin A results in increased phosphorylation of MAPK1 protein]; ochratoxin A promotes the reaction [Citrinin results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:19361540 PMID:23856526 PMID:29673704 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation multiple interactions |
ISO EXP |
Citrinin results in increased phosphorylation of MAPK3 protein Citrinin promotes the reaction [ochratoxin A results in increased phosphorylation of MAPK3 protein]; ochratoxin A promotes the reaction [Citrinin results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:19361540 PMID:23856526 PMID:29673704 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation |
ISO |
Citrinin results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:19361540 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases phosphorylation |
ISO |
Citrinin results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:19361540 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mir1 |
microRNA 1 |
decreases expression multiple interactions |
ISO |
Citrinin results in decreased expression of MIR1 mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR1 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr18:1,887,537...1,887,623
|
|
G |
Mir107 |
microRNA 107 |
decreases expression |
ISO |
Citrinin results in decreased expression of MIR107 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:232,337,767...232,337,853
Ensembl chr 1:232,337,767...232,337,853
|
|
G |
Mir122 |
microRNA 122 |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR122 mRNA Citrinin results in increased expression of MIR122 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr18:58,758,703...58,758,787
|
|
G |
Mir132 |
microRNA 132 |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR132 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:60,023,696...60,023,796
Ensembl chr10:60,023,696...60,023,796
|
|
G |
Mir139 |
microRNA 139 |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR139 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:155,878,828...155,878,895
Ensembl chr 1:155,878,825...155,878,902
|
|
G |
Mir142 |
microRNA 142 |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR142 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:72,557,864...72,557,950
Ensembl chr10:72,557,857...72,557,967
|
|
G |
Mir144 |
microRNA 144 |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR144 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:62,961,348...62,961,430
Ensembl chr10:62,961,348...62,961,430
|
|
G |
Mir152 |
microRNA 152 |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR152 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:81,832,936...81,833,020
Ensembl chr10:81,832,936...81,833,020
|
|
G |
Mir184 |
microRNA 184 |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR184 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 8:90,343,134...90,343,210
Ensembl chr 8:90,343,134...90,343,210
|
|
G |
Mir187 |
microRNA 187 |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR187 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr18:15,731,194...15,731,297
Ensembl chr18:15,731,194...15,731,297
|
|
G |
Mir190b |
microRNA 190b |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR190B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 2:175,514,800...175,514,877
Ensembl chr 2:175,514,800...175,514,877
|
|
G |
Mir200b |
microRNA 200b |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR200B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 5:166,649,272...166,649,366
Ensembl chr 5:166,649,272...166,649,366
|
|
G |
Mir200c |
microRNA 200c |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR200C mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 4:157,523,679...157,523,747
|
|
G |
Mir295-1 |
microRNA 295-1 |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR372 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:65,962,566...65,962,646
Ensembl chr 1:65,962,566...65,962,646
|
|
G |
Mir301a |
microRNA 301a |
decreases expression |
ISO |
Citrinin results in decreased expression of MIR301A mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:71,925,336...71,925,435
Ensembl chr10:71,925,336...71,925,435
|
|
G |
Mir32 |
microRNA 32 |
decreases expression |
ISO |
Citrinin results in decreased expression of MIR32 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 5:71,596,083...71,596,152
Ensembl chr 5:71,596,083...71,596,152
|
|
G |
Mir34a |
microRNA 34a |
decreases expression |
ISO |
Citrinin results in decreased expression of MIR34A mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
|
|
G |
Mir34b |
microRNA 34b |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR34B mRNA Citrinin results in decreased expression of MIR34B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 8:51,410,244...51,410,327
Ensembl chr 8:51,410,244...51,410,327
|
|
G |
Mir34c |
microRNA 34c |
decreases expression multiple interactions |
ISO |
Citrinin results in decreased expression of MIR34C mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR34C mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 8:51,409,726...51,409,802
Ensembl chr 8:51,409,726...51,409,802
|
|
G |
Mir374b |
microRNA 374b |
decreases expression |
ISO |
Citrinin results in decreased expression of MIR374B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr X:68,591,732...68,591,799
Ensembl chr X:68,591,732...68,591,799
|
|
G |
Mir449a |
microRNA 449a |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR449A mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 2:44,670,714...44,670,804
Ensembl chr 2:44,670,714...44,670,804
|
|
G |
Mir449c |
microRNA 449c |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR449C mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 2:44,669,179...44,669,277
Ensembl chr 2:44,669,179...44,669,277
|
|
G |
Mir92a1 |
microRNA 92a-1 |
decreases expression |
ISO |
Citrinin results in decreased expression of MIR92A1 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr15:92,181,336...92,181,413
Ensembl chr15:92,181,336...92,181,413
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
increases expression multiple interactions |
ISO |
Citrinin results in increased expression of MMP3 mRNA pyrazolanthrone inhibits the reaction [Citrinin results in increased expression of MMP3 mRNA] |
CTD |
PMID:19361540 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
Citrinin results in increased expression of NQO1 mRNA |
CTD |
PMID:36460223 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Ntng2 |
netrin G2 |
decreases expression |
ISO |
Citrinin results in decreased expression of NTNG2 mRNA |
CTD |
PMID:36460223 |
|
NCBI chr 3:12,492,574...12,551,104
Ensembl chr 3:12,492,639...12,545,890
|
|
G |
Pak2 |
p21 (RAC1) activated kinase 2 |
increases activity |
ISO |
[Citrinin results in increased activity of CASP3 protein] which results in increased activity of PAK2 protein; Citrinin results in increased activity of PAK2 protein |
CTD |
PMID:18767140 |
|
NCBI chr11:68,707,940...68,768,816
Ensembl chr11:68,707,969...68,768,816
|
|
G |
Pdcd4 |
programmed cell death 4 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of PDCD4 mRNA Citrinin results in decreased expression of PDCD4 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
|
|
G |
Plxna4 |
plexin A4 |
decreases expression |
ISO |
Citrinin results in decreased expression of PLXNA4 mRNA |
CTD |
PMID:36460223 |
|
NCBI chr 4:60,720,246...61,162,206
Ensembl chr 4:60,720,255...61,162,206
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
decreases activity |
ISO |
Citrinin results in decreased activity of PPARG protein |
CTD |
PMID:27481073 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
increases expression |
ISO |
Citrinin results in increased expression of PPP1R15A mRNA |
CTD |
PMID:21844328 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[ochratoxin A co-treated with Citrinin] results in decreased expression of PTGS2 mRNA; [ochratoxin A co-treated with Citrinin] results in decreased expression of PTGS2 protein |
CTD |
PMID:29673704 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Robo2 |
roundabout guidance receptor 2 |
decreases expression |
ISO |
Citrinin results in decreased expression of ROBO2 mRNA |
CTD |
PMID:36460223 |
|
NCBI chr11:12,528,949...14,096,726
Ensembl chr11:12,528,951...13,041,536
|
|
G |
Sema3f |
semaphorin 3F |
decreases expression |
ISO |
Citrinin results in decreased expression of SEMA3F mRNA |
CTD |
PMID:36460223 |
|
NCBI chr 8:108,357,629...108,386,569
Ensembl chr 8:108,357,629...108,387,083
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
multiple interactions |
EXP |
Citrinin inhibits the reaction [SLC22A6 protein results in increased uptake of ochratoxin A] |
CTD |
PMID:10336520 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc5a1 |
solute carrier family 5 member 1 |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of SLC5A1 mRNA |
CTD |
PMID:29673704 |
|
NCBI chr14:77,553,990...77,618,589
Ensembl chr14:77,553,843...77,618,547
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression |
EXP |
Citrinin results in decreased expression of STAR protein |
CTD |
PMID:22564900 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased activity of THRB protein |
CTD |
PMID:27481073 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Tlr2 |
toll-like receptor 2 |
increases expression |
ISO |
Citrinin results in increased expression of TLR2 mRNA |
CTD |
PMID:22771370 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr3 |
toll-like receptor 3 |
decreases expression |
ISO |
Citrinin results in decreased expression of TLR3 mRNA |
CTD |
PMID:22771370 |
|
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Citrinin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Citrinin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Citrinin inhibits the reaction [Poly I-C results in increased expression of TNF mRNA]; Citrinin inhibits the reaction [Poly I-C results in increased expression of TNF protein]; Citrinin promotes the reaction [CPG-oligonucleotide results in increased expression of TNF mRNA]; Citrinin promotes the reaction [CPG-oligonucleotide results in increased expression of TNF protein] [ochratoxin A co-treated with Citrinin] results in increased expression of TNF mRNA; [ochratoxin A co-treated with Citrinin] results in increased expression of TNF protein; pyrazolanthrone inhibits the reaction [[ochratoxin A co-treated with Citrinin] results in increased expression of TNF mRNA]; U 0126 inhibits the reaction [[ochratoxin A co-treated with Citrinin] results in increased expression of TNF mRNA] |
CTD |
PMID:22771370 PMID:29673704 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip1 |
TNF alpha induced protein 1 |
increases expression multiple interactions |
ISO |
Citrinin results in increased expression of TNFAIP1 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of TNFAIP1 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:63,417,774...63,432,466
Ensembl chr10:63,417,775...63,432,466
|
|
G |
Tnfrsf12a |
TNF receptor superfamily member 12A |
increases expression multiple interactions |
ISO |
Citrinin results in increased expression of TNFRSF12A mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of TNFRSF12A mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of TNFRSF1A mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
ISO EXP |
Citrinin results in increased expression of TP53 protein Citrinin results in increased expression of TP53 protein modified form Citrinin results in increased expression of TRP53 protein |
CTD |
PMID:20929984 PMID:21622943 PMID:22564900 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
decreases expression |
ISO |
Citrinin results in decreased expression of TUBB3 mRNA |
CTD |
PMID:36460223 |
|
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
|
|
G |
Vim |
vimentin |
multiple interactions |
ISO |
[ochratoxin A co-treated with Citrinin] results in decreased expression of VIM mRNA; [ochratoxin A co-treated with Citrinin] results in increased expression of VIM protein |
CTD |
PMID:29673704 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
1-phenyl-6,7-dihydroxy-isochroman inhibits the reaction [[Lipopolysaccharides results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; 1-phenyl-6,7-dihydroxy-isochroman inhibits the reaction [[Lipopolysaccharides results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Thromboxane A2]; 1-phenyl-6,7-dihydroxy-isochroman inhibits the reaction [Lipopolysaccharides results in increased activity of PTGS2 protein] |
CTD |
PMID:21269535 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
1-phenyl-6,7-dihydroxy-isochroman inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] |
CTD |
PMID:21269535 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Abcf1 |
ATP binding cassette subfamily F member 1 |
increases expression |
ISO |
cladosporin results in increased expression of ABCF1 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr20:2,802,519...2,815,433
Ensembl chr20:2,802,488...2,815,433
|
|
G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
increases expression |
ISO |
cladosporin results in increased expression of AIMP1 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 2:221,151,907...221,175,458
Ensembl chr 2:221,151,904...221,175,728
|
|
G |
Blvrb |
biliverdin reductase B |
increases expression |
ISO |
cladosporin results in increased expression of BLVRB mRNA |
CTD |
PMID:21356202 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Ccl12 |
C-C motif chemokine ligand 12 |
increases expression |
ISO |
cladosporin results in increased expression of CCL12 mRNA |
CTD |
PMID:21356202 |
|
NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
increases expression |
ISO |
cladosporin results in increased expression of CCL19 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression decreases expression |
ISO |
cladosporin results in increased expression of CCL20 mRNA cladosporin results in decreased expression of CCL20 mRNA |
CTD |
PMID:19818335 PMID:21356202 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl25 |
C-C motif chemokine ligand 25 |
increases expression |
ISO |
cladosporin results in increased expression of CCL25 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr12:2,707,398...2,716,571
Ensembl chr12:2,707,398...2,716,554
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
decreases expression |
ISO |
cladosporin results in decreased expression of CCL3 mRNA |
CTD |
PMID:19818335 PMID:21356202 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
decreases expression |
ISO |
cladosporin results in decreased expression of CCL4 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
decreases expression |
ISO |
cladosporin results in decreased expression of CCL7 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
increases expression |
ISO |
cladosporin results in increased expression of CCR1 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 8:123,556,286...123,561,841
|
|
G |
Ccr10 |
C-C motif chemokine receptor 10 |
increases expression |
ISO |
cladosporin results in increased expression of CCR10 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr10:86,108,551...86,110,988
Ensembl chr10:86,108,551...86,110,988
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
increases expression |
ISO |
cladosporin results in increased expression of CCR2 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
increases expression |
ISO |
cladosporin results in increased expression of CCR3 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
|
|
G |
Ccr4 |
C-C motif chemokine receptor 4 |
increases expression |
ISO |
cladosporin results in increased expression of CCR4 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 8:114,176,291...114,182,033
Ensembl chr 8:114,176,974...114,178,056
|
|
G |
Ccr6 |
C-C motif chemokine receptor 6 |
increases expression |
ISO |
cladosporin results in increased expression of CCR6 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
increases expression |
ISO |
cladosporin results in increased expression of CCR7 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
|
|
G |
Ccr9 |
C-C motif chemokine receptor 9 |
increases expression |
ISO |
cladosporin results in increased expression of CCR9 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 8:123,396,157...123,410,199
Ensembl chr 8:123,395,813...123,413,969
|
|
G |
Cd40lg |
CD40 ligand |
increases expression |
ISO |
cladosporin results in increased expression of CD40LG mRNA |
CTD |
PMID:19818335 |
|
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
increases expression |
ISO |
cladosporin results in increased expression of CX3CL1 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
decreases expression increases expression |
ISO |
cladosporin results in decreased expression of CXCL10 mRNA cladosporin results in increased expression of CXCL10 protein |
CTD |
PMID:19818335 PMID:21356202 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl11 |
C-X-C motif chemokine ligand 11 |
decreases expression |
ISO |
cladosporin results in decreased expression of CXCL11 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
increases expression |
ISO |
cladosporin results in increased expression of CXCL12 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl13 |
C-X-C motif chemokine ligand 13 |
increases expression |
ISO |
cladosporin results in increased expression of CXCL13 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
cladosporin results in increased expression of CXCL2 mRNA; cladosporin results in increased expression of CXCL2 protein |
CTD |
PMID:19818335 PMID:21356202 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
decreases expression increases expression |
ISO |
cladosporin results in decreased expression of CXCL1 mRNA cladosporin results in increased expression of CXCL1 mRNA |
CTD |
PMID:19818335 PMID:21356202 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
decreases expression |
ISO |
cladosporin results in decreased expression of CXCL5 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
decreases expression increases expression |
ISO |
cladosporin results in decreased expression of CXCR2 mRNA cladosporin results in increased expression of CXCR2 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
increases expression |
ISO |
cladosporin results in increased expression of CXCR3 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
|
|
G |
Cxcr5 |
C-X-C motif chemokine receptor 5 |
increases expression |
ISO |
cladosporin results in increased expression of CXCR5 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 8:44,842,098...44,858,425
Ensembl chr 8:44,843,413...44,857,893
|
|
G |
Ifi27 |
interferon, alpha-inducible protein 27 |
decreases expression |
ISO |
cladosporin results in decreased expression of IFI27L1 mRNA |
CTD |
PMID:21356202 |
|
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
|
|
G |
Ifng |
interferon gamma |
increases expression |
ISO |
cladosporin results in increased expression of IFNG mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
increases expression |
ISO |
cladosporin results in increased expression of IL10 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il10ra |
interleukin 10 receptor subunit alpha |
increases expression |
ISO |
cladosporin results in increased expression of IL10RA mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061
|
|
G |
Il10rb |
interleukin 10 receptor subunit beta |
increases expression |
ISO |
cladosporin results in increased expression of IL10RB mRNA |
CTD |
PMID:19818335 |
|
NCBI chr11:30,646,494...30,668,081
Ensembl chr11:30,652,096...30,668,074
|
|
G |
Il15 |
interleukin 15 |
increases expression |
ISO |
cladosporin results in increased expression of IL15 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Il16 |
interleukin 16 |
increases expression |
ISO |
cladosporin results in increased expression of IL16 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Il18 |
interleukin 18 |
increases expression |
ISO |
cladosporin results in increased expression of IL18 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
increases expression decreases expression |
ISO |
cladosporin results in increased expression of IL1B mRNA cladosporin results in decreased expression of IL1B mRNA |
CTD |
PMID:19818335 PMID:21356202 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
increases expression |
ISO |
cladosporin results in increased expression of IL1R1 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Il2rb |
interleukin 2 receptor subunit beta |
increases expression |
ISO |
cladosporin results in increased expression of IL2RB mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 7:110,033,341...110,048,054
Ensembl chr 7:110,033,341...110,048,054
|
|
G |
Il4 |
interleukin 4 |
increases expression |
ISO |
cladosporin results in increased expression of IL4 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5ra |
interleukin 5 receptor subunit alpha |
increases expression |
ISO |
cladosporin results in increased expression of IL5RA mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 4:139,630,652...139,664,593
Ensembl chr 4:139,632,066...139,668,544
|
|
G |
Il6 |
interleukin 6 |
increases expression |
ISO |
cladosporin results in increased expression of IL6 mRNA |
CTD |
PMID:21356202 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6r |
interleukin 6 receptor |
increases expression |
ISO |
cladosporin results in increased expression of IL6RA mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
decreases expression |
ISO |
cladosporin results in decreased expression of IL6ST mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
|
|
G |
Itgam |
integrin subunit alpha M |
increases expression |
ISO |
cladosporin results in increased expression of ITGAM mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Lta |
lymphotoxin alpha |
increases expression |
ISO |
cladosporin results in increased expression of LTA mRNA |
CTD |
PMID:19818335 |
|
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
|
|
G |
Ltb |
lymphotoxin beta |
increases expression |
ISO |
cladosporin results in increased expression of LTB mRNA |
CTD |
PMID:19818335 |
|
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
|
|
G |
Mif |
macrophage migration inhibitory factor |
increases expression |
ISO |
cladosporin results in increased expression of MIF mRNA |
CTD |
PMID:19818335 |
|
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
increases expression |
ISO |
cladosporin results in increased expression of SPP1 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression increases expression |
ISO |
cladosporin results in decreased expression of TNF mRNA cladosporin results in increased expression of TNF mRNA |
CTD |
PMID:19818335 PMID:21356202 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
increases expression |
ISO |
cladosporin results in increased expression of TNFRSF1A mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
galaxolide binds to and results in decreased activity of AR protein; galaxolide inhibits the reaction [Metribolone results in increased activity of AR protein] |
CTD |
PMID:15537743 PMID:17762842 PMID:29427707 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Camk2d |
calcium/calmodulin-dependent protein kinase II delta |
increases expression |
EXP |
galaxolide results in increased expression of CAMK2D mRNA |
CTD |
PMID:37797914 |
|
NCBI chr 2:215,023,785...215,287,351
Ensembl chr 2:215,024,004...215,286,178
|
|
G |
Ces1d |
carboxylesterase 1D |
decreases activity |
ISO |
galaxolide results in decreased activity of CES1 protein |
CTD |
PMID:22489002 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
multiple interactions increases activity decreases activity decreases expression |
ISO EXP |
[galaxolide co-treated with Cyclic AMP] results in decreased activity of CYP17A1 protein; [galaxolide co-treated with Cyclic AMP] results in increased activity of CYP17A1 protein galaxolide results in increased activity of CYP17A1 protein galaxolide results in decreased activity of CYP17A1 protein galaxolide results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:23084589 PMID:37797914 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
decreases expression |
EXP |
galaxolide results in decreased expression of DHCR7 mRNA |
CTD |
PMID:37797914 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dmrtc1c1 |
DMRT-like family C1c1 |
increases expression |
EXP |
galaxolide results in increased expression of DMRTC1C1 mRNA |
CTD |
PMID:37797914 |
|
NCBI chr X:67,896,973...67,904,182
Ensembl chr X:67,896,974...67,904,182
|
|
G |
Dnajc19 |
DnaJ heat shock protein family (Hsp40) member C19 |
decreases expression |
EXP |
galaxolide results in decreased expression of DNAJC19 mRNA |
CTD |
PMID:37797914 |
|
NCBI chr 2:116,923,272...116,945,312
Ensembl chr 2:116,923,272...116,945,264
|
|
G |
Egfr |
epidermal growth factor receptor |
increases expression multiple interactions |
ISO |
galaxolide results in increased expression of EGFR mRNA [galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in increased expression of EGFR mRNA |
CTD |
PMID:34687775 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
galaxolide binds to and results in increased activity of ESR1 protein |
CTD |
PMID:17762842 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
galaxolide binds to and results in decreased activity of ESR2 protein |
CTD |
PMID:15537743 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
increases expression |
EXP |
galaxolide results in increased expression of FSHB protein |
CTD |
PMID:37797914 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Fshr |
follicle stimulating hormone receptor |
increases expression |
EXP |
galaxolide results in increased expression of FSHR mRNA |
CTD |
PMID:37797914 |
|
NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785
|
|
G |
Gnrhr |
gonadotropin releasing hormone receptor |
increases expression |
EXP |
galaxolide results in increased expression of GNRHR mRNA |
CTD |
PMID:37797914 |
|
NCBI chr14:21,856,871...21,874,861
Ensembl chr14:21,856,871...21,874,861
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases expression multiple interactions |
ISO |
galaxolide results in increased expression of HIF1A mRNA [galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in increased expression of HIF1A mRNA; galaxolide inhibits the reaction [acetyl methyl tetramethyl tetralin results in increased expression of HIF1A mRNA]; galaxolide inhibits the reaction [acetyl methyl tetramethyl tetralin results in increased expression of HIF1A protein] |
CTD |
PMID:34687775 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
multiple interactions decreases expression |
ISO |
[galaxolide results in decreased expression of [HSD3B2 co-treated with CYP21A2]] which results in decreased chemical synthesis of Hydrocortisone; [galaxolide results in decreased expression of [HSD3B2 co-treated with CYP21A2]] which results in decreased chemical synthesis of Progesterone galaxolide results in decreased expression of HSD3B2 |
CTD |
PMID:23084589 |
|
NCBI chr 2:186,095,897...186,105,354
Ensembl chr 2:186,095,897...186,101,852
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
galaxolide results in increased expression of IL6 mRNA [galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in increased expression of IL6 mRNA |
CTD |
PMID:34687775 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Jak2 |
Janus kinase 2 |
increases expression multiple interactions |
ISO |
galaxolide results in increased expression of JAK2 mRNA [galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in increased expression of JAK2 mRNA |
CTD |
PMID:34687775 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Kdr |
kinase insert domain receptor |
multiple interactions |
ISO |
[galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in increased expression of KDR mRNA |
CTD |
PMID:34687775 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Lhb |
luteinizing hormone subunit beta |
increases expression |
EXP |
galaxolide results in increased expression of LHB protein |
CTD |
PMID:37797914 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Map3k2 |
mitogen activated protein kinase kinase kinase 2 |
increases expression |
EXP |
galaxolide results in increased expression of MAP3K2 mRNA |
CTD |
PMID:37797914 |
|
NCBI chr18:23,807,218...23,879,722
Ensembl chr18:23,807,218...23,871,433
|
|
G |
Mir155 |
microRNA 155 |
multiple interactions |
ISO |
[galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in increased expression of MIR155 mRNA; galaxolide inhibits the reaction [acetyl methyl tetramethyl tetralin results in increased expression of MIR155 mRNA] |
CTD |
PMID:34687775 |
|
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mir17 |
microRNA 17 |
decreases expression multiple interactions |
ISO |
galaxolide results in decreased expression of MIR17 mRNA [galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in decreased expression of MIR17 mRNA |
CTD |
PMID:34687775 |
|
NCBI chr15:92,180,629...92,180,712
Ensembl chr15:92,180,629...92,180,712
|
|
G |
Mir19b1 |
microRNA 19b-1 |
decreases expression multiple interactions |
ISO |
galaxolide results in decreased expression of MIR19B1 mRNA [galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in decreased expression of MIR19B1 mRNA |
CTD |
PMID:34687775 |
|
NCBI chr15:92,181,214...92,181,300
Ensembl chr15:92,181,214...92,181,300
|
|
G |
Mir20a |
microRNA 20a |
multiple interactions decreases expression |
ISO |
[galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in decreased expression of MIR20A mRNA galaxolide results in decreased expression of MIR20A mRNA |
CTD |
PMID:34687775 |
|
NCBI chr15:92,181,084...92,181,168
Ensembl chr15:92,181,084...92,181,168
|
|
G |
Mir92a1 |
microRNA 92a-1 |
decreases expression multiple interactions |
ISO |
galaxolide results in decreased expression of MIR92A1 mRNA [galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in decreased expression of MIR92A1 mRNA |
CTD |
PMID:34687775 |
|
NCBI chr15:92,181,336...92,181,413
Ensembl chr15:92,181,336...92,181,413
|
|
G |
Mir93 |
microRNA 93 |
multiple interactions |
ISO |
[galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in increased expression of MIR93 mRNA; galaxolide promotes the reaction [acetyl methyl tetramethyl tetralin results in increased expression of MIR93 mRNA] |
CTD |
PMID:34687775 |
|
NCBI chr12:17,043,135...17,043,221
Ensembl chr12:17,043,135...17,043,221
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
increases expression multiple interactions |
ISO |
galaxolide results in increased expression of MMP3 mRNA [galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in increased expression of MMP3 mRNA |
CTD |
PMID:34687775 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions increases expression |
ISO |
[galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in increased expression of MMP9 mRNA; [galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in increased expression of MMP9 protein galaxolide results in increased expression of MMP9 mRNA; galaxolide results in increased expression of MMP9 protein |
CTD |
PMID:34687775 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Pgr |
progesterone receptor |
multiple interactions |
ISO |
galaxolide binds to and results in decreased activity of PGR protein |
CTD |
PMID:15537743 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Snai1 |
snail family transcriptional repressor 1 |
increases expression multiple interactions |
ISO |
galaxolide results in increased expression of SNAI1 mRNA [galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in increased expression of SNAI1 mRNA |
CTD |
PMID:34687775 |
|
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
|
|
G |
Snai2 |
snail family transcriptional repressor 2 |
multiple interactions increases expression |
ISO |
[galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in increased expression of SNAI2 mRNA; galaxolide promotes the reaction [acetyl methyl tetramethyl tetralin results in increased expression of SNAI2 mRNA] galaxolide results in increased expression of SNAI2 mRNA |
CTD |
PMID:34687775 |
|
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
decreases expression |
EXP |
galaxolide results in decreased expression of SRD5A2 mRNA |
CTD |
PMID:37797914 |
|
NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
increases expression multiple interactions |
ISO |
galaxolide results in increased expression of STAT3 mRNA [galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in increased expression of STAT3 mRNA |
CTD |
PMID:34687775 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tex14 |
testis expressed 14, intercellular bridge forming factor |
decreases expression |
EXP |
galaxolide results in decreased expression of TEX14 mRNA |
CTD |
PMID:37797914 |
|
NCBI chr10:72,231,766...72,356,938
Ensembl chr10:72,231,801...72,355,805
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions increases expression |
ISO |
[galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in increased expression of VEGFA mRNA; galaxolide inhibits the reaction [acetyl methyl tetramethyl tetralin results in increased expression of VEGFA protein] galaxolide results in increased expression of VEGFA mRNA |
CTD |
PMID:34687775 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
multiple interactions increases expression |
ISO |
[galaxolide co-treated with acetyl methyl tetramethyl tetralin] results in increased expression of VIM mRNA; galaxolide inhibits the reaction [acetyl methyl tetramethyl tetralin results in increased expression of VIM mRNA] galaxolide results in increased expression of VIM mRNA |
CTD |
PMID:34687775 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Zeb1 |
zinc finger E-box binding homeobox 1 |
multiple interactions increases expression |
ISO |
acetyl methyl tetramethyl tetralin promotes the reaction [galaxolide results in increased expression of ZEB1 mRNA]; galaxolide promotes the reaction [acetyl methyl tetramethyl tetralin results in increased expression of ZEB1 mRNA] |
CTD |
PMID:34687775 |
|
NCBI chr17:51,948,948...52,116,018
Ensembl chr17:51,948,948...52,115,214
|
|
|
G |
A2m |
alpha-2-macroglobulin |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of A2M mRNA ochratoxin A results in decreased expression of A2M mRNA |
CTD |
PMID:12700408 PMID:30008028 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Aadac |
arylacetamide deacetylase |
affects expression |
EXP |
ochratoxin A affects the expression of AADAC mRNA |
CTD |
PMID:17483316 |
|
NCBI chr 2:144,163,436...144,186,086
Ensembl chr 2:144,135,319...144,174,734
|
|
G |
Aars1 |
alanyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr19:38,999,130...39,021,152
Ensembl chr19:38,999,163...39,021,147
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ABAT mRNA |
CTD |
PMID:18417182 |
|
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
|
|
G |
Abca8 |
ATP binding cassette subfamily A member 8 |
affects transport multiple interactions |
ISO |
ABCA8 protein affects the transport of ochratoxin A ochratoxin A inhibits the reaction [ABCA8 protein results in increased uptake of estradiol-17 beta-glucuronide] |
CTD |
PMID:12379217 |
|
NCBI chr10:94,917,520...94,991,199
Ensembl chr10:94,917,520...94,990,988
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ABCB11 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ABCB1A mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
increases expression |
EXP |
ochratoxin A results in increased expression of ABCB1B mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcb6 |
ATP binding cassette subfamily B member 6 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ABCB6 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions increases expression affects transport decreases expression affects export |
ISO EXP |
biochanin A inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; chrysin inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; Genistein inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; Polyphenols inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; Polyphenols metabolite inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; Quercetin inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; resveratrol inhibits the reaction [ABCC2 protein affects the export of ochratoxin A] ochratoxin A results in increased expression of ABCC2 mRNA ABCC2 protein affects the transport of ochratoxin A ochratoxin A results in decreased expression of ABCC2 mRNA |
CTD |
PMID:15955639 PMID:16251485 PMID:19505989 PMID:23358140 PMID:26505656 PMID:28532671 PMID:29126803 More...
|
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ABCG1 mRNA; ochratoxin A results in decreased expression of ABCG1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
affects response to substance increases transport increases expression decreases expression decreases response to substance affects transport decreases transport |
ISO EXP |
ABCG2 protein affects the susceptibility to ochratoxin A ABCG2 protein results in increased transport of ochratoxin A ochratoxin A results in increased expression of ABCG2 mRNA ochratoxin A results in decreased expression of ABCG2 mRNA ABCG2 protein results in decreased susceptibility to ochratoxin A ABCG2 protein affects the transport of ochratoxin A ABCG2 protein results in decreased transport of ochratoxin A |
CTD |
PMID:28532671 PMID:29126803 PMID:32470353 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abcg4 |
ATP binding cassette subfamily G member 4 |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of ABCG4 gene ochratoxin A results in increased expression of ABCG4 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 8:44,611,187...44,629,818
Ensembl chr 8:44,611,187...44,626,881
|
|
G |
Abhd14a |
abhydrolase domain containing 14A |
increases expression |
EXP |
ochratoxin A results in increased expression of ABHD14A mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 8:107,079,139...107,089,004
Ensembl chr 8:107,079,144...107,086,985
|
|
G |
Abhd3 |
abhydrolase domain containing 3, phospholipase |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of ABHD3 mRNA ochratoxin A results in increased methylation of ABHD3 gene |
CTD |
PMID:37162024 |
|
NCBI chr18:1,723,203...1,778,488
Ensembl chr18:1,720,718...1,803,428
|
|
G |
Abi3 |
ABI family, member 3 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ABI3 mRNA; ochratoxin A results in decreased expression of ABI3 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:80,769,819...80,780,816
Ensembl chr10:80,769,822...80,780,816
|
|
G |
Abraxas1 |
abraxas 1, BRCA1 A complex subunit |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ABRAXAS1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr14:8,796,281...8,810,625
Ensembl chr14:8,796,266...8,810,622
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of ACAA1 mRNA ochratoxin A results in decreased expression of ACAA1A mRNA |
CTD |
PMID:12700408 PMID:19287073 |
|
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acp4 |
acid phosphatase 4 |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of ACP4 gene ochratoxin A results in increased expression of ACP4 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 1:94,736,376...94,751,871
Ensembl chr 1:94,735,514...94,744,623
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of ACSL1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Acss1 |
acyl-CoA synthetase short-chain family member 1 |
increases methylation decreases expression |
EXP |
ochratoxin A results in increased methylation of ACSS1 gene ochratoxin A results in decreased expression of ACSS1 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ACSS2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of ACTA2 protein ochratoxin A results in increased expression of ACTA2 mRNA; ochratoxin A results in increased expression of ACTA2 protein 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of ACTA2 protein]; [ochratoxin A co-treated with Citrinin] results in increased expression of ACTA2 mRNA; [ochratoxin A co-treated with Citrinin] results in increased expression of ACTA2 protein; SMAD2 affects the reaction [ochratoxin A results in increased expression of ACTA2 mRNA]; SMAD2 affects the reaction [ochratoxin A results in increased expression of ACTA2 protein]; SMAD3 affects the reaction [ochratoxin A results in increased expression of ACTA2 mRNA]; SMAD3 affects the reaction [ochratoxin A results in increased expression of ACTA2 protein] Ethanol affects the reaction [ochratoxin A results in increased expression of ACTA2 protein] |
CTD |
PMID:16622519 PMID:29673704 PMID:32617660 PMID:33543323 PMID:35543154 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actb |
actin, beta |
increases expression |
ISO |
ochratoxin A results in increased expression of ACTB protein |
CTD |
PMID:31276768 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actn1 |
actinin, alpha 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ACTN1 mRNA; ochratoxin A results in increased expression of ACTN1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
|
|
G |
Acvr2a |
activin A receptor type 2A |
increases expression |
EXP |
ochratoxin A results in increased expression of ACVR2A mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 3:33,204,961...33,292,673
Ensembl chr 3:33,205,523...33,289,968
|
|
G |
Acy1 |
aminoacylase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of ACY1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Adh1c |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ADH1 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Adh6 |
alcohol dehydrogenase 6 (class V) |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ADH6 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 2:226,903,208...226,934,564
Ensembl chr 2:226,903,250...226,934,534
|
|
G |
Adm |
adrenomedullin |
increases expression |
EXP |
ochratoxin A results in increased expression of ADM mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adora2a |
adenosine A2a receptor |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of ADORA2A promoter |
CTD |
PMID:29098329 |
|
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
Afp |
alpha-fetoprotein |
increases expression |
ISO |
ochratoxin A results in increased expression of AFP mRNA |
CTD |
PMID:30008028 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Aggf1 |
angiogenic factor with G patch and FHA domains 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AGGF1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:26,619,336...26,646,050
Ensembl chr 2:26,619,339...26,645,952
|
|
G |
Agt |
angiotensinogen |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AGT mRNA |
CTD |
PMID:16251485 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases expression affects localization multiple interactions |
ISO |
ochratoxin A results in increased expression of AHR mRNA ochratoxin A affects the localization of AHR protein AHR protein affects the reaction [ochratoxin A results in increased expression of GCLC mRNA]; AHR protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA]; AHR protein affects the reaction [ochratoxin A results in increased expression of HMOX1 mRNA]; AHR protein affects the reaction [ochratoxin A results in increased expression of NFE2L2 mRNA] |
CTD |
PMID:21834667 PMID:30291945 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions decreases expression |
ISO |
BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of AIFM1 mRNA] |
CTD |
PMID:24755393 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of AIMP1 mRNA; ochratoxin A results in increased expression of AIMP1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 2:221,151,907...221,175,458
Ensembl chr 2:221,151,904...221,175,728
|
|
G |
Ak1 |
adenylate kinase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of AK1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041
|
|
G |
Ak2 |
adenylate kinase 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of AK2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 5:141,308,650...141,364,633
Ensembl chr 5:141,346,063...141,364,632
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
increases expression |
EXP |
ochratoxin A results in increased expression of AKAP12 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
|
|
G |
Akap17a |
A-kinase anchoring protein 17A |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AKAP17B mRNA |
CTD |
PMID:30449730 |
|
NCBI chr12:16,310,427...16,315,166
Ensembl chr12:16,310,437...16,314,479
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AKR1A1 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
increases expression |
ISO |
ochratoxin A results in increased expression of AKR1B1 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of AKR1B10 mRNA |
CTD |
PMID:18417182 PMID:32905824 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AKR1B7 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 4:63,053,560...63,100,934
Ensembl chr 4:63,076,800...63,089,502
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AKR1C1 mRNA |
CTD |
PMID:19287073 PMID:32905824 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of AKR1C2 mRNA |
CTD |
PMID:19287073 PMID:30449730 PMID:32905824 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AKR1C3 mRNA |
CTD |
PMID:19287073 PMID:32905824 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
multiple interactions decreases expression |
EXP |
[cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of AKR7A3 protein] ochratoxin A results in decreased expression of AKR7A3 mRNA; ochratoxin A results in decreased expression of AKR7A3 protein |
CTD |
PMID:16251485 PMID:17110534 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases expression increases phosphorylation multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of AKT1 mRNA ochratoxin A results in increased phosphorylation of AKT1 protein 5-((2,6-dichlorobenzyl)sulfonyl)-3-((3,5-dimethyl-4-((2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-1,3-dihydro-2H-indol-2-one inhibits the reaction [ochratoxin A results in increased phosphorylation of AKT1 protein]; INS protein inhibits the reaction [ochratoxin A results in decreased phosphorylation of AKT1 protein]; Wortmannin inhibits the reaction [ochratoxin A results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:16251485 PMID:23172667 PMID:25002221 PMID:30287338 PMID:31154016 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alad |
aminolevulinate dehydratase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ALAD mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Alb |
albumin |
affects binding decreases transport |
EXP ISO |
ochratoxin A binds to ALB protein ALB protein results in decreased transport of ochratoxin A |
CTD |
PMID:10454219 PMID:22037670 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ALDH1A1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
increases expression |
EXP |
ochratoxin A results in increased expression of ALDH1A2 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
|
|
G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of ALDH3A2 mRNA ochratoxin A results in decreased expression of ALDH3A2 mRNA |
CTD |
PMID:16251485 PMID:32905824 |
|
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
|
|
G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ALDH4A1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345
|
|
G |
Aldh7a1 |
aldehyde dehydrogenase 7 family, member A1 |
decreases acetylation |
ISO |
ochratoxin A results in decreased acetylation of ALDH7A1 promoter |
CTD |
PMID:29098329 |
|
NCBI chr18:50,003,242...50,042,193
Ensembl chr18:50,009,934...50,042,193
|
|
G |
Aldh8a1 |
aldehyde dehydrogenase 8 family, member A1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ALDH8A1 mRNA; ochratoxin A results in increased expression of ALDH8A1 mRNA |
CTD |
PMID:23824090 PMID:24356939 |
|
NCBI chr 1:16,183,940...16,203,385
Ensembl chr 1:16,183,940...16,203,385
|
|
G |
Alg13 |
ALG13, UDP-N-acetylglucosaminyltransferase subunit |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ALG13 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr X:107,906,320...107,968,232
Ensembl chr X:107,885,093...107,942,695
|
|
G |
Alox15b |
arachidonate 15-lipoxygenase, type B |
increases expression |
EXP |
ochratoxin A results in increased expression of ALOX15B mRNA |
CTD |
PMID:30449730 |
|
NCBI chr10:53,892,496...53,901,812
Ensembl chr10:53,892,466...53,901,812
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
affects expression decreases expression |
ISO |
ochratoxin A affects the expression of ALOX5 mRNA ochratoxin A results in decreased expression of ALOX5 mRNA |
CTD |
PMID:26505656 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases expression |
ISO |
ochratoxin A results in increased expression of ALPL protein |
CTD |
PMID:35543154 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
decreases acetylation affects expression decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of AMIGO2 promoter ochratoxin A affects the expression of AMIGO2 mRNA ochratoxin A results in decreased expression of AMIGO2 mRNA [ochratoxin A results in decreased acetylation of AMIGO2 promoter] which results in decreased expression of AMIGO2 mRNA |
CTD |
PMID:29098329 PMID:30008028 |
|
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
|
|
G |
Amotl2 |
angiomotin like 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AMOTL2 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 8:103,303,368...103,319,161
Ensembl chr 8:103,302,992...103,318,910
|
|
G |
Ang |
angiogenin |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ANG mRNA; ochratoxin A results in decreased expression of ANG mRNA |
CTD |
PMID:26314263 |
|
NCBI chr15:24,312,711...24,323,361
|
|
G |
Angpt1 |
angiopoietin 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of ANGPT1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Ankrd2 |
ankyrin repeat domain 2 |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of ANKRD2 mRNA ochratoxin A results in decreased methylation of ANKRD2 gene |
CTD |
PMID:37162024 |
|
NCBI chr 1:240,847,111...240,856,563
Ensembl chr 1:240,847,072...240,856,566
|
|
G |
Anln |
anillin, actin binding protein |
increases expression |
ISO |
ochratoxin A results in increased expression of ANLN mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
|
|
G |
Ano6 |
anoctamin 6 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of ANO6 gene |
CTD |
PMID:26431795 |
|
NCBI chr 7:126,933,919...127,113,588
Ensembl chr 7:126,933,936...127,113,589
|
|
G |
Anxa1 |
annexin A1 |
increases expression |
EXP |
ochratoxin A results in increased expression of ANXA1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa13 |
annexin A13 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ANXA13 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 7:89,884,356...89,936,907
Ensembl chr 7:89,884,356...89,936,907
|
|
G |
Anxa2 |
annexin A2 |
increases expression |
EXP |
ochratoxin A results in increased expression of ANXA2 mRNA |
CTD |
PMID:12700408 PMID:18417182 |
|
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Anxa3 |
annexin A3 |
increases expression decreases methylation |
EXP ISO |
ochratoxin A results in increased expression of ANXA3 mRNA ochratoxin A results in increased expression of ANXA3 mRNA; ochratoxin A results in increased expression of ANXA3 protein ochratoxin A results in decreased methylation of ANXA3 gene |
CTD |
PMID:18417182 PMID:31276768 PMID:37162024 |
|
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Anxa4 |
annexin A4 |
increases expression |
EXP |
ochratoxin A results in increased expression of ANXA4 protein |
CTD |
PMID:31369848 |
|
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
|
|
G |
Aoc3 |
amine oxidase, copper containing 3 |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of AOC3 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:86,272,757...86,280,702
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression multiple interactions decreases expression |
EXP ISO |
ochratoxin A results in increased expression of APAF1 mRNA [fumonisin B1 co-treated with ochratoxin A] results in increased expression of APAF1 protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of APAF1 mRNA] ochratoxin A results in decreased expression of APAF1 mRNA |
CTD |
PMID:17316727 PMID:19562491 PMID:36397609 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of APEX1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Aplf |
aprataxin and PNKP like factor |
increases expression |
EXP |
ochratoxin A results in increased expression of APLF mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 4:120,070,471...120,122,656
Ensembl chr 4:120,070,471...120,122,633
|
|
G |
Apoa4 |
apolipoprotein A4 |
increases expression |
EXP |
ochratoxin A results in increased expression of APOA4 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Apob |
apolipoprotein B |
decreases expression |
EXP |
ochratoxin A results in decreased expression of APOB mRNA |
CTD |
PMID:16251485 PMID:19717638 |
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Apoc1 |
apolipoprotein C1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of APOC1 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 1:79,347,057...79,350,340
Ensembl chr 1:79,346,136...79,350,375
|
|
G |
Apoe |
apolipoprotein E |
increases expression |
EXP |
ochratoxin A results in increased expression of APOE mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
App |
amyloid beta precursor protein |
increases expression |
ISO |
ochratoxin A results in increased expression of APP mRNA |
CTD |
PMID:30008028 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Appbp2 |
amyloid beta precursor protein binding protein 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of APPBP2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:70,057,774...70,099,877
Ensembl chr10:70,057,774...70,099,835
|
|
G |
Aptx |
aprataxin |
decreases expression |
EXP |
ochratoxin A results in decreased expression of APTX mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:55,798,896...55,822,963
Ensembl chr 5:55,800,248...55,822,855
|
|
G |
Aqp1 |
aquaporin 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AQP1 mRNA |
CTD |
PMID:16251485 PMID:18417182 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Aqp8 |
aquaporin 8 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AQP8 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 1:177,993,313...177,999,158
Ensembl chr 1:177,993,305...177,999,158
|
|
G |
Ar |
androgen receptor |
decreases activity |
ISO |
ochratoxin A results in decreased activity of AR protein |
CTD |
PMID:27481073 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arap2 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of ARAP2 gene |
CTD |
PMID:26431795 |
|
NCBI chr14:46,717,657...46,917,326
Ensembl chr14:46,718,760...46,917,154
|
|
G |
Arfgap2 |
ADP-ribosylation factor GTPase activating protein 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ARFGAP2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:77,236,305...77,248,445
Ensembl chr 3:77,236,322...77,248,455
|
|
G |
Arfgef1 |
ADP ribosylation factor guanine nucleotide exchange factor 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ARFGEF1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 5:8,982,061...9,076,326
Ensembl chr 5:8,981,540...9,076,326
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ARG1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arhgap35 |
Rho GTPase activating protein 35 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ARHGAP35 mRNA; ochratoxin A results in decreased expression of ARHGAP35 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 1:77,202,436...77,319,298
Ensembl chr 1:77,202,436...77,319,298
|
|
G |
Arl4c |
ADP ribosylation factor like GTPase 4C |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ARL4C mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:89,300,335...89,303,770
Ensembl chr 9:89,298,005...89,304,513
|
|
G |
Arl5a |
ADP-ribosylation factor like GTPase 5A |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ARL5A mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:36,878,461...36,903,362
Ensembl chr 3:36,880,712...36,903,211
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ARRDC3 mRNA; ochratoxin A results in decreased expression of ARRDC3 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
|
|
G |
Asb13 |
ankyrin repeat and SOCS box-containing 13 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ASB13 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr17:66,564,653...66,583,365
Ensembl chr17:66,562,434...66,583,337
|
|
G |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of ASCL1 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of ASCL1 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 7:21,903,136...21,906,003
Ensembl chr 7:21,903,126...21,905,993
|
|
G |
Asic1 |
acid sensing ion channel subunit 1 |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of ASIC1 promoter [ochratoxin A results in increased acetylation of ASIC1 promoter] which results in increased expression of ASIC1 mRNA ochratoxin A results in increased expression of ASIC1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:130,798,317...130,828,535
Ensembl chr 7:130,799,917...130,828,541
|
|
G |
Asl |
argininosuccinate lyase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ASL mRNA |
CTD |
PMID:12700408 |
|
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ASNS mRNA; ochratoxin A results in decreased expression of ASNS mRNA |
CTD |
PMID:24356939 PMID:30559759 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Aspa |
aspartoacylase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ASPA mRNA |
CTD |
PMID:12700408 |
|
NCBI chr10:57,891,704...57,945,267
Ensembl chr10:57,892,104...57,945,272
|
|
G |
Asxl1 |
ASXL transcriptional regulator 1 |
multiple interactions decreases acetylation decreases expression |
ISO |
[ochratoxin A results in decreased acetylation of ASXL1 promoter] which results in decreased expression of ASXL1 mRNA ochratoxin A results in decreased expression of ASXL1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:141,814,012...141,881,526
Ensembl chr 3:141,813,433...141,881,538
|
|
G |
Atf3 |
activating transcription factor 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ATF3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf4 |
activating transcription factor 4 |
decreases expression increases expression |
ISO |
ochratoxin A results in decreased expression of ATF4 mRNA ochratoxin A results in increased expression of ATF4 protein |
CTD |
PMID:30559759 PMID:33465424 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
increases expression |
ISO |
ochratoxin A results in increased expression of ATF6 mRNA; ochratoxin A results in increased expression of ATF6 protein |
CTD |
PMID:30559759 PMID:36058351 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atp1a4 |
ATPase Na+/K+ transporting subunit alpha 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ATP1A4 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr13:84,683,766...84,719,790
Ensembl chr13:84,683,768...84,719,687
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ATP1B1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of ATP2A2 mRNA ochratoxin A results in decreased expression of ATP2A2 mRNA |
CTD |
PMID:16251485 PMID:19287073 PMID:22124623 |
|
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Atp2c1 |
ATPase secretory pathway Ca2+ transporting 1 |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of ATP2C1 promoter] which results in increased expression of ATP2C1 mRNA ochratoxin A results in increased expression of ATP2C1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:106,034,777...106,155,854
Ensembl chr 8:106,034,636...106,156,006
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
increases expression |
EXP |
ochratoxin A results in increased expression of ATP5F1A protein |
CTD |
PMID:31369848 |
|
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
increases expression |
ISO |
ochratoxin A results in increased expression of ATP5F1B mRNA ochratoxin A results in increased expression of ATP5F1B protein |
CTD |
PMID:17316727 PMID:19445961 |
|
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
increases expression decreases expression |
ISO EXP |
ochratoxin A results in increased expression of ATP5F1D mRNA ochratoxin A results in decreased expression of ATP5F1D protein |
CTD |
PMID:17316727 PMID:31369848 |
|
NCBI chr 7:9,560,604...9,565,919
Ensembl chr 7:9,560,608...9,565,929
|
|
G |
Atp5pf |
ATP synthase peripheral stalk subunit F6 |
increases expression |
ISO |
ochratoxin A results in increased expression of ATP5PF mRNA |
CTD |
PMID:17316727 |
|
NCBI chr11:23,881,594...23,889,581
Ensembl chr11:23,881,592...23,889,119
|
|
G |
Atp6v0c |
ATPase H+ transporting V0 subunit C |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of ATP6V0C promoter] which results in increased expression of ATP6V0C mRNA ochratoxin A results in increased expression of ATP6V0C mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:13,196,204...13,202,580
Ensembl chr10:13,196,204...13,201,500
|
|
G |
Atp9a |
ATPase phospholipid transporting 9A (putative) |
increases expression |
EXP |
ochratoxin A results in increased expression of ATP9A mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 3:157,360,354...157,467,628
Ensembl chr 3:157,360,359...157,467,818
|
|
G |
Atpaf1 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of ATPAF1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:129,265,789...129,292,463
Ensembl chr 5:129,266,404...129,293,556
|
|
G |
Aurka |
aurora kinase A |
multiple interactions increases expression |
ISO |
TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of AURKA mRNA] |
CTD |
PMID:25636497 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Aurkb |
aurora kinase B |
increases activity increases expression |
EXP |
ochratoxin A results in increased activity of AURKB protein ochratoxin A results in increased expression of AURKB mRNA |
CTD |
PMID:19237604 PMID:19717638 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Avil |
advillin |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of AVIL mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:62,825,459...62,844,103
Ensembl chr 7:62,826,025...62,844,071
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AZGP1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
|
|
G |
Azi2 |
5-azacytidine induced 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of AZI2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:117,773,248...117,797,844
Ensembl chr 8:117,773,279...117,797,847
|
|
G |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
decreases expression increases expression |
ISO EXP |
ochratoxin A results in decreased expression of B3GNT2 mRNA ochratoxin A results in increased expression of B3GNT2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr14:96,808,473...96,833,674
Ensembl chr14:96,806,664...96,835,273
|
|
G |
B4galt7 |
beta-1,4-galactosyltransferase 7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of B4GALT7 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr17:9,018,514...9,027,591
Ensembl chr17:9,018,935...9,027,573
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BAAT mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of BAD mRNA BNIP3L protein inhibits the reaction [ochratoxin A results in increased expression of BAD mRNA] |
CTD |
PMID:19562491 PMID:24755393 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bag3 |
BAG cochaperone 3 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of BAG3 mRNA; [Citrinin co-treated with ochratoxin A] results in increased expression of BAG3 mRNA ochratoxin A results in decreased expression of BAG3 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression multiple interactions decreases expression |
EXP ISO |
ochratoxin A results in increased expression of BAK1 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of BAK1 mRNA ochratoxin A results in decreased expression of BAK1 mRNA; ochratoxin A results in decreased expression of BAK1 protein |
CTD |
PMID:19367635 PMID:23358140 PMID:30428381 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BARD1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression multiple interactions increases expression affects localization increases response to substance |
ISO EXP |
ochratoxin A results in decreased expression of BAX mRNA; ochratoxin A results in decreased expression of BAX protein [fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of BAX mRNA] [Aflatoxin M1 co-treated with ochratoxin A] results in increased expression of BAX protein; BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of BAX mRNA]; Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of BAX protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of BAX protein]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of BAX protein]]; Ursolic Acid inhibits the reaction [ochratoxin A results in increased expression of BAX protein] ochratoxin A affects the localization of BAX protein ochratoxin A results in increased expression of BAX mRNA; ochratoxin A results in increased expression of BAX protein BAX protein results in increased susceptibility to ochratoxin A |
CTD |
PMID:19367635 PMID:20549612 PMID:23208426 PMID:24755393 PMID:31154016 PMID:33465424 PMID:34101318 PMID:34126166 PMID:36397609 PMID:36587836 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
decreases expression increases expression multiple interactions |
ISO EXP |
ochratoxin A results in decreased expression of BBC3 mRNA; ochratoxin A results in decreased expression of BBC3 protein ochratoxin A results in increased expression of BBC3 mRNA [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of BBC3 protein; ochratoxin A promotes the reaction [NFE2L2 protein affects the expression of BBC3 mRNA]; sulforaphane inhibits the reaction [ochratoxin A results in increased expression of BBC3 mRNA] |
CTD |
PMID:19367635 PMID:23208426 PMID:28710020 PMID:30763683 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bbox1 |
gamma-butyrobetaine hydroxylase 1 |
affects expression |
ISO |
ochratoxin A affects the expression of BBOX1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
|
|
G |
Bcam |
basal cell adhesion molecule (Lutheran blood group) |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of BCAM mRNA ochratoxin A results in decreased methylation of BCAM gene |
CTD |
PMID:37162024 |
|
NCBI chr 1:79,415,016...79,429,403
Ensembl chr 1:79,415,017...79,429,403
|
|
G |
Bckdk |
branched chain ketoacid dehydrogenase kinase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BCKDK mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:182,515,335...182,520,007
Ensembl chr 1:182,515,327...182,536,633
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions increases expression decreases response to substance |
EXP ISO |
ochratoxin A results in decreased expression of BCL2 mRNA fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 protein] ochratoxin A results in decreased expression of BCL2 mRNA; ochratoxin A results in decreased expression of BCL2 protein [Aflatoxin M1 co-treated with ochratoxin A] results in decreased expression of BCL2 protein; Oleanolic Acid inhibits the reaction [ochratoxin A results in decreased expression of BCL2 protein]; TRAP1 protein affects the reaction [ochratoxin A results in decreased expression of BCL2 protein]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in decreased expression of BCL2 protein]]; Ursolic Acid inhibits the reaction [ochratoxin A results in decreased expression of BCL2 protein] ochratoxin A results in increased expression of BCL2 mRNA BCL2 protein results in decreased susceptibility to ochratoxin A |
CTD |
PMID:12700408 PMID:20549612 PMID:23208426 PMID:24755393 PMID:33465424 PMID:34101318 PMID:34126166 PMID:36397609 PMID:36587836 More...
|
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
increases expression |
EXP |
ochratoxin A results in increased expression of BCL2A1 mRNA |
CTD |
PMID:19562491 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression increases expression decreases response to substance |
ISO EXP |
ochratoxin A results in decreased expression of BCL2L1 mRNA; ochratoxin A results in decreased expression of BCL2L1 protein ochratoxin A results in increased expression of BCL2L1 mRNA BCL2L1 protein results in decreased susceptibility to ochratoxin A |
CTD |
PMID:15056805 PMID:20549612 PMID:23208426 PMID:24755393 PMID:30763683 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BCL2L11 mRNA |
CTD |
PMID:30559759 PMID:30763683 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl2l12 |
Bcl2 like 12 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of BCL2L12 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of BCL2L12 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:95,472,272...95,480,991
Ensembl chr 1:95,472,272...95,480,991
|
|
G |
Bcl6 |
BCL6, transcription repressor |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BCL6 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Bdh2 |
3-hydroxybutyrate dehydrogenase 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of BDH2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression |
EXP |
ochratoxin A results in increased expression of BDNF mRNA |
CTD |
PMID:27346841 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of BECN1 protein 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in increased expression of BECN1 protein] |
CTD |
PMID:36058351 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bex1 |
brain expressed X-linked 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BEX2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr X:99,219,014...99,220,518
Ensembl chr X:99,219,014...99,220,958
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BHMT mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
Bid |
BH3 interacting domain death agonist |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BID mRNA |
CTD |
PMID:24755393 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Bik |
BCL2-interacting killer |
increases expression |
EXP |
ochratoxin A results in increased expression of BIK mRNA |
CTD |
PMID:23208426 PMID:23358140 |
|
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of BIRC3 mRNA; ochratoxin A results in decreased expression of BIRC3 mRNA |
CTD |
PMID:24356939 PMID:30763683 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of BIRC5 mRNA; ochratoxin A results in increased expression of BIRC5 protein ochratoxin A results in decreased expression of BIRC5 mRNA |
CTD |
PMID:19237604 PMID:19562491 PMID:27193732 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Blcap |
BLCAP, apoptosis inducing factor |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BLCAP mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:146,222,699...146,232,859
Ensembl chr 3:146,222,240...146,232,909
|
|
G |
Blvra |
biliverdin reductase A |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BLVRA mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 3:114,340,778...114,366,048
Ensembl chr 3:114,340,838...114,366,033
|
|
G |
Blvrb |
biliverdin reductase B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BLVRB mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of BMP4 promoter [ochratoxin A results in increased acetylation of BMP4 promoter] which results in increased expression of BMP4 mRNA ochratoxin A results in increased expression of BMP4 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
|
|
G |
Bnip2 |
BCL2 interacting protein 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of BNIP2 mRNA |
CTD |
PMID:19562491 |
|
NCBI chr 8:70,640,436...70,661,782
Ensembl chr 8:70,640,445...70,675,590
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of BNIP3 mRNA |
CTD |
PMID:19562491 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
multiple interactions increases response to substance |
ISO |
BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of AIFM1 mRNA]; BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of BAX mRNA]; BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of SDHA mRNA]; BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of SDHA protein]; BNIP3L protein inhibits the reaction [ochratoxin A results in increased expression of BAD mRNA]; BNIP3L protein promotes the reaction [ochratoxin A results in decreased expression of CASP9 mRNA] BNIP3L protein results in increased susceptibility to ochratoxin A |
CTD |
PMID:24755393 |
|
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
increases expression |
EXP |
ochratoxin A results in increased expression of BRCA1 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brcc3 |
BRCA1/BRCA2-containing complex subunit 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BRCC3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:1,986,942...1,989,484
Ensembl chr 9:1,986,575...1,991,080
|
|
G |
Brd4 |
bromodomain containing 4 |
increases expression |
EXP |
ochratoxin A results in increased expression of BRD4 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:11,216,446...11,296,029
Ensembl chr 7:11,216,446...11,295,539
|
|
G |
Brf1 |
BRF1, RNA polymerase III transcription initiation factor subunit |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BRF1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 6:132,034,378...132,081,313
Ensembl chr 6:132,037,272...132,081,278
|
|
G |
Brip1 |
BRCA1 interacting helicase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of BRIP1 mRNA |
CTD |
PMID:23358140 PMID:24243707 |
|
NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324
|
|
G |
Bsnd |
barttin CLCNK type accessory subunit beta |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of BSND mRNA ochratoxin A results in decreased methylation of BSND gene |
CTD |
PMID:37162024 |
|
NCBI chr 5:121,251,774...121,260,571
Ensembl chr 5:121,251,774...121,260,571
|
|
G |
Btg1 |
BTG anti-proliferation factor 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BTG1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
increases expression |
EXP |
ochratoxin A results in increased expression of BUB1B mRNA |
CTD |
PMID:19237604 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
C1qa |
complement C1q A chain |
affects expression |
EXP |
ochratoxin A affects the expression of C1QA mRNA |
CTD |
PMID:32468156 |
|
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
|
|
G |
C1qb |
complement C1q B chain |
increases expression |
EXP |
ochratoxin A results in increased expression of C1QB mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
|
|
G |
C2h3orf33 |
similar to human chromosome 3 open reading frame 33 |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of C2H3ORF33 mRNA ochratoxin A results in increased methylation of C2H3ORF33 gene |
CTD |
PMID:37162024 |
|
NCBI chr 2:148,376,598...148,404,343
Ensembl chr 2:148,380,581...148,404,387
|
|
G |
C2h5orf34 |
similar to human chromosome 5 open reading frame 34 |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of C2H5ORF34 mRNA ochratoxin A results in increased methylation of C2H5ORF34 gene |
CTD |
PMID:37162024 |
|
NCBI chr 2:51,553,223...51,577,090
Ensembl chr 2:51,555,432...51,577,085
|
|
G |
C8h15orf39 |
similar to human chromosome 15 open reading frame 39 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of C15ORF39 mRNA; ochratoxin A results in decreased expression of C15ORF39 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 8:57,646,324...57,655,896
Ensembl chr 8:57,645,756...57,655,941
|
|
G |
C9 |
complement C9 |
increases expression |
ISO |
ochratoxin A results in increased expression of C9 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338
|
|
G |
Cabp1 |
calcium binding protein 1 |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of CABP1 promoter] which results in increased expression of CABP1 mRNA ochratoxin A results in increased expression of CABP1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr12:41,385,234...41,448,930
Ensembl chr12:41,378,897...41,448,927
|
|
G |
Cacng5 |
calcium voltage-gated channel auxiliary subunit gamma 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CACNG5 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr10:92,827,441...92,869,632
Ensembl chr10:92,829,196...92,869,614
|
|
G |
Calb1 |
calbindin 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CALB1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
|
|
G |
Calm1 |
calmodulin 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of CALM1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
increases expression |
EXP |
ochratoxin A results in increased expression of CAMK2A mRNA |
CTD |
PMID:19237604 |
|
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
increases expression |
EXP |
ochratoxin A results in increased expression of CAMK2B mRNA |
CTD |
PMID:23358140 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Capn6 |
calpain 6 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CAPN6 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:107,380,774...107,405,489
Ensembl chr X:107,380,774...107,405,489
|
|
G |
Capza1 |
capping actin protein of muscle Z-line subunit alpha 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CAPZA1 protein |
CTD |
PMID:31276768 |
|
NCBI chr 2:192,319,696...192,364,755
Ensembl chr 2:192,319,702...192,364,480
|
|
G |
Capzb |
capping actin protein of muscle Z-line subunit beta |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of CAPZB promoter [ochratoxin A results in increased acetylation of CAPZB promoter] which results in increased expression of CAPZB mRNA ochratoxin A results in increased expression of CAPZB mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 5:151,435,600...151,535,409
Ensembl chr 5:151,434,871...151,535,409
|
|
G |
Car10 |
carbonic anhydrase 10 |
increases expression |
ISO |
ochratoxin A results in increased expression of CA10 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:78,055,875...78,556,490
Ensembl chr10:78,054,114...78,555,834
|
|
G |
Casp1 |
caspase 1 |
increases expression increases cleavage |
ISO |
ochratoxin A results in increased expression of CASP1 mRNA ochratoxin A results in increased cleavage of CASP1 protein |
CTD |
PMID:33543323 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
increases expression |
EXP |
ochratoxin A results in increased expression of CASP12 mRNA |
CTD |
PMID:23208426 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp2 |
caspase 2 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CASP2 mRNA ochratoxin A results in decreased expression of CASP2 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
increases cleavage increases expression multiple interactions increases activity decreases expression |
ISO EXP |
ochratoxin A results in increased cleavage of CASP3 protein ochratoxin A results in increased expression of CASP3 mRNA [fumonisin B1 co-treated with ochratoxin A] results in increased cleavage of CASP3 protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP3 mRNA] ochratoxin A results in increased expression of CASP3 protein SLC22A2 protein affects the reaction [ochratoxin A results in increased expression of CASP3 mRNA]; SLC22A2 protein promotes the reaction [ochratoxin A results in increased expression of CASP3 protein] ochratoxin A results in increased expression of CASP3 mRNA; ochratoxin A results in increased expression of CASP3 protein ochratoxin A analog results in increased activity of CASP3 protein; ochratoxin A results in increased activity of CASP3 protein [Aflatoxin M1 co-treated with ochratoxin A] results in increased expression of CASP3 protein; Citrinin inhibits the reaction [ochratoxin A results in increased activity of CASP3 protein]; ochratoxin A results in increased cleavage of and results in increased activity of CASP3 protein; Oleanolic Acid inhibits the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; U 0126 inhibits the reaction [ochratoxin A results in increased activity of CASP3 protein]; Wortmannin promotes the reaction [ochratoxin A results in increased activity of CASP3 protein] ochratoxin A results in decreased expression of CASP3 mRNA |
CTD |
PMID:12700408 PMID:15056805 PMID:17316727 PMID:19367635 PMID:19815060 PMID:20060447 PMID:20549612 PMID:24755393 PMID:25002221 PMID:27193732 PMID:27422291 PMID:29673704 PMID:30120945 PMID:33465424 PMID:34101318 PMID:34126166 PMID:36397609 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
increases expression increases activity multiple interactions decreases expression |
EXP ISO |
ochratoxin A results in increased expression of CASP7 mRNA ochratoxin A results in increased activity of CASP7 protein U 0126 inhibits the reaction [ochratoxin A results in increased activity of CASP7 protein]; wortmannin promotes the reaction [ochratoxin A results in increased activity of CASP7 protein] ochratoxin A results in decreased expression of CASP7 mRNA |
CTD |
PMID:17316727 PMID:19562491 PMID:25002221 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
decreases expression increases activity |
ISO |
ochratoxin A results in decreased expression of CASP8 mRNA ochratoxin A results in increased activity of CASP8 protein |
CTD |
PMID:17316727 PMID:24755393 PMID:27193732 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression decreases expression increases cleavage increases activity |
ISO EXP |
BNIP3L protein promotes the reaction [ochratoxin A results in decreased expression of CASP9 mRNA]; ochratoxin A results in increased cleavage of and results in increased activity of CASP9 protein; Oleanolic Acid inhibits the reaction [ochratoxin A results in increased cleavage of CASP9 protein] ochratoxin A results in increased expression of CASP9 mRNA [fumonisin B1 co-treated with ochratoxin A] results in increased cleavage of CASP9 protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP9 mRNA] ochratoxin A results in increased activity of CASP9 protein |
CTD |
PMID:15056805 PMID:17316727 PMID:19367635 PMID:19562491 PMID:20549612 PMID:24755393 PMID:33465424 PMID:36397609 More...
|
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases expression multiple interactions decreases activity increases expression |
EXP ISO |
ochratoxin A results in decreased expression of CAT mRNA [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of CAT mRNA [Chitosan analog co-treated with Quercetin] inhibits the reaction [ochratoxin A results in decreased activity of CAT protein]; Chitosan analog inhibits the reaction [ochratoxin A results in decreased activity of CAT protein] [fumonisin B1 co-treated with ochratoxin A] results in increased activity of CAT protein; Quercetin inhibits the reaction [ochratoxin A results in decreased activity of CAT protein] ochratoxin A results in increased expression of CAT mRNA |
CTD |
PMID:12700408 PMID:17316727 PMID:25532488 PMID:27923682 PMID:28710020 PMID:37633472 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccdc113 |
coiled-coil domain containing 113 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of CCDC113 gene |
CTD |
PMID:26431795 |
|
NCBI chr19:9,497,000...9,516,917
Ensembl chr19:9,496,886...9,516,923
|
|
G |
Ccdc97 |
coiled-coil domain containing 97 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CCDC97 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:81,219,225...81,227,017
Ensembl chr 1:81,219,230...81,226,986
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
affects expression |
EXP |
ochratoxin A affects the expression of CCL5 mRNA |
CTD |
PMID:32468156 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccn1 |
cellular communication network factor 1 |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of CCN1 mRNA ochratoxin A results in decreased methylation of CCN1 gene |
CTD |
PMID:37162024 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression decreases expression |
EXP |
ochratoxin A results in increased expression of CCN2 mRNA ochratoxin A results in decreased expression of CCN2 mRNA |
CTD |
PMID:19717638 PMID:23358140 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccn4 |
cellular communication network factor 4 |
increases expression |
ISO |
ochratoxin A analog results in increased expression of CCN4 mRNA; ochratoxin A results in increased expression of CCN4 mRNA |
CTD |
PMID:27422291 |
|
NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248
|
|
G |
Ccna2 |
cyclin A2 |
increases expression decreases expression multiple interactions decreases acetylation |
EXP ISO |
ochratoxin A results in increased expression of CCNA2 mRNA ochratoxin A results in decreased expression of CCNA2 mRNA [ochratoxin A results in decreased acetylation of CCNA2 promoter] which results in decreased expression of CCNA2 mRNA |
CTD |
PMID:18417182 PMID:19237604 PMID:23358140 PMID:24243707 PMID:29098329 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions increases expression decreases expression |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of CCNB1 protein]; 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in decreased expression of CCNB1 protein]; [Citrinin co-treated with ochratoxin A] results in decreased expression of CCNB1 mRNA; MAPK1 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CCNB1 protein]; MAPK14 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CCNB1 protein]; ochratoxin A inhibits the reaction [CCNB1 protein binds to CDK1 protein]; ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]; SB 203580 inhibits the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of CCNB1 protein] ochratoxin A results in increased expression of CCNB1 mRNA ochratoxin A results in decreased expression of CCNB1 mRNA; ochratoxin A results in decreased expression of CCNB1 protein |
CTD |
PMID:19237604 PMID:19717638 PMID:20060447 PMID:22230261 PMID:23358140 PMID:30428381 PMID:36058351 More...
|
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb2 |
cyclin B2 |
increases expression |
EXP |
ochratoxin A results in increased expression of CCNB2 mRNA |
CTD |
PMID:19237604 PMID:19717638 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions increases expression |
ISO |
ochratoxin A promotes the reaction [FOS protein binds to CCND1 promoter]; ochratoxin A promotes the reaction [RELA protein binds to CCND1 promoter] ochratoxin A results in increased expression of CCND1 mRNA; ochratoxin A results in increased expression of CCND1 protein |
CTD |
PMID:23172667 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of CCND2 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of CCND2 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccne1 |
cyclin E1 |
increases expression multiple interactions decreases expression |
EXP ISO |
ochratoxin A results in increased expression of CCNE1 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CCNE1 mRNA ochratoxin A results in decreased expression of CCNE1 mRNA TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of CCNE1 mRNA] |
CTD |
PMID:19237604 PMID:23358140 PMID:25636497 PMID:30428381 PMID:31154016 PMID:37162024 More...
|
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccne2 |
cyclin E2 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of CCNE2 mRNA ochratoxin A results in decreased expression of CCNE2 mRNA |
CTD |
PMID:19237604 PMID:30763683 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Ccng1 |
cyclin G1 |
decreases expression multiple interactions increases expression |
ISO EXP |
ochratoxin A results in decreased expression of CCNG1 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CCNG1 mRNA; [Citrinin co-treated with ochratoxin A] results in decreased expression of CCNG1 protein ochratoxin A results in increased expression of CCNG1 mRNA |
CTD |
PMID:19287073 PMID:23358140 PMID:30428381 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Ccng2 |
cyclin G2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CCNG2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Cct8 |
chaperonin containing TCP1 subunit 8 |
affects expression |
ISO |
ochratoxin A affects the expression of CCT8 protein |
CTD |
PMID:26861962 |
|
NCBI chr11:26,710,370...26,722,079
Ensembl chr11:26,710,370...26,722,079
|
|
G |
Cd22 |
CD22 molecule |
increases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in increased expression of CD22 mRNA ochratoxin A results in increased acetylation of CD22 promoter [ochratoxin A results in increased acetylation of CD22 promoter] which results in increased expression of CD22 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:86,116,376...86,132,782
Ensembl chr 1:86,117,459...86,132,322
|
|
G |
Cd24 |
CD24 molecule |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CD24 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
|
|
G |
Cd2bp2 |
Cd2 (cytoplasmic tail) binding protein 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CD2BP2 mRNA |
CTD |
PMID:19287073 PMID:22124623 |
|
NCBI chr 1:181,809,399...181,815,269
Ensembl chr 1:181,809,406...181,813,448
|
|
G |
Cd44 |
CD44 molecule |
increases expression |
EXP |
ochratoxin A results in increased expression of CD44 mRNA |
CTD |
PMID:23358140 PMID:37162024 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd69 |
Cd69 molecule |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CD69 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
|
|
G |
Cd74 |
CD74 molecule |
increases expression |
EXP |
ochratoxin A results in increased expression of CD74 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cd81 |
Cd81 molecule |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of CD81 promoter ochratoxin A results in increased expression of CD81 mRNA [ochratoxin A results in increased acetylation of CD81 promoter] which results in increased expression of CD81 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
|
|
G |
Cd86 |
CD86 molecule |
increases expression |
EXP |
ochratoxin A results in increased expression of CD86 mRNA |
CTD |
PMID:24792326 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdc20 |
cell division cycle 20 |
increases expression |
EXP |
ochratoxin A results in increased expression of CDC20 mRNA |
CTD |
PMID:19237604 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc23 |
cell division cycle 23 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of CDC23 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC23 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr18:26,236,891...26,260,611
Ensembl chr18:26,236,890...26,291,163
|
|
G |
Cdc25a |
cell division cycle 25A |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of CDC25A mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC25A mRNA |
CTD |
PMID:30428381 PMID:30763683 |
|
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
|
|
G |
Cdc25c |
cell division cycle 25C |
multiple interactions decreases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein modified form]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein]; 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein]; [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC25C mRNA; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein modified form]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein modified form]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein modified form]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein] ochratoxin A results in decreased expression of CDC25C mRNA; ochratoxin A results in decreased expression of CDC25C protein; ochratoxin A results in decreased expression of CDC25C protein modified form |
CTD |
PMID:20060447 PMID:22230261 PMID:30428381 PMID:36058351 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdc26 |
cell division cycle 26 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC26 mRNA ochratoxin A results in decreased expression of CDC26 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 5:75,844,852...75,859,830
|
|
G |
Cdc34 |
cell division cycle 34, ubiqiutin conjugating enzyme |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of CDC34 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC34 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 7:10,017,588...10,023,586
Ensembl chr 7:10,017,588...10,023,186
|
|
G |
Cdc42ep1 |
CDC42 effector protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of CDC42EP1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 7:110,395,287...110,403,203
Ensembl chr 7:110,395,332...110,403,200
|
|
G |
Cdc42se1 |
CDC42 small effector 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of CDC42SE1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 2:182,805,691...182,813,520
Ensembl chr 2:182,804,925...182,814,028
|
|
G |
Cdc6 |
cell division cycle 6 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC6 mRNA ochratoxin A results in decreased expression of CDC6 mRNA |
CTD |
PMID:30428381 PMID:30763683 |
|
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
|
|
G |
Cdc7 |
cell division cycle 7 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of CDC7 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC7 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr14:2,804,660...2,824,796
Ensembl chr14:2,804,661...2,824,778
|
|
G |
Cdh1 |
cadherin 1 |
decreases expression multiple interactions |
EXP ISO |
ochratoxin A results in decreased expression of CDH1 mRNA ochratoxin A results in decreased expression of CDH1 mRNA; ochratoxin A results in decreased expression of CDH1 protein 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in decreased expression of CDH1 protein]; [Citrinin co-treated with ochratoxin A] results in decreased expression of CDH1 mRNA; [ochratoxin A co-treated with Citrinin] results in decreased expression of CDH1 protein |
CTD |
PMID:16857307 PMID:29673704 PMID:32617660 PMID:35543154 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions increases expression decreases expression |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein modified form]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein]; 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein]; [Citrinin co-treated with ochratoxin A] results in decreased expression of CDK1 mRNA; MAPK1 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein modified form]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein]; MAPK14 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein modified form]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein]; ochratoxin A inhibits the reaction [CCNB1 protein binds to CDK1 protein]; ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]; SB 203580 inhibits the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein modified form]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein] SLC22A2 protein affects the reaction [ochratoxin A results in increased expression of CDK1 protein] ochratoxin A results in increased expression of CDK1 mRNA; ochratoxin A results in increased expression of CDK1 protein TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of CDK1 mRNA] ochratoxin A results in decreased expression of CDK1 mRNA; ochratoxin A results in decreased expression of CDK1 protein; ochratoxin A results in decreased expression of CDK1 protein modified form |
CTD |
PMID:19237604 PMID:19717638 PMID:20060447 PMID:22230261 PMID:24243707 PMID:25636497 PMID:30120945 PMID:30428381 PMID:36058351 More...
|
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk10 |
cyclin-dependent kinase 10 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDK10 mRNA ochratoxin A results in decreased expression of CDK10 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
|
|
G |
Cdk14 |
cyclin-dependent kinase 14 |
decreases expression multiple interactions decreases acetylation |
ISO |
ochratoxin A results in decreased expression of CDK14 mRNA [ochratoxin A results in decreased acetylation of CDK14 promoter] which results in decreased expression of CDK14 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 4:28,666,416...29,258,865
Ensembl chr 4:28,666,843...29,258,861
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of CDK2 mRNA ochratoxin A results in decreased expression of CDK2 protein |
CTD |
PMID:23358140 PMID:28286205 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CDK4 mRNA |
CTD |
PMID:31154016 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk5r1 |
cyclin-dependent kinase 5 regulatory subunit 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of CDK5R1 mRNA; ochratoxin A results in decreased expression of CDK5R1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression decreases methylation increases expression multiple interactions |
ISO EXP |
ochratoxin A results in decreased expression of CDKN1A mRNA; ochratoxin A results in decreased expression of CDKN1A protein ochratoxin A results in decreased methylation of CDKN1A gene ochratoxin A results in increased expression of CDKN1A mRNA TRP53 gene mutant form inhibits the reaction [ochratoxin A results in increased expression of CDKN1A mRNA] ochratoxin A results in increased expression of CDKN1A mRNA; ochratoxin A results in increased expression of CDKN1A protein |
CTD |
PMID:16251485 PMID:17316727 PMID:18417182 PMID:19237604 PMID:19367635 PMID:23208426 PMID:23358140 PMID:25636497 PMID:28710020 PMID:30008028 PMID:30559759 PMID:30763683 PMID:32910239 PMID:37162024 More...
|
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions decreases expression increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDKN1B mRNA; [Citrinin co-treated with ochratoxin A] results in increased expression of CDKN1B mRNA ochratoxin A results in decreased expression of CDKN1B mRNA ochratoxin A results in increased expression of CDKN1B mRNA |
CTD |
PMID:30428381 PMID:30763683 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
increases expression |
ISO |
ochratoxin A results in increased expression of CDKN2A protein |
CTD |
PMID:28286205 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
decreases acetylation decreases expression |
ISO |
ochratoxin A results in decreased acetylation of CDKN2B promoter ochratoxin A results in decreased expression of CDKN2B mRNA |
CTD |
PMID:29098329 PMID:30763683 |
|
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CDO1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CEBPA |
CTD |
PMID:20590410 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
decreases expression |
ISO EXP |
ochratoxin A metabolite results in decreased expression of CEBPB mRNA; ochratoxin A results in decreased expression of CEBPB mRNA |
CTD |
PMID:19287073 PMID:23358140 PMID:24356939 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpg |
CCAAT/enhancer binding protein gamma |
increases expression |
EXP |
ochratoxin A results in increased expression of CEBPG mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
|
|
G |
Cebpz |
CCAAT/enhancer binding protein zeta |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CEBPZ mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 6:16,119,871...16,137,600
Ensembl chr 6:16,119,872...16,137,600
|
|
G |
Cenps |
centromere protein S |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of CENPS gene |
CTD |
PMID:26431795 |
|
NCBI chr 5:159,563,917...159,573,534
|
|
G |
Cep55 |
centrosomal protein 55 |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of CEP55 promoter [ochratoxin A results in decreased acetylation of CEP55 promoter] which results in decreased expression of CEP55 mRNA ochratoxin A results in decreased expression of CEP55 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394
|
|
G |
Ces1d |
carboxylesterase 1D |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CES1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Ces3a |
carboxylesterase 3a |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CES3 mRNA |
CTD |
PMID:16251485 PMID:17483316 |
|
NCBI chr19:32,992,386...33,000,562
|
|
G |
Cfap53 |
cilia and flagella associated protein 53 |
decreases acetylation |
ISO |
ochratoxin A results in decreased acetylation of CFAP53 promoter |
CTD |
PMID:29098329 |
|
NCBI chr18:67,884,651...67,955,873
Ensembl chr18:67,869,855...67,952,318
|
|
G |
Cfap95 |
cilia and flagella associated protein 95 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of CFAP95 gene |
CTD |
PMID:26431795 |
|
NCBI chr 1:221,123,786...221,242,963
Ensembl chr 1:221,131,813...221,242,963
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CFLAR mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
affects expression decreases expression |
ISO |
ochratoxin A affects the expression of CHAC1 mRNA ochratoxin A metabolite results in decreased expression of CHAC1 mRNA |
CTD |
PMID:23824090 PMID:24356939 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Chd1l |
chromodomain helicase DNA binding protein 1-like |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CHD1L mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:185,138,526...185,217,498
Ensembl chr 2:185,139,308...185,217,595
|
|
G |
Chd8 |
chromodomain helicase DNA binding protein 8 |
increases expression |
EXP |
ochratoxin A results in increased expression of CHD8 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr15:24,905,789...24,965,461
Ensembl chr15:24,905,789...24,951,285
|
|
G |
Chek1 |
checkpoint kinase 1 |
increases expression decreases acetylation |
EXP ISO |
ochratoxin A results in increased expression of CHEK1 mRNA ochratoxin A results in decreased acetylation of CHEK1 promoter |
CTD |
PMID:19237604 PMID:23358140 PMID:24243707 PMID:29098329 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chka |
choline kinase alpha |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CHKA mRNA |
CTD |
PMID:32910239 |
|
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
|
|
G |
Chmp7 |
charged multivesicular body protein 7 |
decreases acetylation |
ISO |
ochratoxin A results in decreased acetylation of CHMP7 promoter |
CTD |
PMID:29098329 |
|
NCBI chr15:44,790,983...44,806,216
Ensembl chr15:44,790,996...44,806,216
|
|
G |
Chrd |
chordin |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CHRD mRNA |
CTD |
PMID:18417182 |
|
NCBI chr11:80,171,994...80,181,166
Ensembl chr11:80,171,994...80,180,673
|
|
G |
Chrna10 |
cholinergic receptor nicotinic alpha 10 subunit |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of CHRNA10 gene ochratoxin A results in increased expression of CHRNA10 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 1:156,487,279...156,494,277
Ensembl chr 1:156,487,279...156,491,476
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CHRNB2 mRNA |
CTD |
PMID:27346841 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Chrne |
cholinergic receptor nicotinic epsilon subunit |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CHRNE mRNA |
CTD |
PMID:12700408 |
|
NCBI chr10:55,331,211...55,339,923
Ensembl chr10:55,331,212...55,335,530
|
|
G |
Cib1 |
calcium and integrin binding 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CIB1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:134,178,331...134,183,895
Ensembl chr 1:134,178,331...134,213,423
|
|
G |
Cideb |
cell death-inducing DFFA-like effector b |
increases expression |
EXP |
ochratoxin A results in increased expression of CIDEB mRNA |
CTD |
PMID:19562491 |
|
NCBI chr15:29,252,208...29,256,482
Ensembl chr15:29,252,213...29,256,605
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CIDEC mRNA |
CTD |
PMID:18417182 PMID:30449730 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Cirbp |
cold inducible RNA binding protein |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of CIRBP mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
|
|
G |
Cisd2 |
CDGSH iron sulfur domain 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of CISD2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:223,828,937...223,853,768
Ensembl chr 2:223,828,937...223,868,946
|
|
G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
increases expression |
EXP |
ochratoxin A results in increased expression of CKS1B mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of CKS2 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr17:13,570,611...13,575,770
|
|
G |
Clasp2 |
cytoplasmic linker associated protein 2 |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of CLASP2 promoter [ochratoxin A results in decreased acetylation of CLASP2 promoter] which results in decreased expression of CLASP2 mRNA ochratoxin A results in decreased expression of CLASP2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:113,677,345...113,859,957
Ensembl chr 8:113,677,284...113,858,731
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CLCF1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
|
|
G |
Cldn1 |
claudin 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CLDN1 protein |
CTD |
PMID:30763683 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn2 |
claudin 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CLDN2 mRNA |
CTD |
PMID:28710020 PMID:30008028 |
|
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Cldn23 |
claudin 23 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CLDN23 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr16:56,413,677...56,415,401
Ensembl chr16:56,413,381...56,415,523
|
|
G |
Cldn3 |
claudin 3 |
multiple interactions decreases expression |
ISO |
illite affects the reaction [ochratoxin A results in decreased expression of CLDN3 mRNA] [ochratoxin A results in increased susceptibility to Antigens] which results in decreased expression of CLDN3 mRNA |
CTD |
PMID:27153755 PMID:28935500 |
|
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
|
|
G |
Cldn4 |
claudin 4 |
multiple interactions decreases expression |
ISO |
illite affects the reaction [ochratoxin A results in decreased expression of CLDN4 mRNA] |
CTD |
PMID:27153755 PMID:30763683 |
|
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
|
|
G |
Cldnd1 |
claudin domain containing 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of CLDND1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr11:41,883,120...41,889,471
Ensembl chr11:41,883,134...41,889,354
|
|
G |
Clic4 |
chloride intracellular channel 4 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of CLIC4 mRNA; ochratoxin A results in increased expression of CLIC4 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 5:147,453,702...147,513,455
Ensembl chr 5:147,453,712...147,513,452
|
|
G |
Clip2 |
CAP-GLY domain containing linker protein 2 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of CLIP2 promoter |
CTD |
PMID:29098329 |
|
NCBI chr12:22,163,044...22,227,023
Ensembl chr12:22,163,218...22,227,023
|
|
G |
Clpx |
caseinolytic mitochondrial matrix peptidase chaperone subunit X |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of CLPX mRNA ochratoxin A results in increased methylation of CLPX gene |
CTD |
PMID:37162024 |
|
NCBI chr 8:65,805,460...65,845,643
Ensembl chr 8:65,805,511...65,845,082
|
|
G |
Clu |
clusterin |
increases expression |
EXP |
ochratoxin A results in increased expression of CLU mRNA; ochratoxin A results in increased expression of CLU protein |
CTD |
PMID:12700408 PMID:18308701 PMID:23358140 PMID:25218026 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cmpk1 |
cytidine/uridine monophosphate kinase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CMPK1 protein |
CTD |
PMID:19445961 |
|
NCBI chr 5:128,480,301...128,507,830
Ensembl chr 5:128,480,301...128,507,830
|
|
G |
Cmtm8 |
CKLF-like MARVEL transmembrane domain containing 8 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of CMTM8 promoter |
CTD |
PMID:29098329 |
|
NCBI chr 8:114,481,730...114,547,107
Ensembl chr 8:114,481,982...114,547,083
|
|
G |
Cndp1 |
carnosine dipeptidase 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CNDP1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr18:77,984,886...78,030,837
Ensembl chr18:77,984,907...78,007,765
|
|
G |
Cnn3 |
calponin 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CNN3 protein |
CTD |
PMID:19445961 |
|
NCBI chr 2:209,518,948...209,550,107
Ensembl chr 2:209,518,948...209,550,104
|
|
G |
Cnot2 |
CCR4-NOT transcription complex, subunit 2 |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of CNOT2 promoter [ochratoxin A results in decreased acetylation of CNOT2 promoter] which results in decreased expression of CNOT2 mRNA ochratoxin A results in decreased expression of CNOT2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:52,130,445...52,222,338
Ensembl chr 7:52,130,441...52,223,575
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CNR1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Cntf |
ciliary neurotrophic factor |
increases expression |
EXP |
ochratoxin A results in increased expression of CNTF mRNA |
CTD |
PMID:12700408 PMID:18417182 |
|
NCBI chr 1:209,887,854...209,889,877
Ensembl chr 1:209,887,854...209,889,877
|
|
G |
Cntn4 |
contactin 4 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of CNTN4 mRNA; ochratoxin A results in decreased expression of CNTN4 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 4:138,624,584...139,622,499
Ensembl chr 4:139,099,152...139,621,090
|
|
G |
Cntnap4 |
contactin associated protein family member 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CNTNAP4 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr19:40,568,684...40,861,879
Ensembl chr19:40,568,684...40,854,656
|
|
G |
Coch |
cochlin |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of COCH promoter [ochratoxin A results in increased acetylation of COCH promoter] which results in increased expression of COCH mRNA ochratoxin A results in increased expression of COCH mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 6:69,031,139...69,045,124
Ensembl chr 6:69,031,167...69,045,109
|
|
G |
Col17a1 |
collagen type XVII alpha 1 chain |
decreases expression |
EXP |
ochratoxin A results in decreased expression of COL17A1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 1:246,530,589...246,577,559
Ensembl chr 1:246,531,367...246,577,632
|
|
G |
Col24a1 |
collagen type XXIV alpha 1 chain |
decreases expression |
EXP |
ochratoxin A results in decreased expression of COL24A1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 2:234,212,256...234,469,445
Ensembl chr 2:234,212,324...234,469,441
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
decreases expression |
EXP |
ochratoxin A results in decreased expression of COL2A1 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of COL3A1 mRNA; [Citrinin co-treated with ochratoxin A] results in increased expression of and results in increased secretion of COL3A1 protein |
CTD |
PMID:29673704 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of COL6A1 promoter [ochratoxin A results in increased acetylation of COL6A1 promoter] which results in increased expression of COL6A1 mRNA ochratoxin A results in increased expression of COL6A1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
|
|
G |
Col6a5 |
collagen type VI alpha 5 chain |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of COL6A5 gene |
CTD |
PMID:26431795 |
|
NCBI chr 8:106,483,806...106,584,114
Ensembl chr 8:106,483,799...106,584,113
|
|
G |
Commd10 |
COMM domain containing 10 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of COMMD10 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr18:39,741,219...39,874,801
Ensembl chr18:39,741,298...39,874,903
|
|
G |
Commd2 |
COMM domain containing 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of COMMD2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:141,848,661...141,852,907
Ensembl chr 2:141,848,680...141,852,888
|
|
G |
Commd5 |
COMM domain containing 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of COMMD5 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 7:108,621,766...108,623,616
Ensembl chr 7:108,598,673...108,624,764
|
|
G |
Copg2 |
COPI coat complex subunit gamma 2 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of COPG2 gene |
CTD |
PMID:26431795 |
|
NCBI chr 4:59,366,086...59,501,591
Ensembl chr 4:59,366,086...59,501,618
|
|
G |
Copz2 |
COPI coat complex subunit zeta 2 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of COPZ2 promoter] which results in increased expression of COPZ2 mRNA ochratoxin A results in increased expression of COPZ2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:81,832,441...81,845,514
Ensembl chr10:81,832,418...81,845,514
|
|
G |
Coq7 |
coenzyme Q7, hydroxylase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of COQ7 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 1:172,836,359...172,851,173
Ensembl chr 1:172,835,188...172,851,158
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of COTL1 protein |
CTD |
PMID:31369848 |
|
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
|
|
G |
Cox5b |
cytochrome c oxidase subunit 5B |
increases expression decreases expression |
ISO EXP |
ochratoxin A results in increased expression of COX5B mRNA ochratoxin A results in decreased expression of COX5B protein |
CTD |
PMID:17316727 PMID:31369848 |
|
NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052
|
|
G |
Cox7a2l |
cytochrome c oxidase subunit 7A2 like |
increases expression |
ISO |
ochratoxin A results in increased expression of COX7A2L mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 6:11,184,064...11,198,287
Ensembl chr 6:11,184,285...11,198,273
|
|
G |
Cox7c |
cytochrome c oxidase subunit 7C |
increases expression |
ISO |
ochratoxin A results in increased expression of COX7C protein |
CTD |
PMID:26861962 |
|
NCBI chr 2:16,841,771...16,843,796
Ensembl chr 2:16,840,837...16,843,760
|
|
G |
Cox8a |
cytochrome c oxidase subunit 8A |
increases expression |
ISO |
ochratoxin A results in increased expression of COX8A mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 1:204,402,118...204,404,439
|
|
G |
Cp |
ceruloplasmin |
increases expression |
EXP |
ochratoxin A results in increased expression of CP mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cpne4 |
copine 4 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of CPNE4 gene |
CTD |
PMID:26431795 |
|
NCBI chr 8:105,177,376...105,653,075
Ensembl chr 8:105,177,376...105,653,068
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of CPS1 protein |
CTD |
PMID:26861962 |
|
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of CRHR1 promoter] which results in increased expression of CRHR1 mRNA ochratoxin A results in increased expression of CRHR1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:89,040,186...89,083,481
Ensembl chr10:89,040,203...89,083,481
|
|
G |
Crlf1 |
cytokine receptor-like factor 1 |
increases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in increased expression of CRLF1 mRNA ochratoxin A results in increased acetylation of CRLF1 promoter [ochratoxin A results in increased acetylation of CRLF1 promoter] which results in increased expression of CRLF1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr16:18,924,722...18,936,049
Ensembl chr16:18,924,722...18,935,997
|
|
G |
Cry2 |
cryptochrome circadian regulator 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of CRY2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965
|
|
G |
Cryab |
crystallin, alpha B |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CRYAB mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
|
|
G |
Crygd |
crystallin, gamma D |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CRYGD mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:66,442,057...66,443,668
Ensembl chr 9:66,442,054...66,444,067
|
|
G |
Crym |
crystallin, mu |
decreases expression increases expression |
EXP |
ochratoxin A results in decreased expression of CRYM mRNA; ochratoxin A results in decreased expression of CRYM protein ochratoxin A results in increased expression of CRYM protein |
CTD |
PMID:12700408 PMID:18417182 PMID:31369848 |
|
NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633
|
|
G |
Cs |
citrate synthase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CS protein |
CTD |
PMID:26861962 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Csdc2 |
cold shock domain containing C2 |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of CSDC2 gene ochratoxin A results in increased expression of CSDC2 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 7:113,451,998...113,466,464
Ensembl chr 7:113,451,998...113,466,463
|
|
G |
Csnk2a1 |
casein kinase 2 alpha 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CSNK2A1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
multiple interactions decreases expression |
EXP |
SHH protein inhibits the reaction [ochratoxin A results in decreased expression of CSPG4 mRNA] |
CTD |
PMID:24792326 |
|
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
|
|
G |
Csrp2 |
cysteine and glycine-rich protein 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CSRP2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:46,349,109...46,367,743
Ensembl chr 7:46,348,686...46,367,745
|
|
G |
Cst3 |
cystatin C |
increases expression |
EXP |
ochratoxin A results in increased expression of CST3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
|
|
G |
Csta |
cystatin A |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of CSTA mRNA |
CTD |
PMID:24356939 |
|
NCBI chr11:64,620,483...64,631,488
Ensembl chr11:64,620,483...64,631,488
|
|
G |
Cstf3 |
cleavage stimulation factor subunit 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of CSTF3 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 3:90,966,415...91,037,669
Ensembl chr 3:90,966,354...91,042,196
|
|
G |
Ctbs |
chitobiase |
increases expression |
ISO |
ochratoxin A results in increased expression of CTBS mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:235,340,520...235,355,091
Ensembl chr 2:235,340,547...235,355,091
|
|
G |
Cth |
cystathionine gamma-lyase |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of CTH mRNA |
CTD |
PMID:23358140 PMID:30559759 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctnna1 |
catenin alpha 1 |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of CTNNA1 mRNA ochratoxin A metabolite results in increased expression of CTNNA1 mRNA; ochratoxin A results in increased expression of CTNNA1 mRNA |
CTD |
PMID:22124623 PMID:26314263 |
|
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
|
|
G |
Ctnnb1 |
catenin beta 1 |
increases expression multiple interactions |
ISO EXP |
ochratoxin A metabolite results in increased expression of CTNNB1 mRNA; ochratoxin A results in increased expression of CTNNB1 mRNA ochratoxin A results in increased expression of and affects the localization of CTNNB1 protein ochratoxin A results in increased expression of CTNNB1 protein |
CTD |
PMID:26314263 PMID:31369848 PMID:32617660 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctnnd1 |
catenin delta 1 |
decreases expression multiple interactions decreases acetylation |
ISO |
ochratoxin A results in decreased expression of CTNND1 mRNA [ochratoxin A results in decreased acetylation of CTNND1 promoter] which results in decreased expression of CTNND1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:69,683,328...69,734,550
Ensembl chr 3:69,683,313...69,734,516
|
|
G |
Ctsa |
cathepsin A |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CTSA protein |
CTD |
PMID:31369848 |
|
NCBI chr 3:153,569,106...153,574,983
Ensembl chr 3:153,568,381...153,576,215
|
|
G |
Ctsk |
cathepsin K |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CTSK mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
|
|
G |
Cubn |
cubilin |
decreases acetylation |
ISO |
ochratoxin A results in decreased acetylation of CUBN promoter |
CTD |
PMID:29098329 |
|
NCBI chr17:76,385,046...76,593,133
Ensembl chr17:76,385,060...76,593,231
|
|
G |
Cul2 |
cullin 2 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of CUL2 gene |
CTD |
PMID:26431795 |
|
NCBI chr17:54,169,093...54,210,197
Ensembl chr17:54,169,086...54,209,968
|
|
G |
Cul7 |
cullin 7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CUL7 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 9:14,319,102...14,333,035
Ensembl chr 9:14,319,108...14,332,741
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of CX3CR1 mRNA; ochratoxin A results in increased expression of CX3CR1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of CXCR4 mRNA ochratoxin A metabolite results in decreased expression of CXCR4 mRNA; ochratoxin A results in decreased expression of CXCR4 mRNA |
CTD |
PMID:19717638 PMID:26314263 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyb5r3 |
cytochrome b5 reductase 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CYB5R3 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
|
|
G |
Cyb5r4 |
cytochrome b5 reductase 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYB5R4 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 8:87,975,596...88,048,356
Ensembl chr 8:87,981,116...88,045,832
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
increases expression multiple interactions increases acetylation |
ISO EXP |
ochratoxin A results in increased expression of CYBA mRNA [ochratoxin A results in increased acetylation of CYBA promoter] which results in increased expression of CYBA mRNA |
CTD |
PMID:17316727 PMID:23358140 PMID:29098329 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cybb |
cytochrome b-245 beta chain |
increases expression |
EXP |
ochratoxin A results in increased expression of CYBB mRNA |
CTD |
PMID:23358140 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cycs |
cytochrome c, somatic |
affects localization multiple interactions increases expression decreases expression |
ISO EXP |
ochratoxin A affects the localization of CYCS protein fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CYCS mRNA] Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of CYCS protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of CYCS protein] ochratoxin A results in decreased expression of CYCS mRNA |
CTD |
PMID:20549612 PMID:23358140 PMID:33465424 PMID:36397609 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cygb |
cytoglobin |
increases expression |
EXP |
ochratoxin A results in increased expression of CYGB mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of CYP19A1 protein |
CTD |
PMID:23296098 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases expression increases expression increases response to substance |
EXP ISO |
ochratoxin A results in decreased expression of CYP1A1 mRNA ochratoxin A results in increased expression of CYP1A1 mRNA; ochratoxin A results in increased expression of CYP1A1 protein CYP1A1 protein results in increased susceptibility to ochratoxin A |
CTD |
PMID:8542584 PMID:17316727 PMID:19717638 PMID:21781659 PMID:21834667 PMID:26505656 PMID:30291945 More...
|
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression increases response to substance |
ISO |
ochratoxin A results in increased expression of CYP1A2 mRNA; ochratoxin A results in increased expression of CYP1A2 protein CYP1A2 protein results in increased susceptibility to ochratoxin A |
CTD |
PMID:8542584 PMID:11189750 PMID:21781659 PMID:21834667 PMID:30291945 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP24A1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
decreases expression increases expression |
ISO |
ochratoxin A results in decreased expression of CYP2B6 mRNA ochratoxin A results in increased expression of CYP2B6 mRNA |
CTD |
PMID:21834667 PMID:26505656 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
decreases expression affects methylation increases expression |
EXP |
ochratoxin A results in decreased expression of CYP2C mRNA; ochratoxin A results in decreased expression of CYP2C11 mRNA ochratoxin A affects the methylation of CYP2C11 promoter ochratoxin A results in increased expression of CYP2C mRNA |
CTD |
PMID:16251485 PMID:18417182 PMID:30449730 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2c13 |
cytochrome P450, family 2, subfamily c, polypeptide 13 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2C13 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 1:238,786,764...238,867,195
Ensembl chr 1:238,786,765...238,867,191
|
|
G |
Cyp2d1 |
cytochrome P450, family 2, subfamily d, polypeptide 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2D1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 7:113,908,950...113,913,420
Ensembl chr 7:113,908,947...113,922,084
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2D4 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2d5 |
cytochrome P450, family 2, subfamily d, polypeptide 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2D5 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 7:113,899,905...113,904,458
Ensembl chr 7:113,899,890...113,904,495
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases response to substance |
ISO |
CYP2E1 protein results in increased susceptibility to ochratoxin A |
CTD |
PMID:11189750 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2F4 mRNA |
CTD |
PMID:17483316 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2J4 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp39a1 |
cytochrome P450, family 39, subfamily a, polypeptide 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of CYP39A1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:17,230,455...17,306,775
Ensembl chr 9:17,230,455...17,306,775
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases expression increases expression multiple interactions increases response to substance |
ISO |
ochratoxin A results in decreased expression of CYP3A4 mRNA ochratoxin A results in increased expression of CYP3A4 mRNA; ochratoxin A results in increased expression of CYP3A4 protein ochratoxin A inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; ochratoxin A inhibits the reaction [Rifampin results in increased expression of CYP3A4 protein] CYP3A4 protein results in increased susceptibility to ochratoxin A |
CTD |
PMID:8542584 PMID:21781659 PMID:21834667 PMID:26341324 PMID:26505656 PMID:30291945 More...
|
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases response to substance decreases expression increases expression |
ISO |
CYP3A5 protein results in increased susceptibility to ochratoxin A ochratoxin A results in decreased expression of CYP3A5 mRNA ochratoxin A results in increased expression of CYP3A5 mRNA |
CTD |
PMID:11189750 PMID:21834667 PMID:26505656 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
increases expression |
EXP |
ochratoxin A results in increased expression of CYP4A8 mRNA |
CTD |
PMID:17483316 |
|
NCBI chr 5:128,702,130...128,733,476
Ensembl chr 5:128,702,131...128,733,476
|
|
G |
Dcun1d5 |
defective in cullin neddylation 1 domain containing 5 |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of DCUN1D5 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 8:4,412,266...4,433,380
Ensembl chr 8:4,412,221...4,433,367
|
|
G |
Dcx |
doublecortin |
multiple interactions decreases expression |
EXP |
SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of DCX mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr X:107,430,767...107,573,612
Ensembl chr X:107,430,767...107,507,476
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions decreases methylation decreases expression |
EXP ISO |
ochratoxin A results in increased expression of DDIT3 mRNA ochratoxin A promotes the reaction [bardoxolone methyl results in increased expression of DDIT3 protein]; Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of DDIT3 protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of DDIT3 protein]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of DDIT3 protein]]; Ursolic Acid inhibits the reaction [ochratoxin A promotes the reaction [bardoxolone methyl results in increased expression of DDIT3 protein]]; Ursolic Acid inhibits the reaction [ochratoxin A results in increased expression of DDIT3 protein] ochratoxin A results in decreased methylation of DDIT3 promoter ochratoxin A results in increased expression of DDIT3 mRNA; ochratoxin A results in increased expression of DDIT3 protein ochratoxin A metabolite results in decreased expression of DDIT3 mRNA; ochratoxin A results in decreased expression of DDIT3 mRNA |
CTD |
PMID:12700408 PMID:24356939 PMID:30008028 PMID:30559759 PMID:30763683 PMID:33465424 PMID:36058351 PMID:36587836 More...
|
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of DDIT4 mRNA; ochratoxin A results in decreased expression of DDIT4 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddt |
D-dopachrome tautomerase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of DDT mRNA |
CTD |
PMID:12700408 |
|
NCBI chr20:12,884,216...12,886,687
Ensembl chr20:12,884,243...12,888,482
|
|
G |
Ddx21 |
DExD-box helicase 21 |
multiple interactions decreases acetylation decreases expression |
ISO |
[ochratoxin A results in decreased acetylation of DDX21 promoter] which results in decreased expression of DDX21 mRNA ochratoxin A results in decreased expression of DDX21 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:30,534,319...30,554,513
Ensembl chr20:30,534,319...30,554,543
|
|
G |
Ddx24 |
DEAD-box helicase 24 |
increases expression |
ISO |
ochratoxin A results in increased expression of DDX24 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:122,564,767...122,582,032
Ensembl chr 6:122,564,767...122,581,927
|
|
G |
Ddx50 |
DExD-box helicase 50 |
decreases expression multiple interactions decreases acetylation |
ISO |
ochratoxin A results in decreased expression of DDX50 mRNA [ochratoxin A results in decreased acetylation of DDX50 promoter] which results in decreased expression of DDX50 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:30,561,623...30,591,324
Ensembl chr20:30,560,544...30,591,152
|
|
G |
Dffa |
DNA fragmentation factor subunit alpha |
decreases expression |
EXP |
ochratoxin A results in decreased expression of DFFA protein |
CTD |
PMID:19562491 |
|
NCBI chr 5:159,540,715...159,553,639
Ensembl chr 5:159,540,715...159,553,633
|
|
G |
Dffb |
DNA fragmentation factor subunit beta |
increases expression |
EXP |
ochratoxin A results in increased expression of DFFB mRNA |
CTD |
PMID:19562491 |
|
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
|
|
G |
Dgcr6 |
DiGeorge syndrome critical region gene 6 |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of DGCR6 promoter ochratoxin A results in increased expression of DGCR6 mRNA [ochratoxin A results in increased acetylation of DGCR6 promoter] which results in increased expression of DGCR6 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr11:82,927,725...82,932,823
Ensembl chr11:82,927,725...82,932,823
|
|
G |
Dgkg |
diacylglycerol kinase, gamma |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of DGKG gene |
CTD |
PMID:26431795 |
|
NCBI chr11:78,384,212...78,579,158
Ensembl chr11:78,384,458...78,577,212
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of DHCR24 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DHCR7 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of DHRS7 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DIABLO mRNA |
CTD |
PMID:17316727 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dido1 |
death inducer-obliterator 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DIDO1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 3:167,772,535...167,825,894
Ensembl chr 3:167,772,770...167,817,218
|
|
G |
Dipk1a |
divergent protein kinase domain 1A |
increases expression |
ISO |
ochratoxin A results in increased expression of FAM69A mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:1,772,412...1,843,508
Ensembl chr14:1,772,422...1,843,743
|
|
G |
Dis3l2 |
DIS3-like 3'-5' exoribonuclease 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of DIS3L2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:87,355,409...87,736,616
Ensembl chr 9:87,356,457...87,736,616
|
|
G |
Dld |
dihydrolipoamide dehydrogenase |
increases expression |
ISO |
ochratoxin A results in increased expression of DLD mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:47,904,153...47,924,814
Ensembl chr 6:47,903,914...47,924,795
|
|
G |
Dlg2 |
discs large MAGUK scaffold protein 2 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of DLG2 gene |
CTD |
PMID:26431795 |
|
NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475
|
|
G |
Dll3 |
delta like canonical Notch ligand 3 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of DLL3 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of DLL3 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 1:83,562,011...83,570,008
Ensembl chr 1:83,562,014...83,569,750
|
|
G |
Dlx5 |
distal-less homeobox 5 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DLX5 mRNA |
CTD |
PMID:20036863 |
|
NCBI chr 4:34,999,139...35,003,504
Ensembl chr 4:34,999,139...35,003,407
|
|
G |
Dmrt1 |
doublesex and mab-3 related transcription factor 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DMRT1 |
CTD |
PMID:22069556 |
|
NCBI chr 1:223,142,859...223,241,333
Ensembl chr 1:223,142,859...223,241,333
|
|
G |
Dmtf1 |
cyclin D binding myb-like transcription factor 1 |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of DMTF1 promoter [ochratoxin A results in decreased acetylation of DMTF1 promoter] which results in decreased expression of DMTF1 mRNA ochratoxin A results in decreased expression of DMTF1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 4:24,909,937...24,950,786
Ensembl chr 4:24,910,534...24,950,967
|
|
G |
Dnaja2 |
DnaJ heat shock protein family (Hsp40) member A2 |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of DNAJA2 promoter ochratoxin A results in decreased expression of DNAJA2 mRNA [ochratoxin A results in decreased acetylation of DNAJA2 promoter] which results in decreased expression of DNAJA2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr19:21,497,792...21,516,904
Ensembl chr19:21,497,729...21,516,901
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of DNAJB4 mRNA; ochratoxin A results in increased expression of DNAJB4 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
increases expression |
EXP |
ochratoxin A results in increased expression of DNAJB6 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659
|
|
G |
Dnajc4 |
DnaJ heat shock protein family (Hsp40) member C4 |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of DNAJC4 promoter] which results in increased expression of DNAJC4 mRNA ochratoxin A results in increased expression of DNAJC4 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:204,178,189...204,182,412
Ensembl chr 1:204,178,191...204,182,387
|
|
G |
Dnal4 |
dynein, axonemal, light chain 4 |
increases expression |
EXP |
ochratoxin A results in increased expression of DNAL4 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 7:111,312,424...111,325,283
Ensembl chr 7:111,312,427...111,325,283
|
|
G |
Dnase1l3 |
deoxyribonuclease 1L3 |
increases expression |
EXP |
ochratoxin A results in increased expression of DNASE1L3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
|
|
G |
Dock1 |
dedicator of cyto-kinesis 1 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of DOCK1 gene |
CTD |
PMID:26431795 |
|
NCBI chr 1:189,467,143...189,983,777
Ensembl chr 1:189,467,143...189,983,768
|
|
G |
Dock3 |
dedicator of cyto-kinesis 3 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of DOCK3 gene |
CTD |
PMID:26431795 |
|
NCBI chr 8:107,552,462...107,903,527
Ensembl chr 8:107,552,463...107,903,514
|
|
G |
Dock6 |
dedicator of cytokinesis 6 |
increases expression |
EXP |
ochratoxin A results in increased expression of DOCK6 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 8:20,342,430...20,394,660
Ensembl chr 8:20,342,089...20,394,552
|
|
G |
Dolk |
dolichol kinase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of DOLK mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:13,557,826...13,559,864
Ensembl chr 3:13,557,817...13,559,917
|
|
G |
Dpagt1 |
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DPAGT1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 8:44,664,055...44,671,102
Ensembl chr 8:44,664,071...44,671,087
|
|
G |
Dppa3 |
developmental pluripotency-associated 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of DPPA3 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 4:155,851,461...155,854,845
Ensembl chr 4:155,815,296...155,854,861 Ensembl chr 5:155,815,296...155,854,861
|
|
G |
Dpy19l1 |
dpy-19 like C-mannosyltransferase 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of DPY19L1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 8:22,933,163...23,021,461
Ensembl chr 8:22,933,163...23,021,751
|
|
G |
Dsc2 |
desmocollin 2 |
decreases expression multiple interactions increases expression |
EXP |
ochratoxin A results in decreased expression of DSC2 mRNA [ochratoxin A co-treated with Ethanol] results in increased expression of DSC2 mRNA ochratoxin A results in increased expression of DSC2 mRNA |
CTD |
PMID:16622519 PMID:16857307 |
|
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
|
|
G |
E2f1 |
E2F transcription factor 1 |
increases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in increased expression of E2F1 mRNA ochratoxin A results in increased acetylation of E2F1 promoter [ochratoxin A results in increased acetylation of E2F1 promoter] which results in increased expression of E2F1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f2 |
E2F transcription factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of E2F2 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217
|
|
G |
E2f3 |
E2F transcription factor 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of E2F3 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
|
|
G |
Eci1 |
enoyl-CoA delta isomerase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ECI1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
|
|
G |
Ect2 |
epithelial cell transforming 2 |
decreases expression multiple interactions decreases acetylation |
ISO |
ochratoxin A results in decreased expression of ECT2 mRNA [ochratoxin A results in decreased acetylation of ECT2 promoter] which results in decreased expression of ECT2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
|
|
G |
Edn1 |
endothelin 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of EDN1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of EEF1A1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of EEF1A2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Eef1d |
eukaryotic translation elongation factor 1 delta |
increases expression |
ISO |
ochratoxin A results in increased expression of EEF1D protein |
CTD |
PMID:19445961 |
|
NCBI chr 7:107,581,930...107,596,735
Ensembl chr 7:107,581,930...107,608,799
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of EEF2 protein |
CTD |
PMID:26861962 |
|
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Eepd1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of EEPD1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 8:23,957,258...24,064,343
Ensembl chr 8:23,957,255...24,064,340
|
|
G |
Efcab14 |
EF-hand calcium binding domain 14 |
increases expression |
ISO |
ochratoxin A results in increased expression of EFCAB14 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:129,218,139...129,258,628
Ensembl chr 5:129,218,424...129,258,625
|
|
G |
Efcab5 |
EF-hand calcium binding domain 5 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of EFCAB5 gene |
CTD |
PMID:26431795 |
|
NCBI chr10:61,926,419...62,042,745
Ensembl chr10:61,926,953...62,042,749
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of EFEMP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
|
|
G |
Egfr |
epidermal growth factor receptor |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of EGFR protein |
CTD |
PMID:23172667 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Ehbp1 |
EH domain binding protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EHBP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:96,093,327...96,380,502
Ensembl chr14:96,093,327...96,345,332
|
|
G |
Ehd4 |
EH-domain containing 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EHD4 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:107,058,191...107,121,985
Ensembl chr 3:107,058,958...107,122,002
|
|
G |
Eif1 |
eukaryotic translation initiation factor 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of EIF1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:85,246,751...85,248,842
Ensembl chr10:85,246,764...85,427,327
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
increases expression |
ISO |
ochratoxin A results in increased expression of EIF2A protein |
CTD |
PMID:36058351 |
|
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
decreases expression increases expression multiple interactions increases phosphorylation |
ISO |
ochratoxin A results in decreased expression of EIF2AK3 mRNA ochratoxin A results in increased expression of EIF2AK3 protein Ursolic Acid inhibits the reaction [ochratoxin A results in increased phosphorylation of EIF2AK3 protein] |
CTD |
PMID:30763683 PMID:33465424 PMID:36058351 PMID:36587836 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
increases phosphorylation multiple interactions |
ISO |
ochratoxin A results in increased phosphorylation of EIF2S1 protein Ursolic Acid inhibits the reaction [ochratoxin A results in increased phosphorylation of EIF2S1 protein] |
CTD |
PMID:33465424 PMID:36587836 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eif2s2 |
eukaryotic translation initiation factor 2 subunit beta |
increases expression |
ISO |
ochratoxin A results in increased expression of EIF2S2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:143,374,652...143,395,460
Ensembl chr 3:143,373,686...143,395,432
|
|
G |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EIF3A protein |
CTD |
PMID:19445961 |
|
NCBI chr 1:259,902,767...259,932,976
Ensembl chr 1:259,902,680...259,932,976
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of EIF4EBP1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
increases phosphorylation |
EXP |
ochratoxin A results in increased phosphorylation of ELK1 protein |
CTD |
PMID:17651772 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Elmo2 |
engulfment and cell motility 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of ELMO2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 3:154,023,661...154,061,259
Ensembl chr 3:154,023,661...154,061,185
|
|
G |
Eml4 |
EMAP like 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EML4 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 6:11,219,545...11,334,824
Ensembl chr 6:11,219,566...11,334,879
|
|
G |
Emp1 |
epithelial membrane protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of EMP1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
|
|
G |
Emp3 |
epithelial membrane protein 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of EMP3 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
|
|
G |
Emx2 |
empty spiracles homeobox 2 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of EMX2 mRNA Folic Acid inhibits the reaction [ochratoxin A results in decreased expression of EMX2 mRNA] |
CTD |
PMID:17688467 |
|
NCBI chr 1:258,626,584...258,633,594
Ensembl chr 1:258,626,584...258,633,594
|
|
G |
Endog |
endonuclease G |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ENDOG protein |
CTD |
PMID:19562491 |
|
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Eno1 |
enolase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of ENO1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
|
|
G |
Eno2 |
enolase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of ENO2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Ensa |
endosulfine alpha |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ENSA mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:183,185,552...183,192,888
Ensembl chr 2:183,185,552...183,194,847
|
|
G |
Ep300 |
E1A binding protein p300 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EP300 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
multiple interactions decreases expression |
ISO |
EPAS1 protein inhibits the reaction [ochratoxin A results in decreased expression of VEGFA protein] ochratoxin A results in decreased expression of EPAS1 protein |
CTD |
PMID:21554934 |
|
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Ephb1 |
Eph receptor B1 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of EPHB1 promoter] which results in increased expression of EPHB1 mRNA ochratoxin A results in increased expression of EPHB1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:102,507,549...102,944,839
Ensembl chr 8:102,507,549...102,944,839
|
|
G |
Ephb6 |
Eph receptor B6 |
increases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in increased expression of EPHB6 mRNA ochratoxin A results in increased acetylation of EPHB6 promoter [ochratoxin A results in increased acetylation of EPHB6 promoter] which results in increased expression of EPHB6 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 4:70,491,973...70,507,230
Ensembl chr 4:70,491,973...70,507,230
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of EPHX1 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Epo |
erythropoietin |
affects expression |
ISO |
ochratoxin A affects the expression of EPO mRNA |
CTD |
PMID:30876885 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Eprs1 |
glutamyl-prolyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EPRS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ERBB4 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
ochratoxin A results in increased expression of EREG mRNA |
CTD |
PMID:30008028 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions increases expression |
ISO |
Ursolic Acid inhibits the reaction [ochratoxin A results in increased expression of ERN1 protein] |
CTD |
PMID:36587836 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Ero1a |
endoplasmic reticulum oxidoreductase 1 alpha |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ERO1A mRNA |
CTD |
PMID:30559759 |
|
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
|
|
G |
Erp44 |
endoplasmic reticulum protein 44 |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of ERP44 promoter [ochratoxin A results in increased acetylation of ERP44 promoter] which results in increased expression of ERP44 mRNA ochratoxin A results in increased expression of ERP44 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 5:62,516,550...62,610,762
Ensembl chr 5:62,516,551...62,610,761
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
increases expression |
EXP |
ochratoxin A results in increased expression of ESPL1 mRNA |
CTD |
PMID:19237604 |
|
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
Esrrg |
estrogen-related receptor gamma |
increases expression |
ISO |
ochratoxin A results in increased expression of ESRRG mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:99,167,656...99,788,016
Ensembl chr13:99,564,669...99,783,397
|
|
G |
Etfdh |
electron transfer flavoprotein dehydrogenase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ETFDH mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:164,729,749...164,762,745
|
|
G |
Etv1 |
ETS variant transcription factor 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of ETV1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:55,590,149...55,681,784
Ensembl chr 6:55,590,234...55,681,775
|
|
G |
Etv5 |
ETS variant transcription factor 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ETV5 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr11:78,608,618...78,666,221
Ensembl chr11:78,608,710...78,666,215
|
|
G |
Evi2a |
ecotropic viral integration site 2A |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of EVI2A mRNA; ochratoxin A results in decreased expression of EVI2A mRNA |
CTD |
PMID:24356939 |
|
NCBI chr10:64,485,760...64,489,660
Ensembl chr10:64,485,200...64,489,843
|
|
G |
Exo1 |
exonuclease 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of EXO1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
|
|
G |
Exosc5 |
exosome component 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of EXOSC5 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:81,168,128...81,177,266
Ensembl chr 1:81,166,023...81,177,265
|
|
G |
Eya3 |
EYA transcriptional coactivator and phosphatase 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of EYA3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:144,806,523...144,934,522
Ensembl chr 5:144,806,577...144,934,518
|
|
G |
Ezr |
ezrin |
increases expression decreases expression increases phosphorylation |
ISO EXP |
ochratoxin A metabolite results in increased expression of EZR mRNA; ochratoxin A results in increased expression of EZR mRNA ochratoxin A results in increased expression of EZR protein ochratoxin A results in decreased expression of EZR mRNA ochratoxin A results in increased phosphorylation of EZR protein |
CTD |
PMID:26314263 PMID:28286205 PMID:30763683 PMID:31369848 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
|
G |
F11r |
F11 receptor |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of F11R mRNA; ochratoxin A results in increased expression of F11R mRNA |
CTD |
PMID:26314263 |
|
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
|
|
G |
F2 |
coagulation factor II, thrombin |
decreases expression |
EXP |
ochratoxin A results in decreased expression of F2 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions increases expression |
ISO EXP |
ochratoxin A inhibits the reaction [IL1B protein results in increased expression of F3 protein]; ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased activity of F3 protein]; ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of F3 mRNA]; ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of F3 protein]; ochratoxin A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of F3 protein]; ochratoxin A inhibits the reaction [TNF protein results in increased expression of F3 protein] ochratoxin A results in increased expression of F3 mRNA |
CTD |
PMID:12700408 PMID:18289624 PMID:23358140 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
F5 |
coagulation factor V |
decreases expression |
ISO |
ochratoxin A results in decreased expression of F5 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr13:76,513,509...76,583,106
Ensembl chr13:76,513,255...76,582,317
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FABP4 |
CTD |
PMID:20590410 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fabp5 |
fatty acid binding protein 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of FABP5 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773
|
|
G |
Fadd |
Fas associated via death domain |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FADD mRNA |
CTD |
PMID:17316727 PMID:30763683 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fads1 |
fatty acid desaturase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FADS1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fahd1 |
fumarylacetoacetate hydrolase domain containing 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FAHD1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:13,873,539...13,874,978
Ensembl chr10:13,873,527...13,875,012
|
|
G |
Fam114a1 |
family with sequence similarity 114, member A1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FAM114A1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:43,275,693...43,346,154
Ensembl chr14:43,275,701...43,346,174
|
|
G |
Fancc |
FA complementation group C |
decreases expression |
EXP |
ochratoxin A results in decreased expression of FANCC mRNA |
CTD |
PMID:23358140 |
|
NCBI chr17:1,680,660...1,822,610
Ensembl chr17:1,681,324...1,829,376
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of FAS mRNA ochratoxin A results in decreased expression of FAS mRNA |
CTD |
PMID:17316727 PMID:19562491 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
increases expression |
EXP |
ochratoxin A results in increased expression of FASLG mRNA |
CTD |
PMID:19562491 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fastk |
Fas-activated serine/threonine kinase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of FASTK mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 4:10,732,273...10,736,332
Ensembl chr 4:10,732,256...10,737,430
|
|
G |
Fbn2 |
fibrillin 2 |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of FBN2 promoter] which results in increased expression of FBN2 mRNA ochratoxin A results in increased expression of FBN2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr18:51,499,670...51,703,976
Ensembl chr18:51,499,737...51,703,976
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of FBP1 protein |
CTD |
PMID:31369848 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fbp2 |
fructose-bisphosphatase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of FBP2 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr17:2,236,088...2,253,702
Ensembl chr17:2,236,336...2,253,698
|
|
G |
Fbxo15 |
F-box protein 15 |
increases expression |
ISO |
ochratoxin A results in increased expression of FBXO15 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr18:78,319,577...78,634,695
Ensembl chr18:78,319,534...78,390,765
|
|
G |
Fbxo22 |
F-box protein 22 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FBXO22 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:55,579,906...55,595,981
Ensembl chr 8:55,579,891...55,596,148
|
|
G |
Fbxo32 |
F-box protein 32 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of FBXO32 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436
|
|
G |
Fcer1g |
Fc epsilon receptor Ig |
increases expression |
EXP |
ochratoxin A results in increased expression of FCER1G mRNA |
CTD |
PMID:22124623 |
|
NCBI chr13:83,649,447...83,654,248
Ensembl chr13:83,649,449...83,671,443
|
|
G |
Fech |
ferrochelatase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FECH mRNA |
CTD |
PMID:32905824 |
|
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
G |
Fgb |
fibrinogen beta chain |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FGB protein |
CTD |
PMID:31276768 |
|
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
|
|
G |
Fgd1 |
FYVE, RhoGEF and PH domain containing 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of FGD1 mRNA |
CTD |
PMID:17483316 |
|
NCBI chr X:20,023,746...20,066,734
Ensembl chr X:20,023,746...20,066,566
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of FGF18 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fgf8 |
fibroblast growth factor 8 |
multiple interactions |
ISO |
[GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA; Folic Acid inhibits the reaction [[GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA]; ochratoxin A promotes the reaction [GLI3 gene mutant form results in increased expression of FGF8 protein] |
CTD |
PMID:16922921 PMID:17688467 |
|
NCBI chr 1:244,584,477...244,590,578
Ensembl chr 1:244,584,652...244,590,359
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of FKBP1A mRNA [ochratoxin A results in increased acetylation of FKBP1A promoter] which results in increased expression of FKBP1A mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
|
|
G |
Fkbp1b |
FKBP prolyl isomerase 1B |
decreases expression |
EXP |
ochratoxin A results in decreased expression of FKBP1B mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 6:27,832,128...27,850,600
Ensembl chr 6:27,838,802...27,848,653
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
increases expression |
EXP |
ochratoxin A results in increased expression of FKBP5 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Fkbp8 |
FKBP prolyl isomerase 8 |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of FKBP8 promoter ochratoxin A results in increased expression of FKBP8 mRNA [ochratoxin A results in increased acetylation of FKBP8 promoter] which results in increased expression of FKBP8 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr16:18,895,608...18,902,648
Ensembl chr16:18,893,576...18,902,612
|
|
G |
Fn1 |
fibronectin 1 |
increases expression multiple interactions decreases expression |
ISO |
ochratoxin A results in increased expression of FN1 mRNA; ochratoxin A results in increased expression of FN1 protein 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of FN1 mRNA]; 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of FN1 protein]; SMAD2 affects the reaction [ochratoxin A results in increased expression of FN1 mRNA]; SMAD2 affects the reaction [ochratoxin A results in increased expression of FN1 protein]; SMAD3 affects the reaction [ochratoxin A results in increased expression of FN1 mRNA]; SMAD3 affects the reaction [ochratoxin A results in increased expression of FN1 protein] ochratoxin A results in decreased expression of FN1 mRNA NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of FN1 mRNA] |
CTD |
PMID:28710020 PMID:30559759 PMID:32617660 PMID:35543154 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fndc10 |
fibronectin type III domain containing 10 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of FNDC10 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 5:166,299,587...166,311,477
Ensembl chr 5:166,300,122...166,310,326
|
|
G |
Fndc3b |
fibronectin type III domain containing 3B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FNDC3B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:110,311,439...110,617,504
Ensembl chr 2:110,312,694...110,547,830
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression decreases expression multiple interactions |
ISO EXP |
ochratoxin A results in increased expression of FOS mRNA ochratoxin A results in decreased expression of FOS mRNA ochratoxin A results in increased expression of FOS protein ochratoxin A promotes the reaction [FOS protein binds to CCND1 promoter]; ochratoxin A promotes the reaction [FOS protein binds to PTGS2 promoter] |
CTD |
PMID:17316727 PMID:19237604 PMID:23172667 PMID:23358140 PMID:30763683 PMID:37162024 More...
|
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Frat1 |
FRAT regulator of WNT signaling pathway 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of FRAT1 mRNA; ochratoxin A results in decreased expression of FRAT1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 1:240,638,309...240,640,857
Ensembl chr 1:240,638,296...240,640,945
|
|
G |
Frmd3 |
FERM domain containing 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of FRMD3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:87,764,755...88,031,091
Ensembl chr 5:87,764,604...88,031,091
|
|
G |
Frzb |
frizzled-related protein |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of FRZB mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
|
|
G |
Fsd1l |
fibronectin type III and SPRY domain containing 1-like |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FSD1L mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:68,258,877...68,334,931
Ensembl chr 5:68,258,932...68,334,928
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of FTH1 mRNA |
CTD |
PMID:30559759 PMID:32905824 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Fubp1 |
far upstream element binding protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FUBP1 protein |
CTD |
PMID:26861962 |
|
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
|
|
G |
Fuca1 |
alpha-L-fucosidase 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of FUCA1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:148,152,718...148,169,972
Ensembl chr 5:148,152,700...148,169,972
|
|
G |
Fut4-ps1 |
fucosyltransferase 4, pseudogene 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FUT6 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 9:1,569,605...1,572,022
|
|
G |
G2e3 |
G2/M-phase specific E3 ubiquitin protein ligase |
increases expression |
ISO |
ochratoxin A results in increased expression of G2E3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:68,763,847...68,795,305
Ensembl chr 6:68,764,185...68,793,924
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of G6PC1 mRNA |
CTD |
PMID:26341324 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of G6PD mRNA |
CTD |
PMID:32905824 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gabbr2 |
gamma-aminobutyric acid type B receptor subunit 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of GABBR2 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 5:60,947,517...61,288,104
Ensembl chr 5:60,947,526...61,288,104
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of GADD45A mRNA ochratoxin A results in decreased expression of GADD45 mRNA; ochratoxin A results in decreased expression of GADD45A mRNA |
CTD |
PMID:12700408 PMID:17316727 PMID:30008028 PMID:30559759 PMID:30763683 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GADD45B mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GADD45G mRNA |
CTD |
PMID:30763683 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Gal |
galanin and GMAP prepropeptide |
increases activity |
EXP ISO |
ochratoxin A results in increased activity of GAL protein |
CTD |
PMID:28286205 |
|
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Galnt11 |
polypeptide N-acetylgalactosaminyltransferase 11 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of GALNT11 promoter |
CTD |
PMID:29098329 |
|
NCBI chr 4:9,837,629...9,871,141
Ensembl chr 4:9,837,629...9,871,140
|
|
G |
Gars1 |
glycyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
|
|
G |
Gbp1 |
guanylate binding protein 1 |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of GBP1 promoter [ochratoxin A results in decreased acetylation of GBP1 promoter] which results in decreased expression of GBP1 mRNA ochratoxin A results in decreased expression of GBP1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
|
|
G |
Gc |
GC, vitamin D binding protein |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GC mRNA |
CTD |
PMID:18417182 PMID:30449730 |
|
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Gcfc2 |
GC-rich sequence DNA-binding factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GCFC2 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 4:114,481,613...114,519,268
Ensembl chr 4:114,481,607...114,519,962
|
|
G |
Gck |
glucokinase |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of GCK gene ochratoxin A results in increased expression of GCK mRNA |
CTD |
PMID:37162024 |
|
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions affects expression increases expression decreases expression |
EXP ISO |
[cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GCLC protein] ochratoxin A affects the expression of GCLC mRNA ochratoxin A results in increased expression of GCLC mRNA AHR protein affects the reaction [ochratoxin A results in increased expression of GCLC mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of GCLC mRNA] ochratoxin A results in decreased expression of GCLC mRNA; ochratoxin A results in decreased expression of GCLC protein |
CTD |
PMID:16251485 PMID:17110534 PMID:18417182 PMID:23358140 PMID:30291945 PMID:32468156 PMID:32905824 More...
|
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
decreases expression affects expression |
EXP ISO |
ochratoxin A results in decreased expression of GCLM mRNA ochratoxin A affects the expression of GCLM mRNA |
CTD |
PMID:16251485 PMID:18417182 PMID:30008028 PMID:30559759 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GCNT3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
|
|
G |
Gen1 |
GEN1 Holliday junction 5' flap endonuclease |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of GEN1 mRNA ochratoxin A results in increased methylation of GEN1 gene |
CTD |
PMID:37162024 |
|
NCBI chr 6:33,947,599...33,978,461
Ensembl chr 6:33,948,206...33,978,401
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions decreases expression |
EXP |
15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA]; SHH protein inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA] ochratoxin A results in decreased expression of GFAP mRNA; ochratoxin A results in decreased expression of GFAP protein |
CTD |
PMID:15994020 PMID:22954530 PMID:24792326 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
decreases activity decreases expression |
EXP |
ochratoxin A results in decreased activity of GGT1 protein ochratoxin A results in decreased expression of GGT1 mRNA |
CTD |
PMID:2569870 PMID:12700408 PMID:16251485 PMID:23358140 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Ggt5 |
gamma-glutamyltransferase 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GGT5 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr20:13,043,255...13,071,523
Ensembl chr20:13,043,257...13,071,450
|
|
G |
Ggt6 |
gamma-glutamyl transferase 6 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GGT6 mRNA |
CTD |
PMID:17483316 |
|
NCBI chr10:57,051,977...57,054,900
Ensembl chr10:57,051,825...57,067,260
|
|
G |
Ghr |
growth hormone receptor |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GHR mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
affects phosphorylation increases phosphorylation decreases expression |
EXP ISO |
ochratoxin A affects the phosphorylation of GJA1 protein ochratoxin A results in increased phosphorylation of GJA1 protein ochratoxin A results in decreased expression of GJA1 mRNA |
CTD |
PMID:11711124 PMID:16857307 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GJB1 mRNA |
CTD |
PMID:16857307 PMID:19237604 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GJB2 mRNA |
CTD |
PMID:16857307 |
|
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
|
|
G |
Gk |
glycerol kinase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GK mRNA |
CTD |
PMID:12700408 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Glb1l |
galactosidase, beta 1-like |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of GLB1L mRNA ochratoxin A results in increased methylation of GLB1L gene |
CTD |
PMID:37162024 |
|
NCBI chr 9:76,693,325...76,705,548
Ensembl chr 9:76,695,173...76,705,510
|
|
G |
Gli1 |
GLI family zinc finger 1 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of GLI1 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of GLI1 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Gli3 |
GLI family zinc finger 3 |
multiple interactions increases response to substance affects response to substance |
ISO |
[GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA; Folic Acid inhibits the reaction [[GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA]; ochratoxin A promotes the reaction [GLI3 gene mutant form results in increased expression of FGF8 protein] GLI3 gene mutant form results in increased susceptibility to ochratoxin A GLI3 gene affects the susceptibility to ochratoxin A |
CTD |
PMID:16922921 PMID:17688467 PMID:20201966 |
|
NCBI chr17:49,438,567...49,709,712
Ensembl chr17:49,438,567...49,709,712
|
|
G |
Glrx |
glutaredoxin |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GLRX mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Gls |
glutaminase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GLS mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
|
|
G |
Glul |
glutamate-ammonia ligase |
decreases activity decreases expression |
EXP |
ochratoxin A results in decreased activity of GLUL protein ochratoxin A results in decreased expression of GLUL mRNA |
CTD |
PMID:12700408 PMID:20558201 |
|
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Glyat |
glycine-N-acyltransferase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GLYAT mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:209,704,213...209,724,949
Ensembl chr 1:209,704,268...209,724,942
|
|
G |
Gng13 |
G protein subunit gamma 13 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GNG13 mRNA |
CTD |
PMID:18417182 PMID:30449730 |
|
NCBI chr10:14,741,179...14,743,083
Ensembl chr10:14,741,239...14,743,083
|
|
G |
Gng5 |
G protein subunit gamma 5 |
increases expression |
EXP |
ochratoxin A results in increased expression of GNG5 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 2:235,394,680...235,403,177
Ensembl chr 1:77,292,043...77,292,513
|
|
G |
Gnmt |
glycine N-methyltransferase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GNMT mRNA |
CTD |
PMID:17483316 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Gnrh1 |
gonadotropin releasing hormone 1 |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of GNRH1 mRNA ochratoxin A metabolite results in increased expression of GNRH1 mRNA; ochratoxin A results in increased expression of GNRH1 mRNA |
CTD |
PMID:22124623 PMID:24356939 |
|
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
|
|
G |
Gp5 |
glycoprotein V (platelet) |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of GP5 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr11:70,443,613...70,446,705
Ensembl chr11:70,443,613...70,446,705
|
|
G |
Gpc1 |
glypican 1 |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of GPC1 promoter] which results in increased expression of GPC1 mRNA ochratoxin A results in increased expression of GPC1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GPI protein |
CTD |
PMID:26861962 |
|
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
|
|
G |
Gpr17 |
G protein-coupled receptor 17 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of GPR17 mRNA; ochratoxin A results in increased expression of GPR17 mRNA |
CTD |
PMID:23824090 PMID:24356939 |
|
NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,577,242...23,582,966
|
|
G |
Gpr18 |
G protein-coupled receptor 18 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of GPR18 mRNA; ochratoxin A results in decreased expression of GPR18 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr15:98,997,427...99,001,177
Ensembl chr15:98,997,259...99,001,470
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of GPT protein [1-aminobenzotriazole co-treated with ochratoxin A] results in increased activity of GPT protein |
CTD |
PMID:35543154 PMID:36227364 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpt2 |
glutamic--pyruvic transaminase 2 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of GPT2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression increases activity decreases expression multiple interactions increases acetylation |
ISO EXP |
ochratoxin A results in increased expression of GPX1 mRNA ochratoxin A results in increased activity of GPX1 protein ochratoxin A results in decreased expression of GPX1 mRNA [fumonisin B1 co-treated with ochratoxin A] affects the activity of GPX1 protein; [ochratoxin A results in increased acetylation of GPX1 promoter] which results in increased expression of GPX1 mRNA [Chitosan analog co-treated with Quercetin] inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA]; Chitosan analog inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA]; Quercetin inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA] |
CTD |
PMID:17316727 PMID:23358140 PMID:24120684 PMID:27923682 PMID:29098329 PMID:32905824 PMID:37633472 More...
|
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of GPX2 mRNA |
CTD |
PMID:24120684 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of GPX3 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of GPX4 promoter] which results in increased expression of GPX4 mRNA ochratoxin A results in increased expression of GPX4 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gpx7 |
glutathione peroxidase 7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GPX7 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:123,144,331...123,153,004
|
|
G |
Gpx8 |
glutathione peroxidase 8 |
increases expression |
EXP |
ochratoxin A results in increased expression of GPX8 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:44,676,448...44,680,042
Ensembl chr 2:44,676,454...44,680,195
|
|
G |
Gria1 |
glutamate ionotropic receptor AMPA type subunit 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of GRIA1 mRNA |
CTD |
PMID:27346841 |
|
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of GRIA2 mRNA |
CTD |
PMID:27346841 |
|
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
increases expression decreases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in increased expression of GRIN1 mRNA ochratoxin A results in decreased expression of GRIN1 mRNA ochratoxin A results in increased acetylation of GRIN1 promoter [ochratoxin A results in increased acetylation of GRIN1 promoter] which results in increased expression of GRIN1 mRNA |
CTD |
PMID:29098329 PMID:34748853 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
increases expression |
EXP |
ochratoxin A results in increased expression of GRIN2A mRNA |
CTD |
PMID:27346841 |
|
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
|
|
G |
Gsdma |
gasdermin A |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of GSDMA mRNA ochratoxin A results in decreased methylation of GSDMA gene |
CTD |
PMID:37162024 |
|
NCBI chr10:83,614,336...83,639,543
Ensembl chr10:83,627,051...83,639,543
|
|
G |
Gsdmd |
gasdermin D |
increases expression |
ISO |
ochratoxin A results in increased expression of GSDMD mRNA; ochratoxin A results in increased expression of GSDMD protein |
CTD |
PMID:33543323 |
|
NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:107,542,083...107,547,055
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of GSK3B protein |
CTD |
PMID:25002221 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gspt1 |
G1 to S phase transition 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of GSPT1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:4,362,528...4,397,215
Ensembl chr10:4,362,510...4,397,198
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO |
[NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of GSR mRNA |
CTD |
PMID:28710020 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gss |
glutathione synthetase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSS mRNA |
CTD |
PMID:12700408 PMID:16251485 PMID:18417182 PMID:23358140 |
|
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTA1 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
decreases expression increases expression |
EXP |
ochratoxin A results in decreased expression of GSTA2 mRNA ochratoxin A results in increased expression of GSTA2 mRNA |
CTD |
PMID:16251485 PMID:23358140 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTA3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTA4 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
multiple interactions decreases expression |
EXP |
[cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GSTA5 protein] |
CTD |
PMID:17110534 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstcd |
glutathione S-transferase, C-terminal domain containing |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GSTCD mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:221,499,732...221,591,888
Ensembl chr 2:221,499,083...221,591,857
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTK1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
decreases expression affects expression |
EXP ISO |
ochratoxin A results in decreased expression of GSTM1 mRNA; ochratoxin A results in decreased expression of GSTM1 protein ochratoxin A affects the expression of GSTM1 mRNA |
CTD |
PMID:17110534 PMID:23358140 PMID:32905824 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
increases expression affects expression |
EXP ISO |
ochratoxin A results in increased expression of GSTM2 mRNA ochratoxin A affects the expression of GSTM2 mRNA |
CTD |
PMID:24120684 PMID:32905824 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GSTM4 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
increases acetylation decreases expression multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of GSTM3 promoter ochratoxin A results in decreased expression of GSTM3 mRNA [ochratoxin A results in increased acetylation of GSTM3 promoter] which results in increased expression of GSTM3 mRNA ochratoxin A results in increased expression of GSTM3 mRNA |
CTD |
PMID:29098329 PMID:32905824 |
|
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GSTO1 mRNA; ochratoxin A results in decreased expression of GSTO1 protein |
CTD |
PMID:19287073 |
|
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases expression multiple interactions |
EXP ISO |
ochratoxin A results in decreased expression of GSTP1 mRNA; ochratoxin A results in decreased expression of GSTP1 protein [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GSTP1 protein]; ochratoxin A inhibits the reaction [NFE2L2 protein binds to GSTP1 protein] |
CTD |
PMID:12700408 PMID:17110534 PMID:23358140 PMID:32905824 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTT1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gstt2 |
glutathione S-transferase theta 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTT2 mRNA |
CTD |
PMID:16251485 PMID:18417182 PMID:23358140 |
|
NCBI chr20:12,819,617...12,823,288
Ensembl chr20:12,819,170...12,823,288
|
|
G |
Gstz1 |
glutathione S-transferase zeta 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GSTZ1 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
|
|
G |
Gtf2h5 |
general transcription factor IIH subunit 5 |
increases expression |
ISO |
ochratoxin A results in increased expression of GTF2H5 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:46,656,804...46,663,512
Ensembl chr 1:46,656,859...46,664,939
|
|
G |
Gtf3c5 |
general transcription factor IIIC subunit 5 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GTF3C5 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:11,893,867...11,914,187
Ensembl chr 3:11,893,875...11,914,180
|
|
G |
Gtse1 |
G-2 and S-phase expressed 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of GTSE1 mRNA |
CTD |
PMID:23208426 |
|
NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806
|
|
G |
Gucy1b2 |
guanylate cyclase 1 soluble subunit beta 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GUCY1B2 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr15:36,589,501...36,669,441
Ensembl chr15:36,598,883...36,669,441
|
|
G |
H1f10 |
H1.10 linker histone |
decreases expression |
EXP |
ochratoxin A results in decreased expression of H1F10 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 4:120,440,515...120,441,578
Ensembl chr 4:120,440,870...120,441,448
|
|
G |
H1f6 |
H1.6 linker histone, cluster member |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of H1-6 mRNA ochratoxin A results in increased expression of H1F6 mRNA |
CTD |
PMID:22124623 PMID:30449730 |
|
NCBI chr17:41,427,365...41,428,109
Ensembl chr17:41,427,323...41,428,119
|
|
G |
H2ax |
H2A.X variant histone |
decreases expression increases expression |
ISO EXP |
ochratoxin A results in decreased expression of H2AX mRNA ochratoxin A results in increased expression of H2AX mRNA; ochratoxin A results in increased expression of H2AX protein modified form |
CTD |
PMID:19287073 PMID:23358140 PMID:24243707 PMID:28286205 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
decreases expression |
ISO |
ochratoxin A results in decreased expression of HADHB protein |
CTD |
PMID:26861962 |
|
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
|
|
G |
Hagh |
hydroxyacyl glutathione hydrolase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HAGH mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:13,874,883...13,889,527
Ensembl chr10:13,875,241...13,889,504
|
|
G |
Has1 |
hyaluronan synthase 1 |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of HAS1 mRNA ochratoxin A results in decreased methylation of HAS1 gene |
CTD |
PMID:37162024 |
|
NCBI chr 1:58,693,411...58,705,653
Ensembl chr 1:58,693,411...58,705,397
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
increases expression multiple interactions increases secretion |
EXP ISO |
ochratoxin A results in increased expression of HAVCR1; ochratoxin A results in increased expression of HAVCR1 mRNA; ochratoxin A results in increased expression of HAVCR1 protein [1-aminobenzotriazole co-treated with ochratoxin A] results in increased expression of HAVCR1 protein HSPA9 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 protein] AHR protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA]; HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of HAVCR1 protein]; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA] ochratoxin A results in increased secretion of HAVCR1 mRNA |
CTD |
PMID:16251485 PMID:18308701 PMID:25218026 PMID:30291945 PMID:30449730 PMID:31369848 PMID:36227364 More...
|
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hbs1l |
HBS1-like translational GTPase |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of HBS1L mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:16,092,529...16,170,082
Ensembl chr 1:16,092,547...16,170,074
|
|
G |
Hcfc1r1 |
host cell factor C1 regulator 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HCFC1R1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:12,705,139...12,706,852
Ensembl chr10:12,705,077...12,706,850
|
|
G |
Hdac3 |
histone deacetylase 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of HDAC3 protein |
CTD |
PMID:17651772 |
|
NCBI chr18:29,770,637...29,789,850
Ensembl chr18:29,770,636...29,793,856
|
|
G |
Hdgfl3 |
HDGF like 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of HDGFL3 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:135,822,600...135,876,719
Ensembl chr 1:135,827,549...135,876,719
|
|
G |
Hdlbp |
high density lipoprotein binding protein |
increases expression |
EXP |
ochratoxin A results in increased expression of HDLBP mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:93,948,099...94,018,040
Ensembl chr 9:93,949,913...94,018,048
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HES1 mRNA |
CTD |
PMID:21703336 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hes5 |
hes family bHLH transcription factor 5 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of HES5 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of HES5 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 5:165,522,138...165,523,684
Ensembl chr 5:165,522,234...165,523,001
|
|
G |
Hgf |
hepatocyte growth factor |
multiple interactions |
EXP |
ochratoxin A inhibits the reaction [HGF protein results in increased uptake of estradiol-17 beta-glucuronide] |
CTD |
PMID:18031729 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases expression affects expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of HIF1A mRNA ochratoxin A affects the expression of HIF1A protein ochratoxin A results in decreased expression of HIF1A mRNA |
CTD |
PMID:12700408 PMID:23358140 PMID:30876885 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hif3a |
hypoxia inducible factor 3 subunit alpha |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of HIF3A mRNA ochratoxin A results in increased methylation of HIF3A gene |
CTD |
PMID:37162024 |
|
NCBI chr 1:77,718,110...77,750,448
Ensembl chr 1:77,722,471...77,749,758
|
|
G |
Hist1h2bq |
histone cluster 1 H2B family member Q |
increases expression |
EXP |
ochratoxin A results in increased expression of HIST1H2BQ mRNA |
CTD |
PMID:22124623 |
|
NCBI chr17:41,432,100...41,441,487
Ensembl chr17:41,429,164...41,442,153
|
|
G |
Hist1h4b |
histone cluster 1 H4 family member B |
increases expression |
EXP |
ochratoxin A results in increased expression of HIST1H4B mRNA |
CTD |
PMID:18417182 |
|
NCBI chr17:42,480,467...42,484,912
Ensembl chr17:42,480,313...42,485,370
|
|
G |
Hk2 |
hexokinase 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of HK2 protein |
CTD |
PMID:32835834 |
|
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Hmcn1 |
hemicentin 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of HMCN1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:62,615,461...63,084,524
Ensembl chr13:62,615,461...63,084,524
|
|
G |
Hmgb2 |
high mobility group box 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of HMGB2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
|
|
G |
Hmgn5 |
high mobility group nucleosome binding domain 5 |
increases expression |
ISO |
ochratoxin A results in increased expression of HMGN5 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441
|
|
G |
Hmmr |
hyaluronan-mediated motility receptor |
increases expression |
EXP |
ochratoxin A results in increased expression of HMMR mRNA |
CTD |
PMID:37162024 |
|
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression affects expression multiple interactions decreases expression |
EXP ISO |
ochratoxin A results in increased expression of HMOX1 mRNA; ochratoxin A results in increased expression of HMOX1 protein ochratoxin A affects the expression of HMOX1 mRNA AHR protein affects the reaction [ochratoxin A results in increased expression of HMOX1 mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of HMOX1 mRNA] ochratoxin A affects the reaction [NFE2L2 protein affects the expression of HMOX1 mRNA] ochratoxin A results in decreased expression of HMOX1 mRNA; ochratoxin A results in decreased expression of HMOX1 protein 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of HMOX1 mRNA]; ochratoxin A inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of HMOX1 mRNA] |
CTD |
PMID:15994020 PMID:16251485 PMID:17316727 PMID:19414514 PMID:23358140 PMID:26260164 PMID:28710020 PMID:30008028 PMID:30291945 PMID:30559759 PMID:32905824 More...
|
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hmox2 |
heme oxygenase 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HMOX2 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr10:10,797,076...10,831,178
Ensembl chr10:10,797,055...10,831,148
|
|
G |
Hnf1a |
HNF1 homeobox A |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HNF1A mRNA |
CTD |
PMID:23358140 |
|
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of HNF4A mRNA; ochratoxin A results in decreased expression of HNF4A protein |
CTD |
PMID:16251485 PMID:23358140 PMID:30008028 |
|
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Hnf4g |
hepatocyte nuclear factor 4, gamma |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of HNF4G mRNA ochratoxin A results in increased methylation of HNF4G gene |
CTD |
PMID:37162024 |
|
NCBI chr 2:97,885,773...98,036,650
Ensembl chr 2:97,887,432...98,036,592
|
|
G |
Hnrnpf |
heterogeneous nuclear ribonucleoprotein F |
decreases expression |
ISO |
ochratoxin A results in decreased expression of HNRNPF protein |
CTD |
PMID:19445961 |
|
NCBI chr 4:151,083,262...151,104,464
Ensembl chr 4:151,083,062...151,109,038
|
|
G |
Hnrnpk |
heterogeneous nuclear ribonucleoprotein K |
decreases expression |
ISO |
ochratoxin A results in decreased expression of HNRNPK protein |
CTD |
PMID:19445961 |
|
NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
increases expression |
EXP |
ochratoxin A results in increased expression of HRAS mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HSD17B1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of HSD3B1 mRNA; ochratoxin A results in increased expression of HSD3B1 protein |
CTD |
PMID:23466516 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of HSP90AA1 protein |
CTD |
PMID:26861962 |
|
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HSP90AB1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of HSPA1A mRNA ochratoxin A results in decreased expression of HSPA1A mRNA; ochratoxin A results in decreased expression of HSPA1A protein |
CTD |
PMID:16857307 PMID:17316727 PMID:19051279 PMID:19367635 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
decreases expression multiple interactions decreases acetylation |
ISO |
ochratoxin A results in decreased expression of HSPA2 mRNA [ochratoxin A results in decreased acetylation of HSPA2 promoter] which results in decreased expression of HSPA2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression multiple interactions decreases methylation increases expression |
ISO |
ochratoxin A results in decreased expression of HSPA5 protein ochratoxin A promotes the reaction [bardoxolone methyl results in increased expression of HSPA5 protein]; Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of HSPA5 protein]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein]]; Ursolic Acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein] ochratoxin A results in decreased methylation of HSPA5 promoter ochratoxin A metabolite results in increased expression of HSPA5 mRNA; ochratoxin A results in increased expression of HSPA5 mRNA; ochratoxin A results in increased expression of HSPA5 protein ochratoxin A results in decreased expression of HSPA5 mRNA |
CTD |
PMID:19051279 PMID:19445961 PMID:24356939 PMID:30559759 PMID:33465424 PMID:36058351 PMID:36587836 More...
|
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa6l-ps1 |
heat shock protein family A (Hsp70) member 6 like, pseudogene 1 |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of HSPA6 mRNA [ochratoxin A results in increased acetylation of HSPA6 promoter] which results in increased expression of HSPA6 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr13:83,273,176...83,274,317
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HSPA8 protein |
CTD |
PMID:31369848 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
decreases expression increases expression multiple interactions |
ISO EXP |
ochratoxin A results in decreased expression of HSPA9 mRNA; ochratoxin A results in decreased expression of HSPA9 protein ochratoxin A results in increased expression of HSPA9 protein HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of HAVCR1 protein]; HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of LONP1 protein] HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of LONP1 protein]; HSPA9 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 protein] |
CTD |
PMID:19051279 PMID:31369848 |
|
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of HSPB1 mRNA; ochratoxin A results in decreased expression of HSPB1 protein |
CTD |
PMID:19051279 PMID:19367635 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of HSPD1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
increases expression |
EXP |
ochratoxin A results in increased expression of HTR1A mRNA |
CTD |
PMID:27346841 |
|
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
|
|
G |
Htr4 |
5-hydroxytryptamine receptor 4 |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of HTR4 gene ochratoxin A results in increased expression of HTR4 mRNA |
CTD |
PMID:26431795 PMID:27346841 |
|
NCBI chr18:55,765,981...55,949,921
Ensembl chr18:55,766,725...55,949,321
|
|
G |
Hyls1 |
HYLS1, centriolar and ciliogenesis associated |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of HYLS1 mRNA; ochratoxin A results in decreased expression of HYLS1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 8:33,912,692...33,921,760
Ensembl chr 8:33,912,692...33,921,760
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions increases expression |
ISO EXP |
[NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of ICAM1 protein ochratoxin A results in increased expression of ICAM1 mRNA |
CTD |
PMID:28710020 PMID:37162024 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ID1 mRNA |
CTD |
PMID:12700408 PMID:17483316 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ID2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ID3 mRNA |
CTD |
PMID:21703336 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Id4 |
inhibitor of DNA binding 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ID4 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IDH1 mRNA; ochratoxin A results in decreased expression of IDH1 protein |
CTD |
PMID:32835834 PMID:32905824 |
|
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
|
|
G |
Idh3b |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IDH3B mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 3:117,481,845...117,486,909
Ensembl chr 3:117,481,845...117,486,982
|
|
G |
Idh3g |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IDH3G mRNA |
CTD |
PMID:19287073 |
|
NCBI chr X:151,515,244...151,524,175
Ensembl chr X:151,515,247...151,524,171
|
|
G |
Idi2l3 |
isopentenyl-diphosphate delta isomerase 2 like 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IDI2L3 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr17:61,518,138...61,535,484
Ensembl chr17:61,519,390...61,531,603
|
|
G |
Ier3 |
immediate early response 3 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of IER3 mRNA; ochratoxin A results in decreased expression of IER3 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifi35 |
interferon-induced protein 35 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IFI35 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
increases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in increased expression of IFITM3 mRNA ochratoxin A results in increased acetylation of IFITM3 promoter [ochratoxin A results in increased acetylation of IFITM3 promoter] which results in increased expression of IFITM3 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of IFNG protein |
CTD |
PMID:28935500 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ifrd1 |
interferon-related developmental regulator 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IFRD1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IGF1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
increases expression |
EXP |
ochratoxin A results in increased expression of IGF1R protein |
CTD |
PMID:17651772 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2 |
insulin-like growth factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IGF2 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
decreases expression increases expression |
ISO EXP |
ochratoxin A results in decreased expression of IGFBP1 mRNA; ochratoxin A results in decreased expression of IGFBP1 protein ochratoxin A results in increased expression of IGFBP1 mRNA |
CTD |
PMID:19287073 PMID:19717638 |
|
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IGFBP4 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
|
|
G |
Ihh |
Indian hedgehog signaling molecule |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IHH mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:76,504,315...76,510,532
Ensembl chr 9:76,504,315...76,510,532
|
|
G |
Il10 |
interleukin 10 |
increases expression |
EXP |
ochratoxin A results in increased expression of IL10 mRNA |
CTD |
PMID:19562491 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12a |
interleukin 12A |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IL12A mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
[Lipopolysaccharides co-treated with ochratoxin A] results in increased expression of IL12B protein |
CTD |
PMID:28935500 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il13 |
interleukin 13 |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of IL13 promoter [ochratoxin A results in increased acetylation of IL13 promoter] which results in increased expression of IL13 mRNA ochratoxin A results in increased expression of IL13 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
[ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of IL17A protein |
CTD |
PMID:28935500 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il17rc |
interleukin 17 receptor C |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of IL17RC mRNA [ochratoxin A results in increased acetylation of IL17RC promoter] which results in increased expression of IL17RC mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 4:146,618,321...146,631,444
Ensembl chr 4:146,619,004...146,631,442
|
|
G |
Il18 |
interleukin 18 |
increases expression |
ISO |
ochratoxin A results in increased expression of IL18 mRNA |
CTD |
PMID:33543323 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il19 |
interleukin 19 |
increases expression |
EXP |
ochratoxin A results in increased expression of IL19 mRNA |
CTD |
PMID:35843423 |
|
NCBI chr13:42,397,715...42,411,637
Ensembl chr13:42,399,138...42,405,473
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
ochratoxin A results in increased expression of IL1A mRNA |
CTD |
PMID:28286205 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
ISO EXP |
ochratoxin A inhibits the reaction [IL1B protein results in increased expression of CXCL8 protein]; ochratoxin A inhibits the reaction [IL1B protein results in increased expression of F3 protein] [Lipopolysaccharides co-treated with ochratoxin A] results in increased expression of IL1B protein; [ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of IL1B protein; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of IL1B mRNA]; sulforaphane inhibits the reaction [ochratoxin A results in increased expression of IL1B mRNA] ochratoxin A results in increased expression of IL1B mRNA; ochratoxin A results in increased expression of IL1B protein |
CTD |
PMID:18289624 PMID:18308354 PMID:24792326 PMID:28710020 PMID:28935500 PMID:33543323 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of IL1R2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Il2 |
interleukin 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IL2 mRNA |
CTD |
PMID:27193732 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il20 |
interleukin 20 |
increases expression |
EXP |
ochratoxin A results in increased expression of IL20 mRNA |
CTD |
PMID:35843423 |
|
NCBI chr13:42,380,981...42,384,625
Ensembl chr13:42,380,981...42,384,625
|
|
G |
Il20ra |
interleukin 20 receptor subunit alpha |
increases expression |
EXP |
ochratoxin A results in increased expression of IL20RA mRNA |
CTD |
PMID:35843423 |
|
NCBI chr 1:14,424,215...14,494,226
Ensembl chr 1:14,451,228...14,493,602
|
|
G |
Il24 |
interleukin 24 |
increases expression |
EXP |
ochratoxin A results in increased expression of IL24 mRNA |
CTD |
PMID:23208426 PMID:23358140 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Il4 |
interleukin 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IL4 mRNA |
CTD |
PMID:24792326 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of IL6 mRNA [Lipopolysaccharides co-treated with ochratoxin A] results in increased expression of IL6 protein; [ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of IL6 protein; sulforaphane inhibits the reaction [ochratoxin A results in increased expression of IL6 mRNA] Quercetin inhibits the reaction [ochratoxin A results in increased expression of IL6 protein] ochratoxin A results in increased expression of IL6 mRNA; ochratoxin A results in increased expression of IL6 protein |
CTD |
PMID:24792326 PMID:25532488 PMID:28286205 PMID:28710020 PMID:28935500 PMID:37162024 More...
|
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Inhba |
inhibin subunit beta A |
increases expression |
EXP |
ochratoxin A results in increased expression of INHBA mRNA |
CTD |
PMID:23358140 |
|
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
INS protein inhibits the reaction [ochratoxin A results in decreased phosphorylation of AKT1 protein]; INS protein inhibits the reaction [ochratoxin A results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:30287338 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Ipcef1 |
interaction protein for cytohesin exchange factors 1 |
increases expression decreases methylation |
ISO |
ochratoxin A results in increased expression of IPCEF1 mRNA ochratoxin A results in decreased methylation of IPCEF1 promoter |
CTD |
PMID:30559759 |
|
NCBI chr 1:43,237,903...43,451,735
Ensembl chr 1:43,269,202...43,427,969
|
|
G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of IQGAP1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 1:134,679,581...134,769,776
Ensembl chr 1:134,679,586...134,769,755
|
|
G |
Isl2 |
ISL LIM homeobox 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ISL2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 8:55,923,805...55,928,790
Ensembl chr 8:55,923,805...55,928,790
|
|
G |
Itch |
itchy E3 ubiquitin protein ligase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ITCH mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 3:143,642,348...143,733,745
Ensembl chr 3:143,645,637...143,733,543
|
|
G |
Itga4 |
integrin subunit alpha 4 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ITGA4 mRNA; ochratoxin A results in increased expression of ITGA4 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
|
|
G |
Itga7 |
integrin subunit alpha 7 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ITGA7 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 7:1,360,125...1,388,886
Ensembl chr 7:1,359,940...1,388,450
|
|
G |
Itgal |
integrin subunit alpha L |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ITGAL mRNA; ochratoxin A results in increased expression of ITGAL mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
|
|
G |
Itgam |
integrin subunit alpha M |
increases expression |
EXP |
ochratoxin A results in increased expression of ITGAM mRNA |
CTD |
PMID:24792326 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Itgb2 |
integrin subunit beta 2 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ITGB2 mRNA; ochratoxin A results in increased expression of ITGB2 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
|
|
G |
Itgb4 |
integrin subunit beta 4 |
increases expression |
EXP |
ochratoxin A results in increased expression of ITGB4 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
|
|
G |
Itk |
IL2-inducible T-cell kinase |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ITK mRNA; ochratoxin A results in decreased expression of ITK mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:30,753,344...30,814,685
Ensembl chr10:30,753,344...30,814,685
|
|
G |
Itpkb |
inositol-trisphosphate 3-kinase B |
increases expression |
ISO |
ochratoxin A results in increased expression of ITPKB mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:92,069,160...92,164,281
Ensembl chr13:92,069,216...92,162,004
|
|
G |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of JAKMIP2 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr18:35,532,552...35,747,938
Ensembl chr18:35,532,552...35,747,775
|
|
G |
Jam3 |
junctional adhesion molecule 3 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of JAM3 mRNA; ochratoxin A results in increased expression of JAM3 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 8:25,508,461...25,569,306
Ensembl chr 8:25,507,057...25,569,355
|
|
G |
Jkamp |
JNK1/MAPK8-associated membrane protein |
increases expression |
ISO |
ochratoxin A results in increased expression of JKAMP mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:90,648,043...90,661,985
Ensembl chr 6:90,648,160...90,662,501
|
|
G |
Jmjd6 |
jumonji domain containing 6, arginine demethylase and lysine hydroxylase |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of JMJD6 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:102,041,131...102,047,182
Ensembl chr10:102,041,120...102,047,182
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression affects expression increases expression |
ISO EXP |
ochratoxin A results in decreased expression of JUN mRNA ochratoxin A affects the expression of JUN mRNA ochratoxin A results in increased expression of JUN protein |
CTD |
PMID:17316727 PMID:23172667 PMID:30763683 PMID:35843423 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
ochratoxin A results in increased expression of JUNB mRNA |
CTD |
PMID:17316727 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kank1 |
KN motif and ankyrin repeat domains 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of KANK1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:222,877,962...223,074,514
Ensembl chr 1:222,877,622...223,074,514
|
|
G |
Kat14 |
lysine acetyltransferase 14 |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of KAT14 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:131,736,430...131,781,732
Ensembl chr 3:131,736,549...131,781,706
|
|
G |
Kcnd2 |
potassium voltage-gated channel subfamily D member 2 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of KCND2 gene |
CTD |
PMID:26431795 |
|
NCBI chr 4:49,775,812...50,277,746
Ensembl chr 4:49,776,246...50,277,728
|
|
G |
Kcnip1 |
potassium voltage-gated channel interacting protein 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of KCNIP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:18,219,519...18,588,833
Ensembl chr10:18,219,519...18,589,045
|
|
G |
Kcnj1 |
potassium inwardly-rectifying channel, subfamily J, member 1 |
decreases expression increases expression |
ISO EXP |
ochratoxin A results in decreased expression of KCNJ1 mRNA ochratoxin A results in increased expression of KCNJ1 mRNA |
CTD |
PMID:22124623 PMID:30559759 |
|
NCBI chr 8:30,779,883...30,808,607
Ensembl chr 8:30,753,617...30,813,796
|
|
G |
Kcnj15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of KCNJ15 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr11:34,577,397...34,621,725
Ensembl chr11:34,577,363...34,621,952
|
|
G |
Kdm1b |
lysine demethylase 1B |
decreases expression |
EXP |
ochratoxin A results in decreased expression of KDM1B mRNA |
CTD |
PMID:23358140 |
|
NCBI chr17:17,602,961...17,643,865
Ensembl chr17:17,602,961...17,643,800
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of KEAP1 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Kif18a |
kinesin family member 18A |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of KIF18A promoter [ochratoxin A results in decreased acetylation of KIF18A promoter] which results in decreased expression of KIF18A mRNA ochratoxin A results in decreased expression of KIF18A mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:95,764,388...95,824,756
Ensembl chr 3:95,764,388...95,824,582
|
|
G |
Kif21b |
kinesin family member 21B |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of KIF21B mRNA |
CTD |
PMID:24356939 |
|
NCBI chr13:47,576,129...47,626,112
Ensembl chr13:47,576,160...47,626,127
|
|
G |
Kitlg |
KIT ligand |
decreases expression |
EXP |
ochratoxin A results in decreased expression of KITLG mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Klf2 |
KLF transcription factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of KLF2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
|
|
G |
Klhdc2 |
kelch domain containing 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of KLHDC2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 6:87,777,183...87,791,609
Ensembl chr 6:87,777,183...87,804,187
|
|
G |
Klhl3 |
kelch-like family member 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of KLHL3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr17:6,523,089...6,645,971
Ensembl chr17:6,521,912...6,642,154
|
|
G |
Klk1b3 |
kallikrein 1-related peptidase B3 |
affects expression |
EXP |
ochratoxin A affects the expression of KLK1B3 mRNA |
CTD |
PMID:32468156 |
|
NCBI chr 1:94,709,105...94,713,308
Ensembl chr 1:94,709,105...94,713,308
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of KRAS mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Krcc1 |
lysine-rich coiled-coil 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of KRCC1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 4:103,261,642...103,274,672
Ensembl chr 4:103,261,536...103,277,156
|
|
G |
Krt15 |
keratin 15 |
increases expression |
ISO |
ochratoxin A results in increased expression of KRT15 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Lactb2 |
lactamase, beta 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of LACTB2 protein |
CTD |
PMID:31369848 |
|
NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429
|
|
G |
Lama3 |
laminin subunit alpha 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of LAMA3 mRNA |
CTD |
PMID:17483316 PMID:18417182 |
|
NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
|
|
G |
Lamb1 |
laminin subunit beta 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of LAMB1 mRNA; ochratoxin A results in decreased expression of LAMB1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 6:47,835,492...47,902,585
Ensembl chr 6:47,835,525...47,902,585
|
|
G |
Lars1 |
leucyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of LARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr18:34,201,555...34,256,003
Ensembl chr18:34,201,549...34,255,931
|
|
G |
Lcn2 |
lipocalin 2 |
increases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of LCN2; ochratoxin A results in increased expression of LCN2 mRNA [1-aminobenzotriazole co-treated with ochratoxin A] results in increased expression of LCN2 protein |
CTD |
PMID:18308701 PMID:25218026 PMID:36227364 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Ldha |
lactate dehydrogenase A |
increases expression |
ISO |
ochratoxin A results in increased expression of LDHA protein |
CTD |
PMID:32835834 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Ldhc |
lactate dehydrogenase C |
decreases acetylation |
ISO |
ochratoxin A results in decreased acetylation of LDHC promoter |
CTD |
PMID:29098329 |
|
NCBI chr 1:97,385,984...97,403,382
Ensembl chr 1:97,382,379...97,403,378
|
|
G |
Ldhd |
lactate dehydrogenase D |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of LDHD mRNA ochratoxin A results in increased methylation of LDHD gene |
CTD |
PMID:18417182 PMID:37162024 |
|
NCBI chr19:39,583,529...39,588,397
Ensembl chr19:39,573,621...39,595,575
|
|
G |
Lig4 |
DNA ligase 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of LIG4 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr16:79,518,393...79,526,956
Ensembl chr16:79,518,312...79,527,040
|
|
G |
Limch1 |
LIM and calponin homology domains 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of LIMCH1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:41,112,579...41,425,001
Ensembl chr14:41,114,803...41,425,191
|
|
G |
Lmnb1 |
lamin B1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of LMNB1 protein |
CTD |
PMID:26861962 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Lmo1 |
LIM domain only 1 |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of LMO1 mRNA ochratoxin A results in decreased methylation of LMO1 gene |
CTD |
PMID:37162024 |
|
NCBI chr 1:163,132,338...163,168,521
Ensembl chr 1:163,132,339...163,168,522
|
|
G |
Lonp1 |
lon peptidase 1, mitochondrial |
decreases expression multiple interactions |
EXP ISO |
ochratoxin A results in decreased expression of LONP1 protein HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of LONP1 protein]; Ursolic Acid inhibits the reaction [ochratoxin A results in decreased expression of LONP1 protein] |
CTD |
PMID:31369848 PMID:36587836 |
|
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
|
|
G |
Lpl |
lipoprotein lipase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of LPL |
CTD |
PMID:20590410 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Lpo |
lactoperoxidase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of LPO mRNA |
CTD |
PMID:34748853 |
|
NCBI chr10:72,606,950...72,626,220
Ensembl chr10:72,606,944...72,626,535
|
|
G |
Lpp |
LIM domain containing preferred translocation partner in lipoma |
decreases expression |
ISO |
ochratoxin A results in decreased expression of LPP mRNA |
CTD |
PMID:30559759 |
|
NCBI chr11:75,787,326...76,426,646
Ensembl chr11:75,797,078...76,422,597
|
|
G |
Lratd1 |
LRAT domain containing 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of LRATD1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 6:36,916,969...36,922,143
Ensembl chr 6:36,913,469...36,922,319
|
|
G |
Lrba |
LPS responsive beige-like anchor protein |
increases expression |
ISO |
ochratoxin A results in increased expression of LRBA mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:171,623,668...172,202,576
Ensembl chr 2:171,621,507...172,202,724
|
|
G |
Lrrc14 |
leucine rich repeat containing 14 |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of LRRC14 mRNA ochratoxin A results in increased methylation of LRRC14 gene |
CTD |
PMID:37162024 |
|
NCBI chr 7:108,430,755...108,437,118
Ensembl chr 7:108,430,792...108,437,111
|
|
G |
Lrrc37a |
leucine rich repeat containing 37A |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of LRRC37A3 mRNA; ochratoxin A results in increased expression of LRRC37A3 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr10:88,395,837...88,433,519
Ensembl chr10:88,396,663...88,433,323
|
|
G |
Lsm10 |
LSM10, U7 small nuclear RNA associated |
decreases expression |
EXP |
ochratoxin A results in decreased expression of LSM10 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:138,365,983...138,375,856
Ensembl chr 5:138,373,119...138,377,505
|
|
G |
Ly6g6c |
lymphocyte antigen 6 family member G6C |
increases expression |
EXP |
ochratoxin A results in increased expression of LY6G6C mRNA |
CTD |
PMID:30449730 |
|
NCBI chr20:3,753,632...3,757,205
Ensembl chr20:3,753,632...3,758,867
|
|
G |
Mafg |
MAF bZIP transcription factor G |
increases expression |
ISO |
ochratoxin A results in increased expression of MAFG mRNA |
CTD |
PMID:32905824 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Mall |
mal, T-cell differentiation protein-like |
decreases expression |
EXP |
ochratoxin A results in decreased expression of MALL mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 3:114,927,897...114,950,840
Ensembl chr 3:114,927,897...114,950,785
|
|
G |
Maoa |
monoamine oxidase A |
increases methylation |
EXP |
ochratoxin A results in increased methylation of MAOA gene |
CTD |
PMID:26431795 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions increases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [ochratoxin A results in increased expression of MAP1LC3B protein] |
CTD |
PMID:36058351 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of MAP2K1 protein |
CTD |
PMID:25002221 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of MAP2K2 protein |
CTD |
PMID:25002221 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MAP3K1 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
|
|
G |
Map3k14 |
mitogen-activated protein kinase kinase kinase 14 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MAP3K14 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr10:88,165,349...88,215,558
Ensembl chr10:88,165,351...88,215,523
|
|
G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MAP3K8 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
|
|
G |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MAP4K4 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation increases response to substance |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in increased phosphorylation of MAPK1 protein]; Citrinin promotes the reaction [ochratoxin A results in increased phosphorylation of MAPK1 protein]; MAPK1 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CCNB1 protein]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein modified form]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein modified form]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein]; ochratoxin A promotes the reaction [Citrinin results in increased phosphorylation of MAPK1 protein]; ochratoxin A results in increased phosphorylation of and results in increased activity of MAPK1 protein; wortmannin promotes the reaction [ochratoxin A results in increased phosphorylation of MAPK1 protein] MAPK1 protein results in increased susceptibility to ochratoxin A |
CTD |
PMID:11711124 PMID:17651772 PMID:22230261 PMID:23172667 PMID:25002221 PMID:27193732 PMID:29673704 PMID:31154016 More...
|
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk12 |
mitogen-activated protein kinase 12 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of MAPK12 mRNA; ochratoxin A results in decreased expression of MAPK12 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 7:120,206,005...120,216,711
Ensembl chr 7:120,206,271...120,216,664
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions increases expression increases response to substance |
ISO |
MAPK14 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CCNB1 protein]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein modified form]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein modified form]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein] ochratoxin A metabolite results in increased expression of MAPK14 mRNA; ochratoxin A results in increased expression of MAPK14 mRNA MAPK14 protein results in increased susceptibility to ochratoxin A |
CTD |
PMID:22230261 PMID:26314263 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk15 |
mitogen-activated protein kinase 15 |
affects expression |
EXP |
ochratoxin A affects the expression of MAPK15 mRNA |
CTD |
PMID:35843423 |
|
NCBI chr 7:107,694,907...107,714,640
Ensembl chr 7:107,694,964...107,714,645
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in increased phosphorylation of MAPK3 protein]; Citrinin promotes the reaction [ochratoxin A results in increased phosphorylation of MAPK3 protein]; ochratoxin A promotes the reaction [Citrinin results in increased phosphorylation of MAPK3 protein]; ochratoxin A results in increased phosphorylation of and results in increased activity of MAPK3 protein; Wortmannin promotes the reaction [ochratoxin A results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:11711124 PMID:17651772 PMID:22230261 PMID:23172667 PMID:25002221 PMID:27193732 PMID:29673704 PMID:31154016 More...
|
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk4 |
mitogen-activated protein kinase 4 |
increases acetylation affects expression |
ISO EXP |
ochratoxin A results in increased acetylation of MAPK4 promoter ochratoxin A affects the expression of MAPK4 mRNA |
CTD |
PMID:29098329 PMID:35843423 |
|
NCBI chr18:67,512,805...67,661,271
Ensembl chr18:67,512,807...67,661,842
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions increases phosphorylation |
EXP ISO |
ochratoxin A results in increased phosphorylation of and results in increased activity of MAPK8 protein ochratoxin A results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:17651772 PMID:31154016 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk8ip2 |
mitogen-activated protein kinase 8 interacting protein 2 |
affects expression |
EXP |
ochratoxin A affects the expression of MAPK8IP2 mRNA |
CTD |
PMID:35843423 |
|
NCBI chr 7:120,526,732...120,536,982
Ensembl chr 7:120,526,732...120,536,982
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
decreases phosphorylation |
ISO |
ochratoxin A results in decreased phosphorylation of MAPK9 protein |
CTD |
PMID:25002221 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mapre1 |
microtubule-associated protein, RP/EB family, member 1 |
decreases expression decreases acetylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of MAPRE1 mRNA ochratoxin A results in decreased acetylation of MAPRE1 promoter [ochratoxin A results in decreased acetylation of MAPRE1 promoter] which results in decreased expression of MAPRE1 mRNA |
CTD |
PMID:19287073 PMID:29098329 |
|
NCBI chr 3:142,218,846...142,246,990
Ensembl chr 3:142,212,955...142,246,983
|
|
G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
increases expression |
EXP |
ochratoxin A results in increased expression of MARCKS mRNA |
CTD |
PMID:19717638 |
|
NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012
|
|
G |
Mars1 |
methionyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:63,121,142...63,138,550
Ensembl chr 7:63,121,142...63,138,495
|
|
G |
Marveld3 |
MARVEL domain containing 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MARVELD3 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr19:37,908,727...37,923,420
Ensembl chr19:37,905,638...37,923,420
|
|
G |
Mbp |
myelin basic protein |
increases expression decreases expression multiple interactions |
ISO EXP |
ochratoxin A results in increased expression of MBP mRNA ochratoxin A results in decreased expression of MBP mRNA; ochratoxin A results in decreased expression of MBP protein [MT1A protein co-treated with MT2A protein] inhibits the reaction [ochratoxin A results in decreased expression of MBP protein] |
CTD |
PMID:22124623 PMID:24792326 |
|
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of MCL1 mRNA ochratoxin A results in decreased expression of MCL1 mRNA |
CTD |
PMID:19562491 PMID:30763683 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Mcm3 |
minichromosome maintenance complex component 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of MCM3 mRNA |
CTD |
PMID:23208426 |
|
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of MDM2 mRNA ochratoxin A results in decreased expression of MDM2 mRNA |
CTD |
PMID:23358140 PMID:30763683 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Me1 |
malic enzyme 1 |
decreases expression increases expression |
EXP ISO |
ochratoxin A results in decreased expression of ME1 mRNA ochratoxin A results in increased expression of ME1 mRNA |
CTD |
PMID:16251485 PMID:30008028 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Med21 |
mediator complex subunit 21 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MED21 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 4:179,560,509...179,583,811
Ensembl chr 4:179,560,579...179,567,548
|
|
G |
Mefv |
MEFV innate immunity regulator, pyrin |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of MEFV gene |
CTD |
PMID:26431795 |
|
NCBI chr10:11,786,948...11,796,977
Ensembl chr10:11,787,422...11,796,973
|
|
G |
Meltf |
melanotransferrin |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of MELTF gene ochratoxin A results in increased expression of MELTF mRNA |
CTD |
PMID:37162024 |
|
NCBI chr11:68,884,446...68,906,300
Ensembl chr11:68,884,446...68,906,300
|
|
G |
Mesd |
mesoderm development LRP chaperone |
decreases expression |
EXP |
ochratoxin A results in decreased expression of MESD mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:137,866,707...137,879,999
Ensembl chr 1:137,874,242...137,879,999
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
multiple interactions |
ISO |
5-((2,6-dichlorobenzyl)sulfonyl)-3-((3,5-dimethyl-4-((2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-1,3-dihydro-2H-indol-2-one inhibits the reaction [ochratoxin A results in increased phosphorylation of MET protein]; ochratoxin A results in increased phosphorylation of and results in increased expression of MET protein |
CTD |
PMID:25002221 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mettl9 |
methyltransferase 9, His-X-His N1(pi)-histidine |
increases expression |
ISO |
ochratoxin A results in increased expression of METTL9 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:175,575,805...175,623,065
Ensembl chr 1:175,577,890...175,623,061
|
|
G |
Mgat4b |
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MGAT4B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:34,548,918...34,559,229
Ensembl chr10:34,549,433...34,559,229
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
increases expression |
EXP |
ochratoxin A results in increased expression of MGMT mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
decreases expression affects expression |
EXP ISO |
ochratoxin A results in decreased expression of MGST1 mRNA ochratoxin A affects the expression of MGST1 mRNA |
CTD |
PMID:17483316 PMID:22124623 PMID:23358140 PMID:32905824 |
|
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
|
|
G |
Micu3 |
mitochondrial calcium uptake family, member 3 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of MICU3 gene |
CTD |
PMID:26431795 |
|
NCBI chr16:51,919,859...52,010,705
Ensembl chr16:51,925,225...52,010,613
|
|
G |
Mif |
macrophage migration inhibitory factor |
decreases expression |
EXP |
ochratoxin A results in decreased expression of MIF mRNA |
CTD |
PMID:23358140 |
|
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
|
|
G |
Miox |
myo-inositol oxygenase |
affects expression |
EXP |
ochratoxin A affects the expression of MIOX mRNA |
CTD |
PMID:32468156 |
|
NCBI chr 7:120,405,031...120,407,529
Ensembl chr 7:120,405,031...120,407,537
|
|
G |
Mir1 |
microRNA 1 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR1 mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR1 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr18:1,887,537...1,887,623
|
|
G |
Mir122 |
microRNA 122 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR122 mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR122 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr18:58,758,703...58,758,787
|
|
G |
Mir1224 |
microRNA 1224 |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR1224 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr11:80,306,902...80,306,986
Ensembl chr11:80,306,902...80,306,986
|
|
G |
Mir127 |
microRNA 127 |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR127 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 6:128,546,215...128,546,311
Ensembl chr 6:128,546,215...128,546,311
|
|
G |
Mir132 |
microRNA 132 |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR132 mRNA ochratoxin A results in increased expression of MIR132 mRNA |
CTD |
PMID:30428381 PMID:30559759 |
|
NCBI chr10:60,023,696...60,023,796
Ensembl chr10:60,023,696...60,023,796
|
|
G |
Mir134 |
microRNA 134 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MIR134 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:128,748,908...128,748,980
|
|
G |
Mir139 |
microRNA 139 |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR139 mRNA ochratoxin A results in increased expression of MIR139 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:155,878,828...155,878,895
Ensembl chr 1:155,878,825...155,878,902
|
|
G |
Mir141 |
microRNA 141 |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR141 mRNA |
CTD |
PMID:30428381 PMID:30559759 |
|
NCBI chr 4:157,523,239...157,523,332
Ensembl chr 4:157,523,239...157,523,332
|
|
G |
Mir142 |
microRNA 142 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR142 mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR142 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:72,557,864...72,557,950
Ensembl chr10:72,557,857...72,557,967
|
|
G |
Mir144 |
microRNA 144 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR144 mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR144 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:62,961,348...62,961,430
Ensembl chr10:62,961,348...62,961,430
|
|
G |
Mir146a |
microRNA 146a |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR146A mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
|
|
G |
Mir146b |
microRNA 146b |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR146B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:245,203,438...245,203,525
Ensembl chr 1:245,203,438...245,203,525
|
|
G |
Mir147 |
microRNA 147 |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR147B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 3:109,722,692...109,722,770
Ensembl chr 3:109,722,692...109,722,770
|
|
G |
Mir148a |
microRNA 148a |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR148A mRNA |
CTD |
PMID:26341324 |
|
NCBI chr 4:80,333,762...80,333,858
Ensembl chr 4:80,333,762...80,333,858
|
|
G |
Mir152 |
microRNA 152 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR152 mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR152 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:81,832,936...81,833,020
Ensembl chr10:81,832,936...81,833,020
|
|
G |
Mir184 |
microRNA 184 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR184 mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR184 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 8:90,343,134...90,343,210
Ensembl chr 8:90,343,134...90,343,210
|
|
G |
Mir187 |
microRNA 187 |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR187 mRNA ochratoxin A results in increased expression of MIR187 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr18:15,731,194...15,731,297
Ensembl chr18:15,731,194...15,731,297
|
|
G |
Mir190b |
microRNA 190b |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR190B mRNA ochratoxin A results in increased expression of MIR190B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 2:175,514,800...175,514,877
Ensembl chr 2:175,514,800...175,514,877
|
|
G |
Mir200b |
microRNA 200b |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR200B mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR200B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 5:166,649,272...166,649,366
Ensembl chr 5:166,649,272...166,649,366
|
|
G |
Mir200c |
microRNA 200c |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR200C mRNA ochratoxin A results in increased expression of MIR200C mRNA |
CTD |
PMID:30428381 PMID:30559759 |
|
NCBI chr 4:157,523,679...157,523,747
|
|
G |
Mir21 |
microRNA 21 |
increases expression decreases expression |
ISO |
ochratoxin A results in increased expression of MIR21A mRNA ochratoxin A results in decreased expression of MIR21 mRNA |
CTD |
PMID:28710020 PMID:30559759 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir219a1 |
microRNA 219a-1 |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR219A1 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr20:4,829,687...4,829,796
Ensembl chr20:4,829,687...4,829,796
|
|
G |
Mir23b |
microRNA 23b |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MIR23B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr17:1,813,667...1,813,763
Ensembl chr17:1,813,667...1,813,763
|
|
G |
Mir295-1 |
microRNA 295-1 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR372 mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR372 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:65,962,566...65,962,646
Ensembl chr 1:65,962,566...65,962,646
|
|
G |
Mir29b1 |
microRNA 29b-1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MIR29B1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:59,650,987...59,651,067
Ensembl chr 4:59,650,986...59,651,067
|
|
G |
Mir32 |
microRNA 32 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MIR32 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 5:71,596,083...71,596,152
Ensembl chr 5:71,596,083...71,596,152
|
|
G |
Mir331 |
microRNA 331 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MIR331 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:28,527,390...28,527,485
Ensembl chr 7:28,527,390...28,527,485
|
|
G |
Mir34a |
microRNA 34a |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR34A mRNA sulforaphane inhibits the reaction [ochratoxin A results in increased expression of MIR34A mRNA] |
CTD |
PMID:28710020 |
|
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
|
|
G |
Mir34b |
microRNA 34b |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR34B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 8:51,410,244...51,410,327
Ensembl chr 8:51,410,244...51,410,327
|
|
G |
Mir34c |
microRNA 34c |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR34C mRNA ochratoxin A results in increased expression of MIR34C mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 8:51,409,726...51,409,802
Ensembl chr 8:51,409,726...51,409,802
|
|
G |
Mir374b |
microRNA 374b |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MIR374B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr X:68,591,732...68,591,799
Ensembl chr X:68,591,732...68,591,799
|
|
G |
Mir449a |
microRNA 449a |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR449A mRNA ochratoxin A results in increased expression of MIR449A mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 2:44,670,714...44,670,804
Ensembl chr 2:44,670,714...44,670,804
|
|
G |
Mir449c |
microRNA 449c |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR449C mRNA ochratoxin A results in increased expression of MIR449C mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 2:44,669,179...44,669,277
Ensembl chr 2:44,669,179...44,669,277
|
|
G |
Mir497 |
microRNA 497 |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR497 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:54,951,514...54,951,582
Ensembl chr10:54,951,505...54,951,584
|
|
G |
Mir542 |
microRNA 542 |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR542 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:132,802,623...132,802,701
Ensembl chr X:132,802,623...132,802,701
|
|
G |
Mir92b |
microRNA 92b |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MIR92B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 2:174,633,890...174,633,972
Ensembl chr 2:174,633,890...174,633,972
|
|
G |
Mis18bp1 |
MIS18 binding protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MIS18BP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:83,182,497...83,231,978
Ensembl chr 6:83,182,499...83,231,383
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of MKI67 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of MKI67 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mlc1 |
modulator of VRAC current 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of MLC1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 7:120,046,705...120,067,049
Ensembl chr 7:120,046,705...120,067,049
|
|
G |
Mme |
membrane metallo-endopeptidase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of MME mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
|
|
G |
Mmp11 |
matrix metallopeptidase 11 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of MMP11 promoter] which results in increased expression of MMP11 mRNA ochratoxin A results in increased expression of MMP11 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:12,730,846...12,739,629
Ensembl chr20:12,730,836...12,739,628
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MMP2 mRNA ochratoxin A results in increased expression of and results in increased activity of MMP2 protein ochratoxin A results in increased expression of MMP2 mRNA; ochratoxin A results in increased expression of MMP2 protein |
CTD |
PMID:31154016 PMID:32617660 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions increases expression |
EXP ISO |
Ethanol affects the reaction [ochratoxin A results in increased expression of MMP9 protein] ochratoxin A results in increased expression of and results in increased activity of MMP9 protein ochratoxin A results in increased expression of MMP9 mRNA ochratoxin A results in increased expression of MMP9 mRNA; ochratoxin A results in increased expression of MMP9 protein NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of MMP9 protein] |
CTD |
PMID:16622519 PMID:28710020 PMID:32617660 PMID:37162024 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mog |
myelin oligodendrocyte glycoprotein |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of MOG mRNA; ochratoxin A results in decreased expression of MOG protein SHH protein inhibits the reaction [ochratoxin A results in decreased expression of MOG mRNA] |
CTD |
PMID:24792326 |
|
NCBI chr20:1,513,137...1,523,473
Ensembl chr20:1,513,239...1,523,474
|
|
G |
Morf4l1 |
mortality factor 4 like 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of MORF4L1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 8:90,642,988...90,664,518
Ensembl chr 8:90,642,988...90,664,519
|
|
G |
Mpdu1 |
mannose-P-dolichol utilization defect 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MPDU1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr10:54,374,719...54,380,301
Ensembl chr10:54,374,725...54,380,447
|
|
G |
Mpg |
N-methylpurine-DNA glycosylase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of MPG mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:15,396,246...15,402,528
Ensembl chr10:15,395,782...15,402,520
|
|
G |
Mprip |
myosin phosphatase Rho interacting protein |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MPRIP mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:44,453,949...44,573,843
Ensembl chr10:44,453,929...44,569,118
|
|
G |
Mrc1 |
mannose receptor, C type 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of MRC1 mRNA |
CTD |
PMID:24792326 |
|
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
|
|
G |
Mrc2 |
mannose receptor, C type 2 |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of MRC2 promoter ochratoxin A results in increased expression of MRC2 mRNA [ochratoxin A results in increased acetylation of MRC2 promoter] which results in increased expression of MRC2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:90,261,986...90,323,187
Ensembl chr10:90,261,394...90,322,856
|
|
G |
Mri1 |
methylthioribose-1-phosphate isomerase 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of MRI1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr19:23,907,327...23,913,721
Ensembl chr19:23,907,335...23,913,320
|
|
G |
Mrpl54 |
mitochondrial ribosomal protein L54 |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of MRPL54 mRNA ochratoxin A results in increased methylation of MRPL54 gene |
CTD |
PMID:37162024 |
|
NCBI chr 7:8,452,801...8,455,321
Ensembl chr 7:8,452,716...8,455,321
|
|
G |
Mrps34 |
mitochondrial ribosomal protein S34 |
increases methylation decreases expression |
EXP |
ochratoxin A results in increased methylation of MRPS34 gene ochratoxin A results in decreased expression of MRPS34 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr10:13,916,024...13,917,155
Ensembl chr10:13,916,026...13,918,406
|
|
G |
Mrtfa |
myocardin related transcription factor A |
increases expression |
EXP |
ochratoxin A results in increased expression of MRTFA mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 7:112,544,305...112,714,418
Ensembl chr 7:112,544,312...112,714,418
|
|
G |
Msh5 |
mutS homolog 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of MSH5 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr20:3,773,867...3,793,337
Ensembl chr20:3,776,942...3,793,336
|
|
G |
Msln |
mesothelin |
increases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in increased expression of MSLN mRNA ochratoxin A results in increased acetylation of MSLN promoter [ochratoxin A results in increased acetylation of MSLN promoter] which results in increased expression of MSLN mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
|
|
G |
Msra |
methionine sulfoxide reductase A |
affects expression |
EXP |
ochratoxin A affects the expression of MSRA mRNA |
CTD |
PMID:17483316 |
|
NCBI chr15:38,363,459...38,677,406
Ensembl chr15:38,351,445...38,676,585
|
|
G |
Mt-atp6 |
mitochondrially encoded ATP synthase membrane subunit 6 |
multiple interactions increases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ATP6 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ATP6 mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of ATP6 mRNA ochratoxin A results in increased expression of ATP6 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
|
|
G |
Mt-atp8 |
mitochondrially encoded ATP synthase membrane subunit 8 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of ATP8 mRNA; [Zearalenone co-treated with ochratoxin A] results in decreased expression of ATP8 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
|
|
G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
multiple interactions decreases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with ochratoxin A] results in decreased expression of COX1 mRNA; [Zearalenone co-treated with ochratoxin A] results in decreased expression of COX1 mRNA ochratoxin A results in decreased expression of COX1 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
|
|
G |
Mt-co3 |
mitochondrially encoded cytochrome c oxidase III |
multiple interactions decreases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with ochratoxin A] results in decreased expression of COX3 mRNA; [Zearalenone co-treated with ochratoxin A] results in decreased expression of COX3 mRNA ochratoxin A results in decreased expression of COX3 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382
Ensembl chr MT:8,599...9,382
|
|
G |
Mt-nd2 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 |
multiple interactions increases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of ND2 mRNA; [Zearalenone co-treated with ochratoxin A] results in increased expression of ND2 mRNA ochratoxin A results in increased expression of ND2 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942
Ensembl chr MT:3,904...4,942
|
|
G |
Mt-nd3 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of ND3 mRNA; [Zearalenone co-treated with ochratoxin A] results in increased expression of ND3 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798
Ensembl chr MT:9,451...9,798
|
|
G |
Mt-nd4 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of ND4 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ND4 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ND4 mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of ND4 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537
Ensembl chr MT:10,160...11,537
|
|
G |
Mt-nd4l |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND4L mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of ND4L mRNA; [Zearalenone co-treated with ochratoxin A] results in increased expression of ND4L mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166
Ensembl chr MT:9,870...10,166
|
|
G |
Mt-nd5 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of ND5 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND5 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in increased expression of ND5 mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of ND5 mRNA; [Zearalenone co-treated with ochratoxin A] results in increased expression of ND5 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565
Ensembl chr MT:11,736...13,565
|
|
G |
Mt-nd6 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ND6 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in increased expression of ND6 mRNA; [Zearalenone co-treated with ochratoxin A] results in increased expression of ND6 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
|
|
G |
Mt1 |
metallothionein 1 |
decreases expression multiple interactions increases expression |
EXP ISO |
ochratoxin A results in decreased expression of MT1A protein [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with Zinc co-treated with ochratoxin A] results in increased expression of MT1A mRNA; Zinc promotes the reaction [ochratoxin A results in increased expression of MT1A mRNA] [MT1A protein co-treated with MT2A protein] inhibits the reaction [ochratoxin A results in decreased expression of MBP protein] |
CTD |
PMID:19720134 PMID:23391613 PMID:24792326 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
|
|
G |
Mt2A |
metallothionein 2A |
multiple interactions decreases expression increases expression |
ISO EXP |
[N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with Zinc co-treated with ochratoxin A] results in increased expression of MT2A mRNA; Zinc deficiency inhibits the reaction [ochratoxin A results in increased expression of MT2A mRNA]; Zinc promotes the reaction [ochratoxin A results in increased expression of MT2A mRNA] [MT1A protein co-treated with MT2A protein] inhibits the reaction [ochratoxin A results in decreased expression of MBP protein] ochratoxin A results in decreased expression of MT2A protein |
CTD |
PMID:19720134 PMID:23391613 PMID:24792326 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mterf3 |
mitochondrial transcription termination factor 3 |
decreases expression multiple interactions decreases acetylation |
ISO |
ochratoxin A results in decreased expression of MTERF3 mRNA [ochratoxin A results in decreased acetylation of MTERF3 promoter] which results in decreased expression of MTERF3 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:63,826,418...63,844,747
Ensembl chr 7:63,826,427...63,844,658
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
increases phosphorylation decreases expression multiple interactions |
ISO |
ochratoxin A results in increased phosphorylation of MTOR protein ochratoxin A results in decreased expression of MTOR mRNA INS protein inhibits the reaction [ochratoxin A results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:25002221 PMID:30287338 PMID:34748853 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mtus1 |
microtubule associated scaffold protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MTUS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr16:51,202,497...51,347,794
Ensembl chr16:51,253,562...51,347,793
|
|
G |
Muc1 |
mucin 1, cell surface associated |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MUC1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
[Aflatoxin M1 co-treated with ochratoxin A] results in decreased secretion of MUC2 protein; [Aflatoxin M1 co-treated with ochratoxin A] results in increased expression of MUC2 mRNA; [Aflatoxin M1 co-treated with Zearalenone co-treated with ochratoxin A] results in decreased expression of MUC2 mRNA; [Aflatoxin M1 co-treated with Zearalenone co-treated with ochratoxin A] results in decreased secretion of MUC2 protein |
CTD |
PMID:30904571 |
|
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
[Aflatoxin M1 co-treated with Zearalenone co-treated with ochratoxin A] results in decreased expression of MUC5AC mRNA; [Aflatoxin M1 co-treated with Zearalenone co-treated with ochratoxin A] results in increased secretion of MUC5AC protein |
CTD |
PMID:30904571 |
|
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
|
|
G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
[Aflatoxin M1 co-treated with ochratoxin A] results in decreased expression of MUC5B mRNA; [Aflatoxin M1 co-treated with ochratoxin A] results in decreased secretion of MUC5B protein; [Aflatoxin M1 co-treated with Zearalenone co-treated with ochratoxin A] results in decreased expression of MUC5B mRNA; [Aflatoxin M1 co-treated with Zearalenone co-treated with ochratoxin A] results in decreased secretion of MUC5B protein |
CTD |
PMID:30904571 |
|
NCBI chr 1:196,916,861...196,948,830
Ensembl chr 1:196,916,825...196,949,250
|
|
G |
Mybl1 |
MYB proto-oncogene like 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of MYBL1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:9,582,934...9,618,183
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression multiple interactions increases expression |
ISO EXP |
ochratoxin A results in decreased expression of MYC mRNA sulforaphane inhibits the reaction [ochratoxin A results in increased expression of MYC mRNA] |
CTD |
PMID:16251485 PMID:17316727 PMID:19237604 PMID:19717638 PMID:28710020 PMID:30763683 PMID:31154016 PMID:37162024 More...
|
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myo1b |
myosin Ib |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MYO1B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:49,690,043...49,852,373
Ensembl chr 9:49,690,086...49,850,798
|
|
G |
Myof |
myoferlin |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MYOF protein |
CTD |
PMID:26861962 |
|
NCBI chr 1:235,673,666...235,822,413
Ensembl chr 1:235,673,666...235,822,334
|
|
G |
Naa40 |
N(alpha)-acetyltransferase 40, NatD catalytic subunit |
decreases expression |
ISO |
ochratoxin A results in decreased expression of NAA40 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 1:204,410,636...204,430,890
Ensembl chr 1:204,413,498...204,430,717
|
|
G |
Naga |
alpha-N-acetylgalactosaminidase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of NAGA mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 7:113,846,358...113,855,430
Ensembl chr 7:113,846,374...113,855,315
|
|
G |
Nagk |
N-acetylglucosamine kinase |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of NAGK mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 4:116,281,179...116,293,870
Ensembl chr 4:116,281,328...116,313,137
|
|
G |
Nanos1 |
nanos C2HC-type zinc finger 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of NANOS1 mRNA; ochratoxin A results in decreased expression of NANOS1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 1:259,897,663...259,901,561
Ensembl chr 1:259,897,939...259,898,730
|
|
G |
Naprt |
nicotinate phosphoribosyltransferase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NAPRT mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 7:107,576,645...107,580,102
Ensembl chr 7:107,576,627...107,580,102
|
|
G |
Nat2 |
N-acetyltransferase 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of NAT2 mRNA |
CTD |
PMID:26505656 |
|
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Nat8 |
N-acetyltransferase 8 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NAT8 mRNA |
CTD |
PMID:17483316 PMID:18417182 |
|
NCBI chr 4:118,279,521...118,284,671
Ensembl chr 4:118,270,954...118,281,763
|
|
G |
Nat8b |
N-acetyltransferase 8B |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NAT8B mRNA |
CTD |
PMID:17483316 PMID:30449730 |
|
NCBI chr 4:118,359,445...118,364,351
Ensembl chr 4:118,359,443...118,363,563
|
|
G |
Nat8f1 |
N-acetyltransferase 8 (GCN5-related) family member 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NAT8F1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 4:118,336,208...118,342,923
Ensembl chr 4:118,332,862...118,344,035
|
|
G |
Nat8f2 |
N-acetyltransferase 8 (GCN5-related) family member 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of NAT8F2 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 4:118,319,984...118,323,159
Ensembl chr 4:118,319,988...118,324,395
|
|
G |
Nat8f3 |
N-acetyltransferase 8 (GCN5-related) family member 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NAT8F3 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 4:118,241,792...118,246,010
Ensembl chr 4:118,239,304...118,285,500
|
|
G |
Ncbp1 |
nuclear cap binding protein subunit 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NCBP1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 5:60,416,023...60,449,004
Ensembl chr 5:60,415,982...60,449,089
|
|
G |
Ncoa3 |
nuclear receptor coactivator 3 |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of NCOA3 promoter ochratoxin A results in decreased expression of NCOA3 mRNA [ochratoxin A results in decreased acetylation of NCOA3 promoter] which results in decreased expression of NCOA3 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:154,738,566...154,821,395
Ensembl chr 3:154,738,581...154,818,594
|
|
G |
Ndufa1 |
NADH:ubiquinone oxidoreductase subunit A1 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFA1 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr X:116,424,223...116,427,875
Ensembl chr X:116,424,223...116,428,633
|
|
G |
Ndufa10 |
NADH:ubiquinone oxidoreductase subunit A10 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFA10 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 9:93,007,034...93,041,825
Ensembl chr 9:93,007,042...93,042,560
|
|
G |
Ndufa2 |
NADH:ubiquinone oxidoreductase subunit A2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of NDUFA2 mRNA |
CTD |
PMID:34481902 |
|
NCBI chr18:28,355,774...28,357,863
Ensembl chr18:28,355,774...28,358,076
|
|
G |
Ndufa3 |
NADH:ubiquinone oxidoreductase subunit A3 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFA3 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 1:65,597,567...65,600,197
Ensembl chr 1:65,597,578...65,600,235
|
|
G |
Ndufa7 |
NADH:ubiquinone oxidoreductase subunit A7 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFA7 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 7:14,609,283...14,622,064
Ensembl chr 7:14,609,146...14,631,976
|
|
G |
Ndufb2 |
NADH:ubiquinone oxidoreductase subunit B2 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFB2 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 4:68,367,526...68,374,609
Ensembl chr15:46,536,062...46,536,851 Ensembl chr 4:46,536,062...46,536,851
|
|
G |
Ndufb7 |
NADH:ubiquinone oxidoreductase subunit B7 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFB7 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr19:24,568,241...24,572,579
Ensembl chr19:24,568,241...24,572,579
|
|
G |
Ndufc1 |
NADH:ubiquinone oxidoreductase subunit C1 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFC1 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 2:135,447,067...135,450,950
Ensembl chr 2:135,447,119...135,450,874
|
|
G |
Ndufs1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of NDUFS1 protein |
CTD |
PMID:26861962 |
|
NCBI chr 9:64,546,430...64,579,751
Ensembl chr 9:64,546,225...64,579,893
|
|
G |
Ndufs6 |
NADH:ubiquinone oxidoreductase subunit S6 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFS6 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 1:29,968,833...29,977,423
Ensembl chr 1:29,968,842...29,977,467
|
|
G |
Ndufs7 |
NADH:ubiquinone oxidoreductase core subunit S7 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFS7 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 7:9,452,556...9,460,135
Ensembl chr 7:9,450,392...9,460,195
|
|
G |
Ndufs8 |
NADH:ubiquinone oxidoreductase core subunit S8 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NDUFS8 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:201,140,585...201,144,573
Ensembl chr 1:201,140,585...201,144,511
|
|
G |
Ndufv2 |
NADH:ubiquinone oxidoreductase core subunit V2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NDUFV2 protein |
CTD |
PMID:31369848 |
|
NCBI chr 9:105,690,454...105,710,669
Ensembl chr 9:105,690,455...105,710,713
|
|
G |
Necab2 |
N-terminal EF-hand calcium binding protein 2 |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of NECAB2 mRNA ochratoxin A results in decreased methylation of NECAB2 gene |
CTD |
PMID:18417182 PMID:37162024 |
|
NCBI chr19:47,501,351...47,527,722
Ensembl chr19:47,501,302...47,527,684
|
|
G |
Nectin1 |
nectin cell adhesion molecule 1 |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of NECTIN1 promoter [ochratoxin A results in increased acetylation of NECTIN1 promoter] which results in increased expression of NECTIN1 mRNA ochratoxin A results in increased expression of NECTIN1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:44,101,776...44,164,863
Ensembl chr 8:44,101,776...44,189,787
|
|
G |
Nefh |
neurofilament heavy chain |
multiple interactions |
EXP |
ochratoxin A results in decreased expression of and results in decreased phosphorylation of NEFH protein |
CTD |
PMID:24792326 |
|
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
|
|
G |
Nes |
nestin |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of NES mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of NES mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
|
|
G |
Neto2 |
neuropilin and tolloid like 2 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of NETO2 promoter |
CTD |
PMID:29098329 |
|
NCBI chr19:21,344,299...21,415,524
Ensembl chr19:21,344,289...21,417,023
|
|
G |
Neurl2 |
neuralized E3 ubiquitin protein ligase 2 |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of NEURL2 mRNA ochratoxin A results in increased methylation of NEURL2 gene |
CTD |
PMID:37162024 |
|
NCBI chr 3:153,566,659...153,569,380
Ensembl chr 3:153,566,660...153,569,380
|
|
G |
Neurod1 |
neuronal differentiation 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NEUROD1 mRNA |
CTD |
PMID:21703336 |
|
NCBI chr 3:64,359,554...64,363,526
Ensembl chr 3:64,359,395...64,363,649
|
|
G |
Nexn |
nexilin (F actin binding protein) |
increases expression |
EXP |
ochratoxin A results in increased expression of NEXN mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:241,186,783...241,218,315
Ensembl chr 2:241,186,790...241,218,342
|
|
G |
Nf1 |
neurofibromin 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of NF1 mRNA; ochratoxin A results in increased expression of NF1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:64,306,027...64,539,112
Ensembl chr10:64,306,301...64,536,658
|
|
G |
Nfatc1 |
nuclear factor of activated T-cells 1 |
increases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in increased expression of NFATC1 mRNA ochratoxin A results in increased acetylation of NFATC1 promoter [ochratoxin A results in increased acetylation of NFATC1 promoter] which results in increased expression of NFATC1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions increases methylation affects localization increases expression affects response to substance decreases activity |
EXP ISO |
[cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased activity of NFE2L2 protein]; ochratoxin A inhibits the reaction [NFE2L2 protein binds to GSTP1 protein] ochratoxin A results in increased methylation of NFE2L2 promoter AHR protein affects the reaction [ochratoxin A results in increased expression of NFE2L2 mRNA]; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of NFE2L2 mRNA] ochratoxin A affects the localization of NFE2L2 protein NFE2L2 protein affects the susceptibility to ochratoxin A [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of CAT mRNA; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of GSR mRNA; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of VEGFA mRNA; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of VEGFA protein; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased abundance of Creatinine; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of BBC3 protein; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of ICAM1 protein; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of TGFB1 protein; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of TIMP2 mRNA; NFE2L2 protein affects the reaction [ochratoxin A results in decreased expression of TGFB2 mRNA]; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of FN1 mRNA]; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of IL1B mRNA]; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of MMP9 protein]; ochratoxin A affects the reaction [NFE2L2 protein affects the expression of HMOX1 mRNA]; ochratoxin A promotes the reaction [NFE2L2 protein affects the expression of BBC3 mRNA] |
CTD |
PMID:17110534 PMID:24120684 PMID:28710020 PMID:30291945 PMID:30559759 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfe2l3 |
NFE2 like bZIP transcription factor 3 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of NFE2L3 mRNA; ochratoxin A results in decreased expression of NFE2L3 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 4:80,506,756...80,534,629
Ensembl chr 4:80,506,756...80,534,629
|
|
G |
Nfia |
nuclear factor I/A |
increases expression |
EXP |
ochratoxin A results in increased expression of NFIA mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 5:112,436,655...112,781,878
Ensembl chr 5:112,436,644...112,775,885
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
increases degradation decreases expression increases phosphorylation |
ISO |
ochratoxin A results in increased degradation of NFKBIA protein ochratoxin A results in decreased expression of NFKBIA mRNA ochratoxin A results in increased phosphorylation of NFKBIA protein |
CTD |
PMID:18647641 PMID:23172667 PMID:30763683 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nisch |
nischarin |
increases expression |
EXP |
ochratoxin A results in increased expression of NISCH mRNA |
CTD |
PMID:23358140 |
|
NCBI chr16:6,364,370...6,400,675
Ensembl chr16:6,364,374...6,400,668
|
|
G |
Nit2 |
nitrilase family, member 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NIT2 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr11:43,363,839...43,378,713
Ensembl chr11:43,363,985...43,375,024
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of NLRP3 mRNA; ochratoxin A results in increased expression of NLRP3 protein |
CTD |
PMID:33543323 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nmb |
neuromedin B |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of NMB gene ochratoxin A results in increased expression of NMB mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 1:134,869,446...134,875,507
Ensembl chr 1:134,869,446...134,872,190
|
|
G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of NME2 protein |
CTD |
PMID:26861962 |
|
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538
|
|
G |
Nnt |
nicotinamide nucleotide transhydrogenase |
increases expression |
ISO |
ochratoxin A results in increased expression of NNT protein |
CTD |
PMID:26861962 |
|
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression multiple interactions |
ISO EXP |
ochratoxin A results in increased expression of NOS2 protein ochratoxin A results in increased expression of NOS2 mRNA; ochratoxin A results in increased expression of NOS2 protein ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [ochratoxin A results in increased expression of NOS2 mRNA]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of NOS2 mRNA] |
CTD |
PMID:15994020 PMID:18647641 PMID:19414514 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Notch1 |
notch receptor 1 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of NOTCH1 promoter |
CTD |
PMID:29098329 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Notch2 |
notch receptor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of NOTCH2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088
|
|
G |
Noxa1 |
NADPH oxidase activator 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NOXA1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 3:7,895,488...7,907,011
Ensembl chr 3:7,895,488...7,905,967
|
|
G |
Npc1l1 |
NPC1 like intracellular cholesterol transporter 1 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of NPC1L1 gene |
CTD |
PMID:26431795 |
|
NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113
|
|
G |
Npm1 |
nucleophosmin 1 |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of NPM1 protein ochratoxin A results in increased expression of NPM1 mRNA |
CTD |
PMID:19445961 PMID:23358140 |
|
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645
|
|
G |
Nppa |
natriuretic peptide A |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of NPPA gene ochratoxin A results in increased expression of NPPA mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
decreases expression increases activity multiple interactions increases expression |
EXP ISO |
ochratoxin A results in decreased expression of NQO1 mRNA; ochratoxin A results in decreased expression of NQO1 protein ochratoxin A results in increased activity of NQO1 protein [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of NQO1 protein] ochratoxin A results in increased expression of NQO1 mRNA |
CTD |
PMID:17110534 PMID:17316727 PMID:19717638 PMID:25209566 PMID:30291945 PMID:30559759 More...
|
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nqo2 |
N-ribosyldihydronicotinamide:quinone dehydrogenase 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NQO2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr17:30,909,482...30,938,725
Ensembl chr17:30,909,187...30,938,320
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions affects localization increases expression decreases expression |
ISO |
Dactinomycin inhibits the reaction [ochratoxin A results in decreased expression of NR1I2 mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of GCLC mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of HMOX1 mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of NFE2L2 mRNA]; ochratoxin A inhibits the reaction [Rifampin results in increased activity of NR1I2 protein] ochratoxin A affects the localization of NR1I2 protein ochratoxin A results in increased expression of NR1I2 mRNA ochratoxin A analog results in decreased expression of NR1I2 protein; ochratoxin A results in decreased expression of NR1I2 mRNA; ochratoxin A results in decreased expression of NR1I2 protein |
CTD |
PMID:26341324 PMID:30291945 PMID:32659470 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nrdc |
nardilysin convertase |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of NRDC mRNA; ochratoxin A results in increased expression of NRDC mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 5:123,755,807...123,818,910
Ensembl chr 5:123,755,806...123,818,595
|
|
G |
Nrde2 |
NRDE-2, necessary for RNA interference, domain containing |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of NRDE2 gene |
CTD |
PMID:26431795 |
|
NCBI chr 6:119,405,103...119,446,861
Ensembl chr 6:119,404,334...119,448,915
|
|
G |
Nrg1 |
neuregulin 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of NRG1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
|
|
G |
Ntrk1 |
neurotrophic receptor tyrosine kinase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of NTRK1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
|
|
G |
Nudt15 |
nudix hydrolase 15 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NUDT15 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr15:48,707,776...48,713,847
Ensembl chr15:48,709,700...48,747,363
|
|
G |
Nudt21 |
nudix hydrolase 21 |
increases expression |
EXP |
ochratoxin A results in increased expression of NUDT21 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr19:10,974,800...10,993,841
Ensembl chr19:10,974,241...10,991,682
|
|
G |
Nuf2 |
NUF2 component of NDC80 kinetochore complex |
increases expression |
EXP |
ochratoxin A results in increased expression of NUF2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr13:81,693,675...81,722,765
Ensembl chr13:81,693,598...81,722,766
|
|
G |
Nup133 |
nucleoporin 133 |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of NUP133 promoter [ochratoxin A results in decreased acetylation of NUP133 promoter] which results in decreased expression of NUP133 mRNA ochratoxin A results in decreased expression of NUP133 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr19:51,891,606...51,941,243
Ensembl chr19:51,891,629...51,941,239
|
|
G |
Nup50 |
nucleoporin 50 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NUP50 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 7:116,047,960...116,065,231
Ensembl chr 7:116,048,021...116,066,905
|
|
G |
Nup88 |
nucleoporin 88 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NUP88 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:55,667,903...55,692,249
Ensembl chr10:55,667,906...55,692,257
|
|
G |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NXPE2 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 8:48,661,708...48,695,555
Ensembl chr 8:48,661,708...48,698,035
|
|
G |
Oat |
ornithine aminotransferase |
increases expression decreases methylation decreases expression |
ISO EXP |
ochratoxin A results in increased expression of OAT protein ochratoxin A results in decreased methylation of OAT gene ochratoxin A results in decreased expression of OAT mRNA |
CTD |
PMID:16251485 PMID:18417182 PMID:19445961 PMID:26431795 |
|
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
|
|
G |
Ocln |
occludin |
decreases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of OCLN mRNA ochratoxin A results in increased acetylation of OCLN promoter illite affects the reaction [ochratoxin A results in decreased expression of OCLN mRNA] |
CTD |
PMID:27153755 PMID:29098329 PMID:30763683 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
increases activity |
ISO |
ochratoxin A results in increased activity of ODC1 protein |
CTD |
PMID:23172667 |
|
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
|
|
G |
Ogdh |
oxoglutarate dehydrogenase |
decreases methylation decreases expression |
EXP ISO |
ochratoxin A results in decreased methylation of OGDH gene ochratoxin A results in decreased expression of OGDH protein |
CTD |
PMID:26431795 PMID:32835834 |
|
NCBI chr14:81,150,021...81,217,479
Ensembl chr14:81,150,091...81,217,479
|
|
G |
Ogfrl1 |
opioid growth factor receptor-like 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of OGFRL1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:25,828,865...25,842,424
Ensembl chr 9:25,828,869...25,842,352
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of OGG1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Olig2 |
oligodendrocyte transcription factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of OLIG2 mRNA |
CTD |
PMID:34748853 |
|
NCBI chr11:30,475,510...30,478,886
Ensembl chr11:30,475,398...30,480,152
|
|
G |
Oosp1 |
oocyte secreted protein 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of OOSP1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 1:208,515,497...208,547,077
|
|
G |
Or2d2 |
olfactory receptor family 2 subfamily D member 2 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of OR2D2 gene |
CTD |
PMID:26431795 |
|
NCBI chr 1:160,979,415...160,980,362
Ensembl chr 1:160,979,043...160,983,787
|
|
G |
Or6c75 |
olfactory receptor family 6 subfamily C member 75 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of OR6C75 gene |
CTD |
PMID:26431795 |
|
NCBI chr 7:5,400,918...5,401,862
Ensembl chr 7:5,398,500...5,403,735
|
|
G |
Ormdl2 |
ORMDL sphingolipid biosynthesis regulator 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ORMDL2 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 7:1,247,869...1,250,999
Ensembl chr 7:1,246,479...1,250,907
|
|
G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of OSGIN1 mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of OSGIN1 mRNA; [Zearalenone co-treated with ochratoxin A] results in increased expression of OSGIN1 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
|
|
G |
Osm |
oncostatin M |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of OSM gene ochratoxin A results in increased expression of OSM mRNA |
CTD |
PMID:37162024 |
|
NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
|
|
G |
Pag1 |
phosphoprotein membrane anchor with glycosphingolipid microdomains 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of PAG1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:91,935,378...92,076,937
Ensembl chr 2:92,057,216...92,069,849
|
|
G |
Pak3 |
p21 (RAC1) activated kinase 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of PAK3 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr X:107,116,308...107,374,342
Ensembl chr X:107,260,898...107,368,314
|
|
G |
Papola |
poly (A) polymerase alpha |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PAPOLA mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 6:124,682,015...124,734,706
Ensembl chr 6:124,682,105...124,734,468
|
|
G |
Pard6b |
par-6 family cell polarity regulator beta |
increases expression decreases expression |
ISO |
ochratoxin A metabolite results in increased expression of PARD6B mRNA; ochratoxin A results in increased expression of PARD6B mRNA ochratoxin A results in decreased expression of PARD6B mRNA |
CTD |
PMID:26314263 PMID:30763683 |
|
NCBI chr 3:156,790,540...156,811,620
Ensembl chr 3:156,790,540...156,811,622
|
|
G |
Parm1 |
prostate androgen-regulated mucin-like protein 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PARM1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr14:16,468,309...16,577,339
Ensembl chr14:16,468,459...16,577,314
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage increases expression multiple interactions decreases expression |
ISO |
ochratoxin A results in increased cleavage of PARP1 protein ochratoxin A results in increased expression of PARP1 protein [Aflatoxin M1 co-treated with ochratoxin A] results in increased expression of PARP1 protein ochratoxin A results in decreased expression of PARP1 mRNA |
CTD |
PMID:25002221 PMID:34126166 PMID:34481902 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Parp12 |
poly (ADP-ribose) polymerase family, member 12 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PARP12 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:67,826,548...67,885,356
Ensembl chr 4:67,839,237...67,883,685
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
multiple interactions decreases expression decreases activity |
EXP |
ochratoxin A inhibits the reaction [Cyclic AMP results in increased expression of PCK1 mRNA] ochratoxin A results in decreased expression of PCK1 mRNA; ochratoxin A results in decreased expression of PCK1 protein ochratoxin A results in decreased activity of PCK1 protein |
CTD |
PMID:2569870 PMID:3753873 PMID:6859860 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pck2 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PCK2 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression increases expression |
ISO EXP |
ochratoxin A results in decreased expression of PCNA mRNA ochratoxin A results in increased expression of PCNA; ochratoxin A results in increased expression of PCNA mRNA |
CTD |
PMID:17316727 PMID:23358140 PMID:25218026 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdcd10 |
programmed cell death 10 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PDCD10 mRNA; ochratoxin A results in decreased expression of PDCD10 protein |
CTD |
PMID:30428381 |
|
NCBI chr 2:160,303,465...160,346,086
Ensembl chr 2:160,303,449...160,346,018
|
|
G |
Pdcd2 |
programmed cell death 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PDCD2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:56,484,947...56,490,437
Ensembl chr 1:56,463,931...56,490,437
|
|
G |
Pdcd4 |
programmed cell death 4 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of PDCD4 mRNA ochratoxin A results in decreased expression of PDCD4 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
|
|
G |
Pde4dip |
phosphodiesterase 4D interacting protein |
increases expression |
EXP |
ochratoxin A results in increased expression of PDE4DIP mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:185,293,236...185,490,100
Ensembl chr 2:185,293,214...185,468,379
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of PDGFRA mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of PDGFRA mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
|
|
G |
Pdhb |
pyruvate dehydrogenase E1 subunit beta |
increases expression |
ISO |
ochratoxin A results in increased expression of PDHB protein |
CTD |
PMID:19445961 |
|
NCBI chr15:16,752,561...16,758,503
Ensembl chr15:16,750,980...16,758,500
|
|
G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of PDIA3 protein |
CTD |
PMID:26861962 |
|
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
|
|
G |
Pdk1 |
pyruvate dehydrogenase kinase 1 |
increases expression affects expression affects phosphorylation increases phosphorylation |
EXP ISO |
ochratoxin A results in increased expression of PDK1 protein ochratoxin A affects the expression of PDK1 protein ochratoxin A affects the phosphorylation of PDK1 protein ochratoxin A results in increased phosphorylation of PDK1 protein |
CTD |
PMID:17651772 PMID:25002221 PMID:30876885 |
|
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
|
|
G |
Pdk2 |
pyruvate dehydrogenase kinase 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PDK2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:79,972,550...79,987,074
Ensembl chr10:79,972,556...79,987,085
|
|
G |
Pdk3 |
pyruvate dehydrogenase kinase 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PDK3 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr X:58,486,699...58,553,533
Ensembl chr X:58,486,554...58,553,557
|
|
G |
Pdpk1 |
3-phosphoinositide dependent protein kinase-1 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of PDPK1 gene |
CTD |
PMID:26431795 |
|
NCBI chr10:13,105,435...13,182,664
Ensembl chr10:13,105,498...13,174,623
|
|
G |
Pdpn |
podoplanin |
increases expression |
EXP |
ochratoxin A results in increased expression of PDPN mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:155,601,691...155,635,656
Ensembl chr 5:155,601,691...155,635,656
|
|
G |
Pear1 |
platelet endothelial aggregation receptor 1 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of PEAR1 promoter |
CTD |
PMID:29098329 |
|
NCBI chr 2:173,206,298...173,234,106
Ensembl chr 2:173,207,664...173,227,440
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of PECAM1 mRNA; ochratoxin A results in increased expression of PECAM1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Pecr |
peroxisomal trans-2-enoyl-CoA reductase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PECR mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 9:73,897,877...73,926,511
Ensembl chr 9:73,897,880...73,926,511
|
|
G |
Pepd |
peptidase D |
increases expression |
EXP |
ochratoxin A results in increased expression of PEPD protein |
CTD |
PMID:31369848 |
|
NCBI chr 1:87,536,650...87,681,233
Ensembl chr 1:87,536,609...87,681,231
|
|
G |
Per3 |
period circadian regulator 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of PER3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:161,460,228...161,495,404
Ensembl chr 5:161,459,533...161,495,607
|
|
G |
Pfkl |
phosphofructokinase, liver type |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PFKL mRNA |
CTD |
PMID:19287073 |
|
NCBI chr20:10,664,285...10,686,324
Ensembl chr20:10,664,272...10,686,315
|
|
G |
Pfkm |
phosphofructokinase, muscle |
increases expression |
EXP |
ochratoxin A results in increased expression of PFKM mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 7:129,221,679...129,259,192
Ensembl chr 7:129,221,653...129,259,192
|
|
G |
Pfkp |
phosphofructokinase, platelet |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of PFKP mRNA ochratoxin A results in increased expression of PFKP protein |
CTD |
PMID:19717638 PMID:32835834 |
|
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
|
|
G |
Pgam2 |
phosphoglycerate mutase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of PGAM2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr14:80,681,796...80,683,907
Ensembl chr14:80,681,776...80,683,940
|
|
G |
Pggt1b |
protein geranylgeranyltransferase type I subunit beta |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PGGT1B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr18:38,952,147...38,995,656
Ensembl chr18:38,952,914...38,995,503
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PGK1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
|
|
G |
Phb1 |
prohibitin 1 |
decreases expression increases expression |
EXP ISO |
ochratoxin A results in decreased expression of PHB1 protein ochratoxin A results in increased expression of PHB1 protein |
CTD |
PMID:19445961 PMID:31369848 |
|
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
|
|
G |
Pheta2 |
PH domain containing endocytic trafficking adaptor 2 |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of PHETA2 gene ochratoxin A results in increased expression of PHETA2 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 7:113,855,437...113,861,910
Ensembl chr 7:113,857,249...113,861,871
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PHGDH mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Phlda3 |
pleckstrin homology-like domain, family A, member 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of PHLDA3 mRNA |
CTD |
PMID:23208426 PMID:23358140 |
|
NCBI chr13:47,193,250...47,196,335
Ensembl chr13:47,193,086...47,196,335
|
|
G |
Phldb2 |
pleckstrin homology-like domain, family B, member 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PHLDB2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr11:54,859,173...55,078,212
Ensembl chr11:54,859,135...55,078,467
|
|
G |
Pigv |
phosphatidylinositol glycan anchor biosynthesis, class V |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PIGV mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 5:145,889,642...145,901,533
Ensembl chr 5:145,889,646...145,901,533
|
|
G |
Pigz |
phosphatidylinositol glycan anchor biosynthesis, class Z |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PIGZ mRNA |
CTD |
PMID:19287073 |
|
NCBI chr11:68,831,847...68,851,798
|
|
G |
Pik3ap1 |
phosphoinositide-3-kinase adaptor protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of PIK3AP1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 1:240,090,854...240,245,007
Ensembl chr 1:240,093,065...240,204,828
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of PIK3CA mRNA; ochratoxin A results in increased expression of PIK3CA mRNA; ochratoxin A results in increased expression of PIK3CA protein |
CTD |
PMID:25002221 PMID:26314263 |
|
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of PIK3CB mRNA; ochratoxin A results in increased expression of PIK3CB mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 8:99,594,600...99,699,772
Ensembl chr 8:99,594,644...99,699,663
|
|
G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of PIK3CD mRNA; ochratoxin A results in decreased expression of PIK3CD mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 5:160,094,952...160,142,962
Ensembl chr 5:160,094,952...160,120,930
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of PIK3CG mRNA; ochratoxin A results in increased expression of PIK3CG mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
|
|
G |
Pik3r3 |
phosphoinositide-3-kinase regulatory subunit 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PIK3R3 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 5:129,700,925...129,772,591
Ensembl chr 5:129,701,229...129,772,583
|
|
G |
Pik3r5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of PIK3R5 mRNA; ochratoxin A results in decreased expression of PIK3R5 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:53,132,585...53,200,663
Ensembl chr10:53,132,603...53,199,374
|
|
G |
Pim3 |
Pim-3 proto-oncogene, serine/threonine kinase |
increases methylation decreases expression |
EXP |
ochratoxin A results in increased methylation of PIM3 gene ochratoxin A results in decreased expression of PIM3 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 7:119,953,377...119,956,587
Ensembl chr 7:119,953,175...119,956,587
|
|
G |
Pink1 |
PTEN induced kinase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of PINK1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|
G |
Pitpnb |
phosphatidylinositol transfer protein, beta |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PITPNB protein |
CTD |
PMID:26861962 |
|
NCBI chr12:45,249,308...45,298,388
Ensembl chr12:45,249,333...45,298,314
|
|
G |
Piwil2 |
piwi-like RNA-mediated gene silencing 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of PIWIL2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr15:45,431,402...45,498,034
Ensembl chr15:45,431,703...45,497,702
|
|
G |
Pkib |
cAMP-dependent protein kinase inhibitor beta |
increases expression |
ISO |
ochratoxin A results in increased expression of PKIB mRNA |
CTD |
PMID:30559759 |
|
NCBI chr20:36,965,172...37,062,190
Ensembl chr20:36,905,340...37,062,187
|
|
G |
Pklr |
pyruvate kinase L/R |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PKLR mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Pkm |
pyruvate kinase M1/2 |
multiple interactions |
ISO |
ochratoxin A results in increased phosphorylation of and results in decreased activity of and affects the localization of PKM protein |
CTD |
PMID:32835834 |
|
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Pkmyt1 |
protein kinase, membrane associated tyrosine/threonine 1 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of PKMYT1 mRNA TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of PKMYT1 mRNA] |
CTD |
PMID:25636497 |
|
NCBI chr10:12,748,221...12,758,995
Ensembl chr10:12,748,237...12,758,995
|
|
G |
Plaat3 |
phospholipase A and acyltransferase 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PLAAT3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:204,782,608...204,816,397
Ensembl chr 1:204,782,729...204,817,667
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of PLAUR mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of PLCG1 mRNA; ochratoxin A results in decreased expression of PLCG1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
|
|
G |
Plcg2 |
phospholipase C, gamma 2 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of PLCG2 mRNA; ochratoxin A results in decreased expression of PLCG2 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr19:45,547,416...45,683,930
Ensembl chr19:45,547,416...45,683,930
|
|
G |
Pld2 |
phospholipase D2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PLD2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:55,256,326...55,274,192
Ensembl chr10:55,256,359...55,272,808
|
|
G |
Plekhg2 |
pleckstrin homology and RhoGEF domain containing G2 |
increases expression |
EXP |
ochratoxin A results in increased expression of PLEKHG2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 1:83,651,902...83,665,063
Ensembl chr 1:83,647,748...83,665,063
|
|
G |
Plin1 |
perilipin 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PLIN1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 1:133,664,294...133,676,854
Ensembl chr 1:133,664,892...133,676,828
|
|
G |
Plin2 |
perilipin 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PLIN2 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Plin3 |
perilipin 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PLIN3 protein |
CTD |
PMID:19445961 |
|
NCBI chr 9:1,111,178...1,123,057
Ensembl chr 9:1,102,366...1,123,147
|
|
G |
Plk1 |
polo-like kinase 1 |
increases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of PLK1 mRNA TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of PLK1 mRNA] |
CTD |
PMID:16251485 PMID:19237604 PMID:23358140 PMID:25636497 |
|
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
|
|
G |
Plk2 |
polo-like kinase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of PLK2 mRNA |
CTD |
PMID:23208426 PMID:23358140 |
|
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
|
|
G |
Plpp1 |
phospholipid phosphatase 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of PPAP2A mRNA; ochratoxin A results in decreased expression of PPAP2A mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 2:44,439,002...44,500,430
Ensembl chr 2:44,438,994...44,501,268
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PMAIP1 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
|
|
G |
Pmp22 |
peripheral myelin protein 22 |
increases expression |
EXP |
ochratoxin A results in increased expression of PMP22 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:47,795,709...47,825,715
Ensembl chr10:47,795,709...47,825,714
|
|
G |
Pms1 |
PMS1 homolog 1, mismatch repair system component |
decreases expression multiple interactions decreases acetylation |
ISO |
ochratoxin A results in decreased expression of PMS1 mRNA [ochratoxin A results in decreased acetylation of PMS1 promoter] which results in decreased expression of PMS1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 9:48,229,403...48,340,237
Ensembl chr 9:48,253,410...48,340,237
|
|
G |
Pnkp |
polynucleotide kinase 3'-phosphatase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PNKP mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:95,341,465...95,346,921
Ensembl chr 1:95,341,620...95,346,920
|
|
G |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PNRC1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 5:47,647,070...47,657,832
Ensembl chr 5:47,647,071...47,650,161
|
|
G |
Polb |
DNA polymerase beta |
increases expression |
EXP |
ochratoxin A results in increased expression of POLB mRNA |
CTD |
PMID:19562491 |
|
NCBI chr16:69,379,438...69,402,710
Ensembl chr16:69,379,400...69,404,812
|
|
G |
Pold4 |
DNA polymerase delta 4, accessory subunit |
decreases expression |
EXP |
ochratoxin A results in decreased expression of POLD4 mRNA |
CTD |
PMID:18417182 PMID:23358140 |
|
NCBI chr 1:201,526,591...201,528,406
Ensembl chr 1:201,526,665...201,528,401
|
|
G |
Polr2i |
RNA polymerase II subunit I |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of POLR2I promoter [ochratoxin A results in increased acetylation of POLR2I promoter] which results in increased expression of POLR2I mRNA ochratoxin A results in increased expression of POLR2I mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:85,483,515...85,484,952
Ensembl chr 1:85,483,515...85,484,952
|
|
G |
Pom121 |
POM121 transmembrane nucleoporin |
increases expression |
EXP |
ochratoxin A results in increased expression of POM121 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr12:21,273,713...21,294,299
Ensembl chr12:21,276,913...21,294,294
|
|
G |
Pon1 |
paraoxonase 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PON1 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Postn |
periostin |
increases expression |
EXP |
ochratoxin A results in increased expression of POSTN mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
decreases expression increases expression multiple interactions increases phosphorylation decreases activity |
ISO EXP |
ochratoxin A results in decreased expression of PPARG ochratoxin A results in increased expression of PPARG mRNA 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA] ochratoxin A results in increased phosphorylation of PPARG protein ochratoxin A results in decreased activity of PPARG protein |
CTD |
PMID:15994020 PMID:20590410 PMID:27481073 PMID:32905824 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppif |
peptidylprolyl isomerase F |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of PPIF protein Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of PPIF protein] |
CTD |
PMID:33465424 |
|
NCBI chr16:1,257,197...1,263,919
Ensembl chr16:1,257,106...1,263,913
|
|
G |
Ppm1d |
protein phosphatase, Mg2+/Mn2+ dependent, 1D |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of PPM1D mRNA |
CTD |
PMID:23358140 PMID:30559759 |
|
NCBI chr10:70,172,603...70,208,607
Ensembl chr10:70,172,603...70,208,607
|
|
G |
Ppp1r11 |
protein phosphatase 1, regulatory (inhibitor) subunit 11 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PPP1R11 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr20:1,601,350...1,604,857
Ensembl chr20:1,601,346...1,604,846
|
|
G |
Ppp1r14b |
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of PPP1R14B promoter] which results in increased expression of PPP1R14B mRNA ochratoxin A results in increased expression of PPP1R14B mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:204,165,210...204,167,320
Ensembl chr 1:204,163,299...204,167,319
|
|
G |
Ppp2r1b |
protein phosphatase 2 scaffold subunit A beta |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PPP2R1B mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 8:51,195,860...51,228,442
Ensembl chr 8:51,186,717...51,228,485
|
|
G |
Ppp3cb |
protein phosphatase 3 catalytic subunit beta |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of PPP3CB mRNA |
CTD |
PMID:19287073 PMID:22124623 |
|
NCBI chr15:3,759,950...3,804,976
Ensembl chr15:3,760,030...3,804,981
|
|
G |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha |
increases expression |
EXP |
ochratoxin A results in increased expression of PPP3R1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr14:91,556,743...91,606,391
Ensembl chr14:91,604,121...91,606,907
|
|
G |
Prcp |
prolylcarboxypeptidase |
increases expression |
ISO |
ochratoxin A results in increased expression of PRCP mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:146,931,487...146,983,891
Ensembl chr 1:146,930,561...146,984,530
|
|
G |
Prdx2 |
peroxiredoxin 2 |
multiple interactions decreases expression increases acetylation increases expression |
ISO EXP |
[ochratoxin A results in increased acetylation of PRDX2 promoter] which results in increased expression of PRDX2 mRNA ochratoxin A results in decreased expression of PRDX2 protein ochratoxin A results in increased expression of PRDX2 mRNA; ochratoxin A results in increased expression of PRDX2 protein |
CTD |
PMID:29098329 PMID:31276768 PMID:31369848 |
|
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
|
|
G |
Prdx6 |
peroxiredoxin 6 |
increases expression |
ISO |
ochratoxin A results in increased expression of PRDX6 protein |
CTD |
PMID:19445961 |
|
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
|
|
G |
Preb |
prolactin regulatory element binding |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of PREB mRNA |
CTD |
PMID:19287073 PMID:22124623 |
|
NCBI chr 6:25,418,805...25,422,594
Ensembl chr 6:25,418,776...25,422,590
|
|
G |
Prelp |
proline and arginine rich end leucine rich repeat protein |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of PRELP promoter ochratoxin A results in increased expression of PRELP mRNA [ochratoxin A results in increased acetylation of PRELP promoter] which results in increased expression of PRELP mRNA |
CTD |
PMID:29098329 |
|
NCBI chr13:45,368,407...45,391,480
Ensembl chr13:45,370,533...45,380,270
|
|
G |
Prg2 |
proteoglycan 2, pro eosinophil major basic protein |
increases expression |
ISO |
ochratoxin A results in increased expression of PRG2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:70,062,535...70,066,102
Ensembl chr 3:70,062,535...70,066,101
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of PRKACA promoter [ochratoxin A results in increased acetylation of PRKACA promoter] which results in increased expression of PRKACA mRNA ochratoxin A results in increased expression of PRKACA mRNA |
CTD |
PMID:29098329 |
|
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
|
|
G |
Prkca |
protein kinase C, alpha |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PRKCA mRNA |
CTD |
PMID:12700408 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Prkcb |
protein kinase C, beta |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of PRKCB mRNA; ochratoxin A results in increased expression of PRKCB mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
|
|
G |
Prkcsh |
PRKCSH beta subunit of glucosidase II |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of PRKCSH promoter] which results in increased expression of PRKCSH mRNA ochratoxin A results in increased expression of PRKCSH mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:20,534,787...20,546,493
Ensembl chr 8:20,534,880...20,546,492
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
increases expression |
EXP |
ochratoxin A results in increased expression of PRKDC mRNA |
CTD |
PMID:23358140 |
|
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
|
|
G |
Prlr |
prolactin receptor |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PRLR mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
|
|
G |
Prox1 |
prospero homeobox 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PROX1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr13:101,669,184...101,719,804
Ensembl chr13:101,669,184...101,711,183
|
|
G |
Prpf4b |
pre-mRNA processing factor 4B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PRP4K mRNA |
CTD |
PMID:22124623 |
|
NCBI chr17:29,985,343...30,020,285
Ensembl chr17:29,985,343...30,019,625
|
|
G |
Psen1 |
presenilin 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PSEN1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 6:103,323,052...103,375,088
Ensembl chr 6:103,323,120...103,371,650
|
|
G |
Psmb6 |
proteasome 20S subunit beta 6 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PSMB6 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:55,239,256...55,241,586
Ensembl chr10:55,239,241...55,241,586
|
|
G |
Psmd11 |
proteasome 26S subunit, non-ATPase 11 |
increases expression |
EXP |
ochratoxin A results in increased expression of PSMD11 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:65,433,853...65,479,774
Ensembl chr10:65,433,853...65,479,766
|
|
G |
Psme2 |
proteasome activator subunit 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PSME2 protein |
CTD |
PMID:26861962 |
|
NCBI chr15:29,078,495...29,082,794
Ensembl chr15:29,078,500...29,082,946
|
|
G |
Psme3 |
proteasome activator subunit 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PSME3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:86,257,672...86,265,458
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Pten |
phosphatase and tensin homolog |
decreases expression increases expression decreases phosphorylation |
ISO |
ochratoxin A results in decreased expression of PTEN mRNA ochratoxin A metabolite results in increased expression of PTEN mRNA; ochratoxin A results in increased expression of PTEN mRNA; ochratoxin A results in increased expression of PTEN protein ochratoxin A results in decreased phosphorylation of PTEN protein |
CTD |
PMID:19287073 PMID:25002221 PMID:26314263 PMID:34101318 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptgds |
prostaglandin D2 synthase |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of PTGDS promoter [ochratoxin A results in increased acetylation of PTGDS promoter] which results in increased expression of PTGDS mRNA ochratoxin A results in increased expression of PTGDS mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:8,281,899...8,284,833
Ensembl chr 3:8,281,899...8,284,833
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
increases expression |
ISO |
ochratoxin A results in increased expression of PTGER4 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
|
|
G |
Ptgfrn |
prostaglandin F2 receptor inhibitor |
increases expression |
EXP |
ochratoxin A results in increased expression of PTGFRN mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 2:188,469,521...188,544,795
Ensembl chr 2:188,469,521...188,544,795
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PTGR1 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases expression increases expression |
ISO |
ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; ochratoxin A promotes the reaction [FOS protein binds to PTGS2 promoter]; ochratoxin A promotes the reaction [RELA protein binds to PTGS2 promoter] [ochratoxin A co-treated with Citrinin] results in decreased expression of PTGS2 mRNA; [ochratoxin A co-treated with Citrinin] results in decreased expression of PTGS2 protein ochratoxin A results in decreased expression of PTGS2 mRNA ochratoxin A results in increased expression of PTGS2 mRNA; ochratoxin A results in increased expression of PTGS2 protein |
CTD |
PMID:18647641 PMID:23172667 PMID:26505656 PMID:29673704 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of PTK2 mRNA; ochratoxin A results in increased expression of PTK2 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Ptma |
prothymosin alpha |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PTMA mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 9:87,176,251...87,180,333
Ensembl chr 9:87,176,230...87,180,333
|
|
G |
Ptp4a1 |
protein tyrosine phosphatase 4A1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PTP4A1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:33,214,201...33,245,046
Ensembl chr 9:33,214,208...33,221,964
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of PTPN11 mRNA; ochratoxin A results in increased expression of PTPN11 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
|
|
G |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
increases expression |
EXP |
ochratoxin A results in increased expression of PTPRK mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:16,738,896...17,236,687
Ensembl chr 1:16,850,576...17,103,605
|
|
G |
Ptrh2 |
peptidyl-tRNA hydrolase 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PTRH2 protein |
CTD |
PMID:26861962 |
|
NCBI chr10:71,505,113...71,515,297
Ensembl chr10:71,504,956...71,515,398
|
|
G |
Pttg1 |
PTTG1 regulator of sister chromatid separation, securin |
increases expression |
EXP |
ochratoxin A results in increased expression of PTTG1 mRNA |
CTD |
PMID:19237604 |
|
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
|
|
G |
Pwp1 |
PWP1 homolog, endonuclein |
decreases expression multiple interactions decreases acetylation |
ISO |
ochratoxin A results in decreased expression of PWP1 mRNA [ochratoxin A results in decreased acetylation of PWP1 promoter] which results in decreased expression of PWP1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:17,982,730...17,998,728
Ensembl chr 7:17,982,235...17,998,731
|
|
G |
Pycard |
PYD and CARD domain containing |
increases expression |
ISO |
ochratoxin A results in increased expression of PYCARD mRNA; ochratoxin A results in increased expression of PYCARD protein |
CTD |
PMID:33543323 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Pygm |
glycogen phosphorylase, muscle associated |
increases expression |
EXP |
ochratoxin A results in increased expression of PYGM mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:203,690,550...203,705,369
Ensembl chr 1:203,690,533...203,705,368
|
|
G |
Rab40c |
Rab40c, member RAS oncogene family |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RAB40C mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:14,900,926...14,936,153
Ensembl chr10:14,900,929...14,936,557
|
|
G |
Rac2 |
Rac family small GTPase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of RAC2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 7:110,101,344...110,128,718
Ensembl chr 7:110,116,260...110,128,720
|
|
G |
Rad1 |
RAD1 checkpoint DNA exonuclease |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of RAD1 promoter ochratoxin A results in decreased expression of RAD1 mRNA [ochratoxin A results in decreased acetylation of RAD1 promoter] which results in decreased expression of RAD1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 2:59,461,597...59,469,707
Ensembl chr 2:59,461,607...59,469,689
|
|
G |
Rad18 |
RAD18 E3 ubiquitin protein ligase |
increases expression |
EXP |
ochratoxin A results in increased expression of RAD18 mRNA |
CTD |
PMID:18417182 PMID:23358140 PMID:24243707 |
|
NCBI chr 4:145,735,654...145,821,102
Ensembl chr 4:145,735,654...145,821,069
|
|
G |
Rad51 |
RAD51 recombinase |
multiple interactions increases expression decreases expression |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of RAD51]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of RAD51]; TP53 mutant form inhibits the reaction [ochratoxin A results in decreased expression of RAD51] ochratoxin A results in increased expression of RAD51 mRNA; ochratoxin A results in increased expression of RAD51 protein |
CTD |
PMID:24243707 PMID:24525463 PMID:37162024 |
|
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
|
|
G |
Rad54b |
RAD54 homolog B |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of RAD54B promoter [ochratoxin A results in decreased acetylation of RAD54B promoter] which results in decreased expression of RAD54B mRNA ochratoxin A results in decreased expression of RAD54B mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 5:25,032,112...25,104,630
Ensembl chr 5:25,032,066...25,104,616
|
|
G |
Radx |
RPA1 related single stranded DNA binding protein, X-linked |
increases expression |
ISO |
ochratoxin A results in increased expression of RADX mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:103,089,284...103,176,840
Ensembl chr X:103,089,284...103,176,838
|
|
G |
Ralbp1 |
ralA binding protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of RALBP1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:105,456,425...105,493,235
Ensembl chr 9:105,456,425...105,492,707
|
|
G |
Ralgdsl1 |
ral guanine nucleotide dissociation stimulator like 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of RGL1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:64,634,489...64,904,170
Ensembl chr13:64,635,246...64,904,191
|
|
G |
Ranbp1 |
RAN binding protein 1 |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of RANBP1 mRNA ochratoxin A results in increased expression of RANBP1 protein |
CTD |
PMID:19445961 PMID:23358140 |
|
NCBI chr11:82,742,603...82,750,836
Ensembl chr11:82,742,600...82,750,838
|
|
G |
Rap2b |
RAP2B, member of RAS oncogene family |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RAP2B mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:145,599,714...145,600,265
Ensembl chr 2:145,599,116...145,603,069
|
|
G |
Rapgef2 |
Rap guanine nucleotide exchange factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RAPGEF2 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 2:164,207,513...164,322,157
Ensembl chr 2:164,207,513...164,244,247
|
|
G |
Rapgef4 |
Rap guanine nucleotide exchange factor 4 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of RAPGEF4 mRNA; ochratoxin A results in increased expression of RAPGEF4 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316
|
|
G |
Rapgef6 |
Rap guanine nucleotide exchange factor 6 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RAPGEF6 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr10:38,655,854...38,824,227
Ensembl chr10:38,655,867...38,823,211
|
|
G |
Rara |
retinoic acid receptor, alpha |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RARA mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
|
|
G |
Rasgrp1 |
RAS guanyl releasing protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RASGRP1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:104,168,549...104,230,107
Ensembl chr 3:104,170,013...104,230,056
|
|
G |
Rassf5 |
Ras association domain family member 5 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of RASSF5 mRNA; ochratoxin A results in increased expression of RASSF5 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr13:42,637,513...42,703,024
Ensembl chr13:42,637,549...42,703,024
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO |
ochratoxin A affects the expression of and affects the phosphorylation of RB1 protein |
CTD |
PMID:28286205 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rbbp4 |
RB binding protein 4, chromatin remodeling factor |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RBBP4 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 5:141,655,863...141,675,157
Ensembl chr 5:141,638,421...141,675,284
|
|
G |
Rbbp6 |
RB binding protein 6, ubiquitin ligase |
decreases expression increases expression |
EXP |
ochratoxin A results in decreased expression of RBBP6 mRNA ochratoxin A results in increased expression of RBBP6 mRNA |
CTD |
PMID:17483316 PMID:22124623 |
|
NCBI chr 1:177,503,988...177,537,397
Ensembl chr 1:177,503,313...177,535,678
|
|
G |
Rbm3 |
RNA binding motif protein 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of RBM3 mRNA |
CTD |
PMID:17483316 |
|
NCBI chr X:14,348,909...14,352,387
Ensembl chr X:14,348,910...14,353,580
|
|
G |
Rbp4 |
retinol binding protein 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RBP4 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
|
|
G |
Rchy1 |
ring finger and CHY zinc finger domain containing 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RCHY1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr14:16,113,263...16,129,017
Ensembl chr14:16,113,224...16,129,167
|
|
G |
Rdh5 |
retinol dehydrogenase 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RDH5 mRNA |
CTD |
PMID:18417182 PMID:30449730 |
|
NCBI chr 7:1,341,172...1,346,863
Ensembl chr 7:1,340,934...1,351,558
|
|
G |
Rdx |
radixin |
increases expression |
EXP |
ochratoxin A results in increased expression of RDX mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 8:52,379,494...52,437,673
Ensembl chr 8:52,379,494...52,437,678
|
|
G |
Recql4 |
RecQ like helicase 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RECQL4 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 7:108,423,453...108,430,790
Ensembl chr 7:108,423,455...108,430,619
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of RELA protein ochratoxin A promotes the reaction [RELA protein binds to CCND1 promoter]; ochratoxin A promotes the reaction [RELA protein binds to PTGS2 promoter] |
CTD |
PMID:18647641 PMID:23172667 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rev1 |
REV1, DNA directed polymerase |
increases expression |
EXP |
ochratoxin A results in increased expression of REV1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:40,278,100...40,351,764
Ensembl chr 9:40,278,101...40,351,576
|
|
G |
Rfc4 |
replication factor C subunit 4 |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of RFC4 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122
|
|
G |
Rfc5 |
replication factor C subunit 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RFC5 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr12:39,207,484...39,217,041
Ensembl chr12:39,207,484...39,217,312
|
|
G |
Rfwd3 |
ring finger and WD repeat domain 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RFWD3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr19:39,235,883...39,268,479
Ensembl chr19:39,236,787...39,268,479
|
|
G |
Rfx5 |
regulatory factor X5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RFX5 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:182,521,191...182,528,720
Ensembl chr 2:182,521,202...182,528,717
|
|
G |
Rgn |
regucalcin |
affects expression decreases expression |
EXP |
ochratoxin A affects the expression of RGN mRNA ochratoxin A results in decreased expression of RGN mRNA; ochratoxin A results in decreased expression of RGN protein |
CTD |
PMID:12700408 PMID:16251485 PMID:17483316 PMID:18417182 PMID:19237604 PMID:31369848 More...
|
|
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
|
|
G |
Rgs2 |
regulator of G-protein signaling 2 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of RGS2 mRNA ochratoxin A metabolite results in decreased expression of RGS2 mRNA; ochratoxin A results in decreased expression of RGS2 mRNA |
CTD |
PMID:23358140 PMID:24356939 |
|
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
|
|
G |
Rgs20 |
regulator of G-protein signaling 20 |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of RGS20 mRNA ochratoxin A results in decreased methylation of RGS20 gene |
CTD |
PMID:37162024 |
|
NCBI chr 5:14,484,436...14,614,317
Ensembl chr 5:14,534,775...14,614,084
|
|
G |
Rhob |
ras homolog family member B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RHOB mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
|
|
G |
Rhoq |
ras homolog family member Q |
increases expression |
EXP |
ochratoxin A results in increased expression of RHOQ mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 6:7,613,632...7,652,047
|
|
G |
Ripk1 |
receptor interacting serine/threonine kinase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RIPK1 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824
|
|
G |
Ripk2 |
receptor-interacting serine-threonine kinase 2 |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of RIPK2 promoter [ochratoxin A results in decreased acetylation of RIPK2 promoter] which results in decreased expression of RIPK2 mRNA ochratoxin A results in decreased expression of RIPK2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657
|
|
G |
Rnf113a1 |
ring finger protein 113A1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RNF113A mRNA |
CTD |
PMID:18417182 |
|
NCBI chr X:116,427,941...116,429,164
Ensembl chr X:116,427,684...116,433,762
|
|
G |
Rnf144b |
ring finger protein 144B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RNF144B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr17:17,431,271...17,580,687
Ensembl chr17:17,432,786...17,562,760
|
|
G |
Rnf167 |
ring finger protein 167 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RNF167 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:55,360,603...55,364,927
Ensembl chr10:55,360,543...55,364,927
|
|
G |
Rnf2 |
ring finger protein 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of RNF2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr13:63,553,964...63,584,047
Ensembl chr13:63,554,862...63,583,099
|
|
G |
Rnf8 |
ring finger protein 8 |
decreases expression multiple interactions decreases acetylation |
ISO |
ochratoxin A results in decreased expression of RNF8 mRNA [ochratoxin A results in decreased acetylation of RNF8 promoter] which results in decreased expression of RNF8 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:7,682,258...7,710,448
Ensembl chr20:7,682,322...7,708,491
|
|
G |
Rnmt |
RNA (guanine-7-) methyltransferase |
increases expression |
EXP |
ochratoxin A results in increased expression of RNMT mRNA |
CTD |
PMID:18417182 |
|
NCBI chr18:61,886,230...61,909,775
Ensembl chr18:61,886,292...61,909,775
|
|
G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ROCK1 mRNA; ochratoxin A results in increased expression of ROCK1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571
|
|
G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ROCK2 mRNA; ochratoxin A results in increased expression of ROCK2 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 6:39,679,116...39,774,033
Ensembl chr 6:39,679,082...39,774,031
|
|
G |
Ror1 |
receptor tyrosine kinase-like orphan receptor 1 |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of ROR1 mRNA ochratoxin A results in increased methylation of ROR1 gene |
CTD |
PMID:37162024 |
|
NCBI chr 5:114,744,311...115,088,155
Ensembl chr 5:114,744,304...115,088,155
|
|
G |
Rpa1 |
replication protein A1 |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of RPA1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
|
|
G |
Rpe |
ribulose-5-phosphate-3-epimerase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RPE mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:68,191,027...68,211,295
Ensembl chr 9:68,191,292...68,211,591
|
|
G |
Rpl13 |
ribosomal protein L13 |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of RPL13 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr19:51,153,990...51,156,541
Ensembl chr19:51,153,924...51,163,014
|
|
G |
Rpl6 |
ribosomal protein L6 |
increases expression |
EXP |
ochratoxin A results in increased expression of RPL6 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr12:35,347,493...35,352,011
Ensembl chr12:35,347,497...35,351,921
|
|
G |
Rpp30 |
ribonuclease P/MRP subunit p30 |
increases expression |
ISO |
ochratoxin A results in increased expression of RPP30 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:233,786,048...233,808,958
Ensembl chr 1:233,786,099...233,808,952
|
|
G |
Rprm |
reprimo, TP53 dependent G2 arrest mediator homolog |
increases expression |
EXP |
ochratoxin A results in increased expression of RPRM mRNA |
CTD |
PMID:23208426 |
|
NCBI chr 3:38,539,581...38,540,998
Ensembl chr 3:38,539,581...38,540,998
|
|
G |
Rps15 |
ribosomal protein S15 |
increases expression |
ISO |
ochratoxin A results in increased expression of RPS15 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:9,416,003...9,417,442
Ensembl chr 7:9,416,004...9,417,450
|
|
G |
Rps15a |
ribosomal protein S15a |
increases expression |
EXP |
ochratoxin A results in increased expression of RPS15A mRNA |
CTD |
PMID:19717638 PMID:22124623 |
|
NCBI chr 1:172,420,151...172,427,021
Ensembl chr 1:172,419,761...172,426,995
|
|
G |
Rps6 |
ribosomal protein S6 |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of RPS6 protein |
CTD |
PMID:25002221 PMID:31154016 |
|
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
|
|
G |
Rps6ka1 |
ribosomal protein S6 kinase A1 |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of RPS6KA1 protein |
CTD |
PMID:31154016 |
|
NCBI chr 5:146,079,018...146,118,272
Ensembl chr 5:146,079,021...146,118,272
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of RPS6KB1 protein |
CTD |
PMID:31154016 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Rptor |
regulatory associated protein of MTOR, complex 1 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of RPTOR gene |
CTD |
PMID:26431795 |
|
NCBI chr10:104,878,487...105,176,986
Ensembl chr10:104,878,487...105,176,983
|
|
G |
Rrm2b |
ribonucleotide reductase regulatory TP53 inducible subunit M2B |
increases expression |
ISO |
ochratoxin A results in increased expression of RRM2B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:69,078,291...69,108,633
|
|
G |
Rrs1 |
ribosome biogenesis regulator 1 homolog |
increases expression |
EXP |
ochratoxin A results in increased expression of RRS1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:9,733,486...9,735,119
Ensembl chr 5:9,733,091...9,735,140
|
|
G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of RSAD2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
|
|
G |
Rsrc1 |
arginine and serine rich coiled-coil 1 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of RSRC1 gene |
CTD |
PMID:26431795 |
|
NCBI chr 2:151,226,821...151,632,771
Ensembl chr 2:151,231,156...151,632,765
|
|
G |
RT1-A2 |
RT1 class Ia, locus A2 |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of HLA-E promoter] which results in increased expression of HLA-E mRNA ochratoxin A results in increased expression of HLA-E mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:4,870,939...4,910,183
|
|
G |
RT1-CE5 |
RT1 class I, locus CE5 |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of HLA-F promoter] which results in increased expression of HLA-F mRNA ochratoxin A results in increased expression of HLA-F mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:3,403,418...3,479,476
|
|
G |
Rtn4r |
reticulon 4 receptor |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of RTN4R mRNA ochratoxin A results in decreased methylation of RTN4R gene |
CTD |
PMID:37162024 |
|
NCBI chr11:82,844,309...82,869,251
Ensembl chr11:82,844,309...82,869,466
|
|
G |
Rufy1 |
RUN and FYVE domain containing 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RUFY1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:34,705,741...34,750,644
Ensembl chr10:34,705,741...34,750,644
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RUNX1 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RUNX2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Ruvbl1 |
RuvB-like AAA ATPase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of RUVBL1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 4:120,932,486...120,967,400
Ensembl chr 4:120,932,417...121,029,384
|
|
G |
S100g |
S100 calcium binding protein G |
increases expression |
EXP |
ochratoxin A results in increased expression of S100G mRNA |
CTD |
PMID:30449730 |
|
NCBI chr X:31,705,853...31,708,422
Ensembl chr X:31,705,866...31,708,433
|
|
G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of S1PR1 mRNA; ochratoxin A results in decreased expression of S1PR1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 2:203,624,752...203,629,110
Ensembl chr 2:203,621,587...203,629,681
|
|
G |
Sars1 |
seryl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:196,065,543...196,081,240
Ensembl chr 2:196,065,430...196,081,277
|
|
G |
Sbds |
Sbds, ribosome maturation factor |
increases expression |
EXP |
ochratoxin A results in increased expression of SBDS mRNA |
CTD |
PMID:23358140 |
|
NCBI chr12:26,420,410...26,429,650
Ensembl chr12:26,420,414...26,429,649
|
|
G |
Sbf1 |
SET binding factor 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SBF1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 7:120,358,338...120,385,022
Ensembl chr 7:120,358,338...120,384,902
|
|
G |
Sc5d |
sterol-C5-desaturase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SC5D mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
|
|
G |
Scaf4 |
SR-related CTD-associated factor 4 |
increases expression |
EXP |
ochratoxin A results in increased expression of SCAF4 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr11:29,460,479...29,521,153
Ensembl chr11:29,465,106...29,521,153
|
|
G |
Scaf8 |
SR-related CTD-associated factor 8 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SCAF8 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:43,727,686...43,855,889
Ensembl chr 1:43,727,794...43,804,977
|
|
G |
Scand1 |
SCAN domain-containing 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SCAND1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:144,818,615...144,819,479
Ensembl chr 3:144,818,611...144,820,025
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SCD mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Sct |
secretin |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of SCT gene ochratoxin A results in increased expression of SCT mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 1:196,382,857...196,383,668
Ensembl chr 1:196,382,856...196,383,658
|
|
G |
Sdha |
succinate dehydrogenase complex flavoprotein subunit A |
multiple interactions decreases expression |
ISO |
BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of SDHA mRNA]; BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of SDHA protein] ochratoxin A results in decreased expression of SDHA mRNA; ochratoxin A results in decreased expression of SDHA protein |
CTD |
PMID:24755393 |
|
NCBI chr 1:28,935,965...28,960,936
Ensembl chr 1:28,940,164...28,961,535
|
|
G |
Sdhb |
succinate dehydrogenase complex iron sulfur subunit B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SDHB mRNA |
CTD |
PMID:34481902 |
|
NCBI chr 5:153,264,906...153,285,570
Ensembl chr 5:153,264,899...153,314,293
|
|
G |
Sele |
selectin E |
increases expression |
ISO |
ochratoxin A results in increased expression of SELE protein |
CTD |
PMID:28710020 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Selenop |
selenoprotein P |
increases expression |
EXP |
ochratoxin A results in increased expression of SELENOP mRNA |
CTD |
PMID:17483316 |
|
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
|
|
G |
Sema3g |
semaphorin 3G |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of SEMA3G mRNA; ochratoxin A results in decreased expression of SEMA3G mRNA |
CTD |
PMID:24356939 |
|
NCBI chr16:6,413,589...6,425,221
Ensembl chr16:6,413,589...6,425,221
|
|
G |
Sema4f |
ssemaphorin 4F |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of SEMA4F mRNA; ochratoxin A results in decreased expression of SEMA4F mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 4:115,411,411...115,437,721
Ensembl chr 4:115,411,417...115,437,721
|
|
G |
Septin4 |
septin 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SEPTIN4 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:72,366,729...72,390,764
Ensembl chr10:72,366,873...72,390,768
|
|
G |
Serpina1 |
serpin family A member 1 |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of SERPINA1 promoter [ochratoxin A results in increased acetylation of SERPINA1 promoter] which results in increased expression of SERPINA1 mRNA ochratoxin A results in increased expression of SERPINA1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
|
|
G |
Serpinb2 |
serpin family B member 2 |
multiple interactions |
ISO |
ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of SERPINB2 mRNA]; ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of SERPINB2 protein] |
CTD |
PMID:18289624 |
|
NCBI chr13:23,537,312...23,551,823
Ensembl chr13:23,541,400...23,550,408
|
|
G |
Serpine1 |
serpin family E member 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of SERPINE1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Sertad1 |
SERTA domain containing 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SERTAD1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:82,775,692...82,778,961
Ensembl chr 1:82,775,252...82,779,091
|
|
G |
Sesn2 |
sestrin 2 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of SESN2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
|
|
G |
Set |
Set nuclear proto-oncogene |
increases expression |
EXP |
ochratoxin A results in increased expression of SET mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 3:13,334,564...13,345,598
Ensembl chr 3:13,335,041...13,363,567
|
|
G |
Setd6 |
SET domain containing 6, protein lysine methyltransferase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SETD6 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr19:9,343,309...9,350,477
Ensembl chr19:9,347,458...9,350,453
|
|
G |
Sfn |
stratifin |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of SFN mRNA ochratoxin A results in decreased expression of SFN mRNA |
CTD |
PMID:19237604 PMID:30008028 PMID:30559759 |
|
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Sfrp2 |
secreted frizzled-related protein 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of SFRP2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of SGK1 mRNA; ochratoxin A results in decreased expression of SGK1 mRNA |
CTD |
PMID:24356939 PMID:32910239 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Sh3rf1 |
SH3 domain containing ring finger 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SH3RF1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr16:28,735,522...28,901,261
Ensembl chr16:28,735,440...28,901,644
|
|
G |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SHANK2 mRNA |
CTD |
PMID:34748853 |
|
NCBI chr 1:199,146,210...199,590,962
Ensembl chr 1:199,169,429...199,589,394
|
|
G |
Shc1 |
SHC adaptor protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SHC1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
|
|
G |
Shh |
sonic hedgehog signaling molecule |
multiple interactions |
EXP |
SHH protein inhibits the reaction [ochratoxin A affects the expression of SOX10 mRNA]; SHH protein inhibits the reaction [ochratoxin A results in decreased expression of CSPG4 mRNA]; SHH protein inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA]; SHH protein inhibits the reaction [ochratoxin A results in decreased expression of MOG mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of ASCL1 mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of CCND2 mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of DCX mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of DLL3 mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of GLI1 mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of HES5 mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of MKI67 mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of NES mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of PDGFRA mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of SOX2 mRNA] |
CTD |
PMID:21703336 PMID:24792326 |
|
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
|
|
G |
Shisa2 |
shisa family member 2 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of SHISA2 mRNA; ochratoxin A results in decreased expression of SHISA2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr15:33,806,715...33,811,013
Ensembl chr15:33,805,958...33,811,013
|
|
G |
Siae |
sialic acid acetylesterase |
increases expression |
ISO |
ochratoxin A results in increased expression of SIAE mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:37,318,724...37,354,004
Ensembl chr 8:37,318,747...37,353,996
|
|
G |
Siah1 |
siah E3 ubiquitin protein ligase 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of SIAH1 mRNA; ochratoxin A results in decreased expression of SIAH1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr19:20,378,908...20,402,512
Ensembl chr19:20,378,439...20,403,808
|
|
G |
Sigirr |
single Ig and TIR domain containing |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SIGIRR mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:196,195,363...196,208,692
Ensembl chr 1:196,199,462...196,202,269
|
|
G |
Sigmar1 |
sigma non-opioid intracellular receptor 1 |
multiple interactions decreases expression |
ISO |
Ursolic Acid inhibits the reaction [ochratoxin A results in decreased expression of SIGMAR1 protein] |
CTD |
PMID:36587836 |
|
NCBI chr 5:56,904,155...56,907,012
Ensembl chr 5:56,904,159...56,907,017
|
|
G |
Sirt1 |
sirtuin 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of SIRT1 mRNA |
CTD |
PMID:34481902 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Ska1 |
spindle and kinetochore associated complex subunit 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of SKA1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr18:67,794,722...67,805,037
Ensembl chr18:67,794,725...67,805,037
|
|
G |
Ska2 |
spindle and kinetochore associated complex subunit 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of SKA2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:71,921,474...71,939,461
Ensembl chr10:71,921,582...71,939,458
|
|
G |
Slc11a2 |
solute carrier family 11 member 2 |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of SLC11A2 mRNA |
CTD |
PMID:19287073 PMID:22124623 |
|
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
|
|
G |
Slc15a1 |
solute carrier family 15 member 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC15A1 mRNA |
CTD |
PMID:29126803 |
|
NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545
|
|
G |
Slc15a2 |
solute carrier family 15 member 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC15A2 mRNA |
CTD |
PMID:29126803 |
|
NCBI chr11:64,014,182...64,043,228
Ensembl chr11:64,014,182...64,043,225
|
|
G |
Slc16a13 |
solute carrier family 16, member 13 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC16A13 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr10:54,925,973...54,937,860
Ensembl chr10:54,926,760...54,937,788
|
|
G |
Slc16a14 |
solute carrier family 16, member 14 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of SLC16A14 gene |
CTD |
PMID:26431795 |
|
NCBI chr 9:86,110,066...86,137,546
Ensembl chr 9:86,112,894...86,137,318
|
|
G |
Slc17a1 |
solute carrier family 17 member 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC17A1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr17:41,219,461...41,255,199
Ensembl chr17:41,222,049...41,253,304
|
|
G |
Slc17a9 |
solute carrier family 17 member 9 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC17A9 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 3:167,839,246...167,857,462
Ensembl chr 3:167,839,385...167,855,985
|
|
G |
Slc1a2 |
solute carrier family 1 member 2 |
affects expression |
EXP |
ochratoxin A affects the expression of SLC1A2 protein |
CTD |
PMID:20558201 |
|
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
|
|
G |
Slc1a3 |
solute carrier family 1 member 3 |
affects expression |
EXP |
ochratoxin A affects the expression of SLC1A3 protein |
CTD |
PMID:20558201 |
|
NCBI chr 2:57,755,495...57,830,605
Ensembl chr 2:57,755,497...57,830,605
|
|
G |
Slc1a4 |
solute carrier family 1 member 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SLC1A4 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:94,530,801...94,560,190
Ensembl chr14:94,529,084...94,560,418
|
|
G |
Slc1a5 |
solute carrier family 1 member 5 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SLC1A5 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
decreases expression increases expression |
EXP |
ochratoxin A results in decreased expression of SLC22A1 mRNA; ochratoxin A results in decreased expression of SLC22A1 protein ochratoxin A results in increased expression of SLC22A1 mRNA |
CTD |
PMID:16251485 PMID:17483316 PMID:30120945 |
|
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Slc22a12 |
solute carrier family 22 member 12 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC22A12 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:203,845,039...203,852,496
Ensembl chr 1:203,845,048...203,853,555
|
|
G |
Slc22a13 |
solute carrier family 22 member 13 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC22A13 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 8:118,922,367...118,934,020
Ensembl chr 8:118,922,367...118,953,635
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
decreases expression increases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of SLC22A2 mRNA; ochratoxin A results in decreased expression of SLC22A2 protein ochratoxin A results in increased expression of SLC22A2 mRNA; ochratoxin A results in increased expression of SLC22A2 protein SLC22A2 protein affects the reaction [ochratoxin A results in increased expression of CASP3 mRNA]; SLC22A2 protein affects the reaction [ochratoxin A results in increased expression of CDK1 protein]; SLC22A2 protein promotes the reaction [ochratoxin A results in increased expression of CASP3 protein] |
CTD |
PMID:12700408 PMID:16251485 PMID:18417182 PMID:30120945 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc22a20 |
solute carrier family 22 member 20 |
multiple interactions |
ISO |
ochratoxin A inhibits the reaction [SLC22A20 protein results in increased uptake of estrone sulfate] |
CTD |
PMID:16478971 |
|
NCBI chr 1:203,257,374...203,273,854
Ensembl chr 1:203,257,374...203,273,822
|
|
G |
Slc22a22 |
solute carrier family 22 member 22 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC22A22 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 7:88,720,425...88,750,111
Ensembl chr 7:88,720,427...88,750,111
|
|
G |
Slc22a24 |
solute carrier family 22, member 24 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC22A24 mRNA |
CTD |
PMID:29126803 |
|
NCBI chr 1:204,910,450...204,965,538
Ensembl chr 1:204,910,455...204,965,538
|
|
G |
Slc22a25 |
solute carrier family 22, member 25 |
increases expression increases uptake affects transport multiple interactions decreases expression |
EXP ISO |
ochratoxin A results in increased expression of SLC22A9 protein SLC22A19 protein results in increased uptake of ochratoxin A SLC22A19 protein affects the transport of ochratoxin A 2,4-Dichlorophenoxyacetic Acid inhibits the reaction [SLC22A19 protein results in increased uptake of ochratoxin A]; estrone sulfate inhibits the reaction [SLC22A19 protein results in increased uptake of ochratoxin A]; Probenecid inhibits the reaction [SLC22A19 protein results in increased uptake of ochratoxin A]; Salicylates inhibits the reaction [SLC22A19 protein results in increased uptake of ochratoxin A] SLC22A9 protein results in increased uptake of ochratoxin A ochratoxin A results in decreased expression of SLC22A9 mRNA |
CTD |
PMID:15068970 PMID:16079298 PMID:18441515 PMID:19538982 |
|
NCBI chr 1:205,338,698...205,498,486
Ensembl chr 1:205,338,699...205,433,085
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
multiple interactions decreases expression increases uptake increases expression |
EXP ISO |
Citrinin inhibits the reaction [SLC22A6 protein results in increased uptake of ochratoxin A]; Glutarates affects the reaction [SLC22A6 protein results in increased uptake of ochratoxin A]; octanoic acid inhibits the reaction [SLC22A6 protein results in increased uptake of ochratoxin A]; p-Aminohippuric Acid inhibits the reaction [SLC22A6 protein results in increased uptake of ochratoxin A]; Piroxicam inhibits the reaction [SLC22A6 protein results in increased uptake of ochratoxin A]; Probenecid inhibits the reaction [SLC22A6 protein results in increased uptake of ochratoxin A] ochratoxin A results in decreased expression of SLC22A6 mRNA; ochratoxin A results in decreased expression of SLC22A6 protein Chlorides promotes the reaction [SLC22A6 protein results in increased uptake of ochratoxin A] ochratoxin A results in increased expression of SLC22A6 protein |
CTD |
PMID:10336520 PMID:12700408 PMID:15068970 PMID:16098483 PMID:16251485 PMID:17353191 PMID:18417182 PMID:19538982 PMID:19717638 PMID:29126803 More...
|
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc22a7 |
solute carrier family 22 member 7 |
decreases expression affects methylation increases uptake increases expression |
EXP ISO |
ochratoxin A results in decreased expression of SLC22A7 mRNA ochratoxin A affects the methylation of SLC22A7 promoter SLC22A7 protein results in increased uptake of ochratoxin A ochratoxin A results in increased expression of SLC22A7 protein |
CTD |
PMID:12065749 PMID:19538982 PMID:29126803 PMID:30449730 |
|
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
decreases expression increases uptake affects transport increases expression |
EXP ISO |
ochratoxin A results in decreased expression of SLC22A8 mRNA; ochratoxin A results in decreased expression of SLC22A8 protein SLC22A8 protein results in increased uptake of ochratoxin A SLC22A8 protein affects the transport of ochratoxin A ochratoxin A results in increased expression of SLC22A8 mRNA; ochratoxin A results in increased expression of SLC22A8 protein |
CTD |
PMID:10224140 PMID:11306713 PMID:16098483 PMID:19538982 PMID:29126803 PMID:30120945 More...
|
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Slc25a20 |
solute carrier family 25 member 20 |
increases expression |
EXP |
ochratoxin A results in increased expression of SLC25A20 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
|
|
G |
Slc25a23 |
solute carrier family 25 member 23 |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of SLC25A23 mRNA ochratoxin A results in increased methylation of SLC25A23 gene |
CTD |
PMID:37162024 |
|
NCBI chr 9:1,882,636...1,898,369
Ensembl chr 9:1,882,621...1,898,561
|
|
G |
Slc25a3 |
solute carrier family 25 member 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of SLC25A3 protein |
CTD |
PMID:26861962 |
|
NCBI chr 7:25,611,937...25,619,401
Ensembl chr 7:25,586,725...25,667,727
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of SLC2A1 mRNA; ochratoxin A results in increased expression of SLC2A1 protein |
CTD |
PMID:32835834 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc2a2 |
solute carrier family 2 member 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of SLC2A2 mRNA |
CTD |
PMID:16251485 PMID:19717638 |
|
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
|
|
G |
Slc2a5 |
solute carrier family 2 member 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC2A5 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 5:160,583,055...160,609,994
Ensembl chr 5:160,583,234...160,611,106
|
|
G |
Slc30a1 |
solute carrier family 30 member 1 |
multiple interactions |
ISO |
ochratoxin A promotes the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of SLC30A1 mRNA]; Zinc inhibits the reaction [ochratoxin A promotes the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of SLC30A1 mRNA]] |
CTD |
PMID:19720134 |
|
NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910
|
|
G |
Slc30a5 |
solute carrier family 30 member 5 |
multiple interactions |
ISO |
[N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with ochratoxin A] results in decreased expression of SLC30A5 mRNA |
CTD |
PMID:19720134 |
|
NCBI chr 2:31,945,745...31,975,969
Ensembl chr 2:31,945,729...31,975,934
|
|
G |
Slc30a6 |
solute carrier family 30 member 6 |
multiple interactions |
ISO |
[N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with ochratoxin A] results in decreased expression of SLC30A6 mRNA |
CTD |
PMID:19720134 |
|
NCBI chr 6:21,020,931...21,050,785
Ensembl chr 6:21,020,931...21,050,785
|
|
G |
Slc30a7 |
solute carrier family 30 member 7 |
multiple interactions decreases expression |
ISO |
[N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with ochratoxin A co-treated with Zinc] results in decreased expression of SLC30A7 mRNA; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [ochratoxin A results in decreased expression of SLC30A7 mRNA] |
CTD |
PMID:19720134 |
|
NCBI chr 2:203,855,484...203,922,155
Ensembl chr 2:203,859,175...203,922,132
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC34A1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr17:9,218,876...9,233,852
Ensembl chr17:9,218,876...9,233,852
|
|
G |
Slc39a1 |
solute carrier family 39 member 1 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of SLC39A1 mRNA Zinc deficiency promotes the reaction [ochratoxin A results in decreased expression of SLC39A1 mRNA] |
CTD |
PMID:19720134 |
|
NCBI chr 2:175,703,413...175,709,063
Ensembl chr 2:175,703,441...175,709,058
|
|
G |
Slc39a10 |
solute carrier family 39 member 10 |
multiple interactions |
ISO |
[ochratoxin A co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with Zinc] results in decreased expression of SLC39A10 mRNA; [ochratoxin A co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of SLC39A10 mRNA |
CTD |
PMID:19720134 |
|
NCBI chr 9:54,836,841...54,960,325
Ensembl chr 9:54,876,141...54,960,325
|
|
G |
Slc39a14 |
solute carrier family 39 member 14 |
multiple interactions |
ISO |
[ochratoxin A co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of SLC39A14 mRNA |
CTD |
PMID:19720134 |
|
NCBI chr15:45,376,806...45,423,549
Ensembl chr15:45,376,917...45,423,524
|
|
G |
Slc39a6 |
solute carrier family 39 member 6 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SLC39A6 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr18:15,864,874...15,885,417
Ensembl chr18:15,864,875...15,885,417
|
|
G |
Slc39a7 |
solute carrier family 39 member 7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SLC39A7 mRNA |
CTD |
PMID:19720134 |
|
NCBI chr20:4,823,166...4,826,538
Ensembl chr20:4,822,012...4,826,537
|
|
G |
Slc39a9 |
solute carrier family 39, member 9 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SLC39A9 mRNA |
CTD |
PMID:19720134 |
|
NCBI chr 6:100,291,537...100,330,419
Ensembl chr 6:100,291,573...100,330,408
|
|
G |
Slc3a1 |
solute carrier family 3 member 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC3A1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 6:9,608,169...9,641,881
Ensembl chr 6:9,608,178...9,641,907
|
|
G |
Slc43a1 |
solute carrier family 43 member 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of SLC43A1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 3:69,920,586...69,946,768
Ensembl chr 3:69,920,649...69,946,768
|
|
G |
Slc4a1 |
solute carrier family 4 member 1 (Diego blood group) |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of SLC4A1 gene ochratoxin A results in increased expression of SLC4A1 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr10:87,306,865...87,323,132
Ensembl chr10:87,306,872...87,323,117
|
|
G |
Slc50a1 |
solute carrier family 50 member 1 |
decreases expression increases acetylation increases expression multiple interactions |
EXP ISO |
ochratoxin A results in decreased expression of RAG1AP1 mRNA ochratoxin A results in increased acetylation of SLC50A1 promoter ochratoxin A results in increased expression of SLC50A1 mRNA [ochratoxin A results in increased acetylation of SLC50A1 promoter] which results in increased expression of SLC50A1 mRNA |
CTD |
PMID:22124623 PMID:29098329 |
|
NCBI chr 2:174,677,985...174,680,366
Ensembl chr 2:174,677,708...174,680,366
|
|
G |
Slc51b |
SLC51 subunit beta |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC51B mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 8:65,931,891...65,939,953
Ensembl chr 8:65,931,890...65,940,145
|
|
G |
Slc5a1 |
solute carrier family 5 member 1 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of SLC5A1 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of SLC5A1 mRNA |
CTD |
PMID:29673704 |
|
NCBI chr14:77,553,990...77,618,589
Ensembl chr14:77,553,843...77,618,547
|
|
G |
Slc5a10 |
solute carrier family 5 member 10 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC5A10 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr10:46,352,060...46,400,795
Ensembl chr10:46,352,061...46,399,811
|
|
G |
Slc5a2 |
solute carrier family 5 member 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of SLC5A2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 1:182,847,185...182,853,309
Ensembl chr 1:182,847,106...182,853,306
|
|
G |
Slc6a18 |
solute carrier family 6 member 18 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC6A18 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:29,607,288...29,621,925
Ensembl chr 1:29,608,077...29,621,925
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SLC6A4 mRNA |
CTD |
PMID:34748853 |
|
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
affects expression |
ISO |
ochratoxin A affects the expression of SLC7A11 mRNA |
CTD |
PMID:23824090 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slc7a12 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 12 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC7A12 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 2:87,079,724...87,146,875
Ensembl chr 2:87,079,749...87,146,875
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
increases expression |
ISO |
ochratoxin A results in increased expression of SLC7A5 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Slc9a8 |
solute carrier family 9 member A8 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of SLC9A8 promoter |
CTD |
PMID:29098329 |
|
NCBI chr 3:156,147,855...156,198,497
Ensembl chr 3:156,148,104...156,198,471
|
|
G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
affects transport increases uptake decreases expression |
ISO EXP |
SLCO1A4 protein affects the transport of ochratoxin A SLCO1A2 protein results in increased uptake of ochratoxin A ochratoxin A results in decreased expression of SLCO1A2 mRNA |
CTD |
PMID:9928634 PMID:19833843 PMID:28532671 PMID:29126803 |
|
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
|
|
G |
Slco1b2 |
solute carrier organic anion transporter family member 1B2 |
increases transport |
ISO |
SLCO1B2 protein results in increased transport of ochratoxin A SLCO1B3 protein results in increased transport of ochratoxin A |
CTD |
PMID:32470353 |
|
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
|
|
G |
Slco2b1 |
solute carrier organic anion transporter family, member 2b1 |
increases uptake |
ISO |
SLCO2B1 protein results in increased uptake of ochratoxin A |
CTD |
PMID:28532671 |
|
NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353
|
|
G |
Slfn5 |
schlafen family member 5 |
decreases expression increases methylation |
ISO |
ochratoxin A results in decreased expression of SLFN5 mRNA ochratoxin A results in increased methylation of SLFN5 promoter |
CTD |
PMID:30559759 |
|
NCBI chr10:67,881,068...67,895,013
Ensembl chr10:67,880,009...67,893,109
|
|
G |
Smad2 |
SMAD family member 2 |
multiple interactions increases response to substance increases expression |
ISO |
4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of SMAD2 mRNA]; 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of SMAD2 protein]; ochratoxin A results in increased expression of and results in increased phosphorylation of SMAD2 protein; SMAD2 affects the reaction [ochratoxin A results in increased expression of ACTA2 mRNA]; SMAD2 affects the reaction [ochratoxin A results in increased expression of ACTA2 protein]; SMAD2 affects the reaction [ochratoxin A results in increased expression of FN1 mRNA]; SMAD2 affects the reaction [ochratoxin A results in increased expression of FN1 protein] SMAD2 results in increased susceptibility to ochratoxin A |
CTD |
PMID:32617660 PMID:35543154 |
|
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Smad3 |
SMAD family member 3 |
increases expression multiple interactions increases response to substance |
ISO |
ochratoxin A results in increased expression of SMAD3 mRNA ochratoxin A results in increased expression of and results in increased phosphorylation of SMAD3 protein SMAD3 results in increased susceptibility to ochratoxin A 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of SMAD3 mRNA]; 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of SMAD3 protein]; ochratoxin A results in increased expression of and results in increased phosphorylation of SMAD3 protein; SMAD3 affects the reaction [ochratoxin A results in increased expression of ACTA2 mRNA]; SMAD3 affects the reaction [ochratoxin A results in increased expression of ACTA2 protein]; SMAD3 affects the reaction [ochratoxin A results in increased expression of FN1 mRNA]; SMAD3 affects the reaction [ochratoxin A results in increased expression of FN1 protein] |
CTD |
PMID:32617660 PMID:35543154 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Snrpc |
small nuclear ribonucleoprotein polypeptide C |
increases expression |
EXP |
ochratoxin A results in increased expression of SNRPC mRNA |
CTD |
PMID:18417182 |
|
NCBI chr20:5,888,453...5,906,638
Ensembl chr20:5,888,453...5,906,638
|
|
G |
Snx12 |
sorting nexin 12 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SNX12 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr X:66,226,995...66,356,945
Ensembl chr X:66,227,053...66,356,950
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
multiple interactions |
ISO |
ochratoxin A inhibits the reaction [Antigens results in increased expression of SOCS1 mRNA] |
CTD |
PMID:28935500 |
|
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
|
|
G |
Socs2 |
suppressor of cytokine signaling 2 |
multiple interactions |
ISO |
ochratoxin A inhibits the reaction [Antigens results in increased expression of SOCS2 mRNA] |
CTD |
PMID:28935500 |
|
NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of SOCS3 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases expression increases expression |
EXP ISO |
ochratoxin A results in decreased expression of SOD1 mRNA ochratoxin A results in increased expression of SOD1 mRNA |
CTD |
PMID:23358140 PMID:23391613 PMID:27923682 PMID:28710020 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of SOD2 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sod3 |
superoxide dismutase 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of SOD3 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Sord |
sorbitol dehydrogenase |
increases expression |
ISO |
ochratoxin A results in increased expression of SORD mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
|
|
G |
Sos2 |
SOS Ras/Rho guanine nucleotide exchange factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SOS2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 6:88,042,966...88,156,140
Ensembl chr 6:88,042,966...88,156,692
|
|
G |
Sox10 |
SRY-box transcription factor 10 |
affects expression multiple interactions |
EXP |
ochratoxin A affects the expression of SOX10 mRNA SHH protein inhibits the reaction [ochratoxin A affects the expression of SOX10 mRNA] |
CTD |
PMID:24792326 |
|
NCBI chr 7:110,725,274...110,734,651
Ensembl chr 7:110,725,274...110,735,544
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of SOX2 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of SOX2 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
|
|
G |
Spaca9 |
sperm acrosome associated 9 |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of SPACA9 gene ochratoxin A results in increased expression of SPACA9 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 3:12,019,376...12,028,801
Ensembl chr 3:12,019,363...12,029,119
|
|
G |
Spart |
spartin |
increases expression |
ISO |
ochratoxin A results in increased expression of SPART mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:139,292,630...139,319,248
Ensembl chr 2:139,292,355...139,319,248
|
|
G |
Spast |
spastin |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SPAST mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 6:21,055,349...21,106,586
Ensembl chr 6:21,055,349...21,107,954
|
|
G |
Spata20 |
spermatogenesis associated 20 |
increases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in increased expression of SPATA20 mRNA ochratoxin A results in increased acetylation of SPATA20 promoter [ochratoxin A results in increased acetylation of SPATA20 promoter] which results in increased expression of SPATA20 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:79,427,525...79,435,472
Ensembl chr10:79,427,528...79,434,368
|
|
G |
Spata7 |
spermatogenesis associated 7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SPATA7 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 6:117,879,828...117,925,284
Ensembl chr 6:117,879,823...117,925,284
|
|
G |
Spats2l |
spermatogenesis associated, serine-rich 2-like |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of SPATS2L mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:59,319,949...59,493,864
Ensembl chr 9:59,320,276...59,493,967
|
|
G |
Spdl1 |
spindle apparatus coiled-coil protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of SPDL1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:19,269,125...19,294,213
Ensembl chr10:19,269,127...19,294,127
|
|
G |
Spetex2d |
Spetex-2D protein |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SPETEX2D mRNA |
CTD |
PMID:30449730 |
|
|
|
G |
Spetex2e |
Spetex-2E protein |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SPETEX2E mRNA |
CTD |
PMID:30449730 |
|
NCBI chr15:4,813,644...4,816,793
Ensembl chr15:4,739,331...4,816,815
|
|
G |
Spetex2f |
Spetex-2F protein |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SPETEX2F mRNA |
CTD |
PMID:30449730 |
|
NCBI chr15:17,716,315...17,720,203
Ensembl chr15:17,716,358...17,733,744
|
|
G |
Spetex2g |
Spetex-2G protein |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SPETEX2G mRNA |
CTD |
PMID:30449730 |
|
NCBI chr15:4,615,554...4,619,166
Ensembl chr15:4,615,466...4,662,812
|
|
G |
Spetex2h |
Spetex-2H protein |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SPETEX2H mRNA |
CTD |
PMID:30449730 |
|
|
|
G |
Sphk1 |
sphingosine kinase 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of SPHK1 mRNA; ochratoxin A results in decreased expression of SPHK1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
|
|
G |
Spock1 |
sparc/osteonectin, cwcv and kazal like domains proteoglycan 1 |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of SPOCK1 promoter [ochratoxin A results in increased acetylation of SPOCK1 promoter] which results in increased expression of SPOCK1 mRNA ochratoxin A results in increased expression of SPOCK1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr17:6,741,504...7,221,685
Ensembl chr17:6,742,273...7,224,935
|
|
G |
Spon1 |
spondin 1 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of SPON1 gene |
CTD |
PMID:26431795 |
|
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
|
|
G |
Spon2 |
spondin 2 |
increases expression increases acetylation multiple interactions |
ISO |
ochratoxin A metabolite results in increased expression of SPON2 mRNA; ochratoxin A results in increased expression of SPON2 mRNA ochratoxin A results in increased acetylation of SPON2 promoter [ochratoxin A results in increased acetylation of SPON2 promoter] which results in increased expression of SPON2 mRNA |
CTD |
PMID:26314263 PMID:29098329 |
|
NCBI chr14:77,505,695...77,518,001
Ensembl chr14:77,511,901...77,517,996
|
|
G |
Spop |
speckle type BTB/POZ protein |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of SPOP gene |
CTD |
PMID:26431795 |
|
NCBI chr10:80,358,121...80,438,983
Ensembl chr10:80,358,124...80,483,955
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of SPP1 mRNA; ochratoxin A results in increased expression of SPP1 protein |
CTD |
PMID:18308701 PMID:30008028 PMID:30449730 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Spr |
sepiapterin reductase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SPR mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 4:117,671,948...117,676,292
Ensembl chr 4:117,671,949...117,675,678
|
|
G |
Sptbn1 |
spectrin, beta, non-erythrocytic 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SPTBN1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr14:103,841,713...104,016,900
Ensembl chr14:103,842,684...104,008,507
|
|
G |
Sqstm1 |
sequestosome 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SQSTM1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of SRC protein |
CTD |
PMID:25002221 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srpk2 |
SRSF protein kinase 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SRPK2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 4:11,464,684...11,655,993
Ensembl chr 4:11,464,674...11,655,990
|
|
G |
Srpra |
SRP receptor subunit alpha |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SRPRA mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:33,560,365...33,566,458
Ensembl chr 8:33,560,348...33,566,470
|
|
G |
Srsf1 |
serine and arginine rich splicing factor 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SRSF1 protein |
CTD |
PMID:19445961 |
|
NCBI chr10:72,838,926...72,859,066
Ensembl chr10:72,839,274...72,845,336
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression multiple interactions decreases expression |
ISO |
ochratoxin A results in increased expression of SRXN1 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of SRXN1 mRNA; [Plant Extracts co-treated with ochratoxin A] results in decreased expression of SRXN1 mRNA; [Zearalenone co-treated with ochratoxin A] results in decreased expression of SRXN1 mRNA ochratoxin A results in decreased expression of SRXN1 mRNA |
CTD |
PMID:32905824 PMID:34015425 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Ssu72 |
SSU72 homolog, RNA polymerase II CTD phosphatase |
increases expression |
EXP |
ochratoxin A results in increased expression of SSU72 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 5:166,312,267...166,343,432
Ensembl chr 5:166,313,650...166,343,429
|
|
G |
St13 |
ST13, Hsp70 interacting protein |
increases expression |
ISO |
ochratoxin A results in increased expression of ST13 protein |
CTD |
PMID:26861962 |
|
NCBI chr 7:112,891,007...112,925,727
Ensembl chr 7:112,844,375...112,925,945
|
|
G |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
increases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in increased expression of ST3GAL5 mRNA ochratoxin A results in increased acetylation of ST3GAL5 promoter [ochratoxin A results in increased acetylation of ST3GAL5 promoter] which results in increased expression of ST3GAL5 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 4:104,134,613...104,192,558
Ensembl chr 4:104,134,613...104,192,558
|
|
G |
Stag2 |
STAG2 cohesin complex component |
increases expression |
EXP |
ochratoxin A results in increased expression of STAG2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr X:120,974,687...121,105,677
Ensembl chr X:120,974,857...121,105,677
|
|
G |
Stam2 |
signal transducing adaptor molecule 2 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of STAM2 mRNA; ochratoxin A results in decreased expression of STAM2 mRNA |
CTD |
PMID:19287073 PMID:24356939 |
|
NCBI chr 3:37,186,145...37,234,810
Ensembl chr 3:37,186,145...37,234,812
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
[ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of STAT1 mRNA |
CTD |
PMID:28935500 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
[ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of STAT3 mRNA |
CTD |
PMID:28935500 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
multiple interactions |
ISO |
[ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of STAT4 mRNA |
CTD |
PMID:28935500 |
|
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stc1 |
stanniocalcin 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of STC1 mRNA |
CTD |
PMID:22124623 PMID:30559759 |
|
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
|
|
G |
Stra6 |
signaling receptor and transporter of retinol STRA6 |
increases expression |
EXP |
ochratoxin A results in increased expression of STRA6 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 8:58,548,899...58,568,861
Ensembl chr 8:58,549,736...58,568,860
|
|
G |
Stx3 |
syntaxin 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of STX3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:208,617,018...208,686,240
Ensembl chr 1:208,639,115...208,685,805
|
|
G |
Stx7 |
syntaxin 7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of STX7 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:21,197,075...21,237,320
Ensembl chr 1:21,197,075...21,237,279
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of SULT1A1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Sult1c2a |
sulfotransferase family 1C member 2A |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SULT1C2A mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 9:6,873,697...6,904,736
Ensembl chr 9:6,874,249...6,904,734
|
|
G |
Supt16h |
SPT16 homolog, facilitates chromatin remodeling subunit |
increases expression |
EXP |
ochratoxin A results in increased expression of SUPT16H mRNA |
CTD |
PMID:17483316 |
|
NCBI chr15:24,867,697...24,904,818
Ensembl chr15:24,866,489...24,904,846
|
|
G |
Syk |
spleen associated tyrosine kinase |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of SYK mRNA; ochratoxin A results in increased expression of SYK mRNA |
CTD |
PMID:26314263 |
|
NCBI chr17:12,604,615...12,678,437
Ensembl chr17:12,604,619...12,661,410
|
|
G |
Syvn1 |
synoviolin 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SYVN1 protein |
CTD |
PMID:26861962 |
|
NCBI chr 1:203,339,235...203,346,137
Ensembl chr 1:203,339,619...203,346,152
|
|
G |
Tacc2 |
transforming, acidic coiled-coil containing protein 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of TACC2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:185,139,223...185,327,881
Ensembl chr 1:185,116,111...185,327,881
|
|
G |
Taf9 |
TATA-box binding protein associated factor 9 |
increases expression |
EXP |
ochratoxin A results in increased expression of TAF9 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:31,794,316...31,798,324
Ensembl chr 2:31,794,142...31,798,769
|
|
G |
Tagln2 |
transgelin 2 |
affects expression |
ISO |
ochratoxin A affects the expression of TAGLN2 protein |
CTD |
PMID:26861962 |
|
NCBI chr13:84,966,980...84,973,973
Ensembl chr13:84,967,009...84,973,972
|
|
G |
Tagln3 |
transgelin 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of TAGLN3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr11:55,099,887...55,113,457
Ensembl chr11:55,099,743...55,113,485
|
|
G |
Tardbp |
TAR DNA binding protein |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TARDBP mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:159,051,799...159,062,055
|
|
G |
Tars1 |
threonyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:60,368,893...60,387,715
Ensembl chr 2:60,367,796...60,387,717
|
|
G |
Tbc1d1 |
TBC1 domain family member 1 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of TBC1D1 gene |
CTD |
PMID:26431795 |
|
NCBI chr14:43,936,820...44,135,133
Ensembl chr14:43,935,636...44,136,499
|
|
G |
Tbc1d5 |
TBC1 domain family, member 5 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of TBC1D5 gene |
CTD |
PMID:26431795 |
|
NCBI chr 9:3,503,328...4,017,131
Ensembl chr 9:3,513,623...4,016,913
|
|
G |
Tbx10 |
T-box transcription factor 10 |
increases expression |
EXP |
ochratoxin A results in increased expression of TBX10 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 1:201,285,729...201,292,676
Ensembl chr 1:201,279,829...201,292,601
|
|
G |
Tcf3 |
transcription factor 3 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of TCF3 gene |
CTD |
PMID:26431795 |
|
NCBI chr 7:9,280,571...9,302,315
Ensembl chr 7:9,280,571...9,302,314
|
|
G |
Tdg |
thymine-DNA glycosylase |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of TDG promoter ochratoxin A results in decreased expression of TDG mRNA [ochratoxin A results in decreased acetylation of TDG promoter] which results in decreased expression of TDG mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:21,077,853...21,097,617
Ensembl chr 7:21,077,853...21,097,567
|
|
G |
Terf2ip |
TERF2 interacting protein |
increases expression |
EXP |
ochratoxin A results in increased expression of TERF2IP mRNA |
CTD |
PMID:23358140 |
|
NCBI chr19:39,976,965...39,984,055
Ensembl chr19:39,976,906...39,984,064
|
|
G |
Tesk2 |
testis associated actin remodelling kinase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of TESK2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:130,178,715...130,270,594
Ensembl chr 5:130,185,033...130,271,292
|
|
G |
Tf |
transferrin |
increases expression |
EXP |
ochratoxin A results in increased expression of TF mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Tfam |
transcription factor A, mitochondrial |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TFAM mRNA |
CTD |
PMID:34481902 |
|
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
|
|
G |
Tfdp2 |
transcription factor Dp-2 |
multiple interactions decreases expression decreases acetylation |
ISO |
[ochratoxin A results in decreased acetylation of TFDP2 promoter] which results in decreased expression of TFDP2 mRNA ochratoxin A results in decreased expression of TFDP2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:96,760,459...96,901,466
Ensembl chr 8:96,760,504...96,896,682
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
increases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of TGFB1 mRNA ochratoxin A results in increased expression of TGFB1 mRNA; ochratoxin A results in increased expression of TGFB1 protein [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of TGFB1 protein |
CTD |
PMID:23358140 PMID:28710020 PMID:30876885 PMID:32617660 PMID:33543323 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
increases expression decreases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of TGFB2 mRNA ochratoxin A results in decreased expression of TGFB2 mRNA NFE2L2 protein affects the reaction [ochratoxin A results in decreased expression of TGFB2 mRNA] ochratoxin A metabolite results in increased expression of TGFB2 mRNA; ochratoxin A results in increased expression of TGFB2 mRNA |
CTD |
PMID:23208426 PMID:23358140 PMID:26314263 PMID:28710020 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of TGFBR1 mRNA; ochratoxin A results in increased expression of TGFBR1 protein |
CTD |
PMID:32617660 PMID:35543154 |
|
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions decreases activity |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased activity of THRB protein ochratoxin A results in decreased activity of THRB protein |
CTD |
PMID:27481073 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Thy1 |
Thy-1 cell surface antigen |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of THY1 mRNA; ochratoxin A results in decreased expression of THY1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659
|
|
G |
Ticam1 |
TIR domain containing adaptor molecule 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TICAM1 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 9:1,102,559...1,111,023
Ensembl chr 9:1,102,366...1,123,147
|
|
G |
Timm10b |
translocase of inner mitochondrial membrane 10B |
decreases expression |
EXP |
ochratoxin A results in decreased expression of TIMM10B mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:159,980,525...159,983,371
Ensembl chr 1:159,980,484...159,981,642
|
|
G |
Timm22 |
translocase of inner mitochondrial membrane 22 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of TIMM22 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:61,253,459...61,261,217
Ensembl chr10:61,253,450...61,261,755
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of TIMP1 mRNA; ochratoxin A results in increased expression of TIMP1 protein |
CTD |
PMID:16622519 PMID:18308701 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
multiple interactions increases expression increases acetylation |
ISO |
[NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of TIMP2 mRNA [ochratoxin A results in increased acetylation of TIMP2 promoter] which results in increased expression of TIMP2 mRNA ochratoxin A results in increased expression of TIMP2 mRNA |
CTD |
PMID:28710020 PMID:29098329 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of TIMP3 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions |
ISO |
ochratoxin A results in decreased expression of and affects the localization of TJP1 protein |
CTD |
PMID:30763683 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tmco6 |
transmembrane and coiled-coil domains 6 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of TMCO6 mRNA; ochratoxin A results in decreased expression of TMCO6 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr18:28,349,248...28,355,843
Ensembl chr18:28,349,248...28,355,843
|
|
G |
Tmem177 |
transmembrane protein 177 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of TMEM177 mRNA; ochratoxin A results in decreased expression of TMEM177 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr13:31,023,893...31,027,368
Ensembl chr13:31,023,455...31,027,378
|
|
G |
Tmem236 |
transmembrane protein 236 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of TMEM236 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr17:77,180,919...77,241,258
Ensembl chr17:77,188,163...77,238,671
|
|
G |
Tmem35a |
transmembrane protein 35A |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of TMEM35A mRNA ochratoxin A results in decreased methylation of TMEM35A gene |
CTD |
PMID:37162024 |
|
NCBI chr X:97,503,350...97,514,198
Ensembl chr X:97,503,350...97,514,197
|
|
G |
Tmem37 |
transmembrane protein 37 |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of TMEM37 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr13:31,184,322...31,191,477
Ensembl chr13:31,171,355...31,191,077
|
|
G |
Tmem42 |
transmembrane protein 42 |
increases methylation decreases expression |
EXP |
ochratoxin A results in increased methylation of TMEM42 gene ochratoxin A results in decreased expression of TMEM42 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 8:122,674,793...122,677,290
Ensembl chr 8:122,674,070...122,677,276
|
|
G |
Tmem50b |
transmembrane protein 50B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TMEM50B mRNA |
CTD |
PMID:22124623 |
|
NCBI chr11:30,804,835...30,837,675
Ensembl chr11:30,804,837...30,837,661
|
|
G |
Tmem67 |
transmembrane protein 67 |
decreases acetylation |
ISO |
ochratoxin A results in decreased acetylation of TMEM67 promoter |
CTD |
PMID:29098329 |
|
NCBI chr 5:25,536,458...25,589,378
Ensembl chr 5:25,536,458...25,589,334
|
|
G |
Tmigd1 |
transmembrane and immunoglobulin domain containing 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of TMIGD1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr10:61,739,071...61,751,025
Ensembl chr10:61,736,462...61,751,025
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
[ochratoxin A co-treated with Citrinin] results in increased expression of TNF mRNA; [ochratoxin A co-treated with Citrinin] results in increased expression of TNF protein; ochratoxin A inhibits the reaction [TNF protein results in increased expression of F3 protein]; pyrazolanthrone inhibits the reaction [[ochratoxin A co-treated with Citrinin] results in increased expression of TNF mRNA]; Quercetin inhibits the reaction [ochratoxin A results in increased expression of TNF protein]; U 0126 inhibits the reaction [[ochratoxin A co-treated with Citrinin] results in increased expression of TNF mRNA] [Lipopolysaccharides co-treated with ochratoxin A] results in increased expression of TNF protein; [ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of TNF protein ochratoxin A results in increased expression of TNF mRNA; ochratoxin A results in increased expression of TNF protein |
CTD |
PMID:18289624 PMID:24792326 PMID:25532488 PMID:27193732 PMID:28935500 PMID:29673704 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip1 |
TNF alpha induced protein 1 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of TNFAIP1 mRNA ochratoxin A results in decreased expression of TNFAIP1 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:63,417,774...63,432,466
Ensembl chr10:63,417,775...63,432,466
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
multiple interactions decreases expression increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of TNFAIP3 promoter] which results in increased expression of TNFAIP3 mRNA ochratoxin A results in decreased expression of TNFAIP3 mRNA ochratoxin A results in increased expression of TNFAIP3 mRNA |
CTD |
PMID:29098329 PMID:30559759 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfrsf12a |
TNF receptor superfamily member 12A |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of TNFRSF12A mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of TNFRSF12A mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
increases expression multiple interactions decreases expression |
EXP ISO |
ochratoxin A results in increased expression of TNFRSF1A mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of TNFRSF1A mRNA ochratoxin A results in decreased expression of TNFRSF1A mRNA |
CTD |
PMID:17316727 PMID:19562491 PMID:30428381 PMID:30763683 |
|
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tnfsf9 |
TNF superfamily member 9 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TNFSF9 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
|
|
G |
Tomm70 |
translocase of outer mitochondrial membrane 70 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TOMM70 protein |
CTD |
PMID:26861962 |
|
NCBI chr11:43,378,719...43,417,166
Ensembl chr11:43,377,216...43,417,202
|
|
G |
Top2a |
DNA topoisomerase II alpha |
increases expression |
EXP |
ochratoxin A results in increased expression of TOP2A mRNA; ochratoxin A results in increased expression of TOP2A protein |
CTD |
PMID:19237604 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Topbp1 |
DNA topoisomerase II binding protein 1 |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of TOPBP1 promoter ochratoxin A results in decreased expression of TOPBP1 mRNA [ochratoxin A results in decreased acetylation of TOPBP1 promoter] which results in decreased expression of TOPBP1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:103,887,805...103,931,662
Ensembl chr 8:103,887,865...103,931,674
|
|
G |
Tp53 |
tumor protein p53 |
increases expression increases response to substance multiple interactions decreases expression decreases response to substance increases phosphorylation |
ISO EXP |
ochratoxin A results in increased expression of TP53 mRNA; ochratoxin A results in increased expression of TP53 protein TRP53 gene mutant form results in increased susceptibility to ochratoxin A TRP53 gene mutant form inhibits the reaction [ochratoxin A results in increased expression of CDKN1A mRNA]; TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of AURKA mRNA]; TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of CCNE1 mRNA]; TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of CDK1 mRNA]; TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of PKMYT1 mRNA]; TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of PLK1 mRNA] ochratoxin A results in increased expression of TRP53 protein ochratoxin A results in increased expression of and results in increased phosphorylation of TP53 protein; TP53 mutant form inhibits the reaction [ochratoxin A results in decreased expression of RAD51] ochratoxin A results in decreased expression of TP53 TRP53 protein results in decreased susceptibility to ochratoxin A ochratoxin A results in increased phosphorylation of TRP53 protein |
CTD |
PMID:19367635 PMID:19445961 PMID:19562491 PMID:23208426 PMID:23261758 PMID:24525463 PMID:25218026 PMID:25636497 PMID:28286205 PMID:31154016 PMID:32910239 More...
|
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TP53INP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
|
|
G |
Tph2 |
tryptophan hydroxylase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of TPH2 mRNA |
CTD |
PMID:27346841 |
|
NCBI chr 7:50,685,694...50,789,424
Ensembl chr 7:50,685,694...50,789,424
|
|
G |
Tpm3 |
tropomyosin 3 |
increases expression decreases expression |
ISO EXP |
ochratoxin A results in increased expression of TPM3 mRNA ochratoxin A results in decreased expression of TPM3 protein |
CTD |
PMID:22124623 PMID:31369848 |
|
NCBI chr 2:175,517,198...175,545,014
Ensembl chr 2:175,517,226...175,545,013
|
|
G |
Tpm4 |
tropomyosin 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of TPM4 protein |
CTD |
PMID:31369848 |
|
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
|
|
G |
Traf6 |
TNF receptor associated factor 6 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TRAF6 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
|
|
G |
Trak1 |
trafficking kinesin protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TRAK1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 8:120,984,445...121,139,357
Ensembl chr 8:120,984,431...121,139,367
|
|
G |
Trak2 |
trafficking kinesin protein 2 |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of TRAK2 promoter ochratoxin A results in decreased expression of TRAK2 mRNA [ochratoxin A results in decreased acetylation of TRAK2 promoter] which results in decreased expression of TRAK2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 9:60,348,531...60,414,036
Ensembl chr 9:60,350,012...60,413,996
|
|
G |
Trap1 |
TNF receptor-associated protein 1 |
multiple interactions decreases expression |
ISO |
Oleanolic Acid inhibits the reaction [ochratoxin A results in decreased expression of TRAP1 protein]; TRAP1 protein affects the reaction [ochratoxin A results in decreased expression of BCL2 protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of BAX protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of CYCS protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of DDIT3 protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of HSPA5 protein]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in decreased expression of BCL2 protein]]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in decreased expression of TRAP1 protein]]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of BAX protein]]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of DDIT3 protein]]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein]] |
CTD |
PMID:33465424 |
|
NCBI chr10:11,464,882...11,498,931
Ensembl chr10:11,464,821...11,498,981
|
|
G |
Triap1 |
TP53 regulated inhibitor of apoptosis 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TRIAP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr12:41,267,534...41,270,053
Ensembl chr12:41,267,549...41,270,042
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression decreases acetylation decreases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of TRIB3 mRNA ochratoxin A results in decreased acetylation of TRIB3 promoter ochratoxin A results in decreased expression of TRIB3 mRNA [ochratoxin A results in decreased acetylation of TRIB3 promoter] which results in decreased expression of TRIB3 mRNA |
CTD |
PMID:23358140 PMID:29098329 PMID:30008028 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Trim24 |
tripartite motif-containing 24 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TRIM24 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 4:66,567,342...66,692,029
Ensembl chr 4:66,566,686...66,717,241
|
|
G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of TRPM8 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:88,897,039...88,990,167
Ensembl chr 9:88,903,880...88,988,552
|
|
G |
Trrap |
transformation/transcription domain-associated protein |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TRRAP mRNA |
CTD |
PMID:19287073 |
|
NCBI chr12:9,738,006...9,827,708
Ensembl chr12:9,738,006...9,827,674
|
|
G |
Tsc2 |
TSC complex subunit 2 |
increases response to substance |
EXP |
TSC2 gene mutant form results in increased susceptibility to ochratoxin A |
CTD |
PMID:17483316 |
|
NCBI chr10:13,621,135...13,655,773
Ensembl chr10:13,621,136...13,655,951
|
|
G |
Tsnax |
translin-associated factor X |
multiple interactions decreases acetylation decreases expression |
ISO |
[ochratoxin A results in decreased acetylation of TSNAX promoter] which results in decreased expression of TSNAX mRNA ochratoxin A results in decreased expression of TSNAX mRNA |
CTD |
PMID:29098329 |
|
NCBI chr19:52,975,848...52,989,886
Ensembl chr19:52,975,659...52,989,878
|
|
G |
Tspoap1 |
TSPO associated protein 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of TSPOAP1 mRNA; ochratoxin A results in increased expression of TSPOAP1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr10:72,554,220...72,586,402
Ensembl chr10:72,560,980...72,586,412
|
|
G |
Tubal3 |
tubulin, alpha-like 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TUBAL3 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr17:66,323,733...66,332,423
Ensembl chr17:66,323,733...66,335,355
|
|
G |
Tubb1 |
tubulin, beta 1 class VI |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TUBB1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 3:163,247,990...163,257,460
Ensembl chr 3:163,247,967...163,256,063
|
|
G |
Tubb5 |
tubulin, beta 5 class I |
increases expression |
EXP |
ochratoxin A results in increased expression of TUBB5 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
|
|
G |
Twf1 |
twinfilin actin-binding protein 1 |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of TWF1 promoter ochratoxin A results in decreased expression of TWF1 mRNA [ochratoxin A results in decreased acetylation of TWF1 promoter] which results in decreased expression of TWF1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:125,715,938...125,727,834
Ensembl chr 7:125,716,015...125,727,894
|
|
G |
Txn2 |
thioredoxin 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of TXN2 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
|
|
G |
Txnip |
thioredoxin interacting protein |
multiple interactions increases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of TXNIP mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in increased expression of TXNIP mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of TXNIP mRNA; [Zearalenone co-treated with ochratoxin A] results in increased expression of TXNIP mRNA ochratoxin A results in increased expression of TXNIP mRNA |
CTD |
PMID:34015425 |
|
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of TXNRD1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Uba1 |
ubiquitin-like modifier activating enzyme 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of UBA1 protein |
CTD |
PMID:26861962 |
|
NCBI chr X:1,508,700...1,530,677
Ensembl chr X:1,508,666...1,530,636
|
|
G |
Ubap2l |
ubiquitin associated protein 2-like |
increases expression |
ISO |
ochratoxin A results in increased expression of UBAP2L mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:175,438,703...175,494,085
Ensembl chr 2:175,438,703...175,493,998
|
|
G |
Ubb |
ubiquitin B |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of UBB mRNA; ochratoxin A results in decreased expression of UBB mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:47,247,630...47,249,335
Ensembl chr10:47,245,637...47,249,333
|
|
G |
Ubd |
ubiquitin D |
increases expression |
EXP |
ochratoxin A results in increased expression of UBD mRNA |
CTD |
PMID:23208426 |
|
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
|
|
G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
increases expression |
EXP |
ochratoxin A results in increased expression of UBE2C mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
|
|
G |
Ube2l3 |
ubiquitin-conjugating enzyme E2L 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of UBE2L3 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr11:83,797,722...83,838,862
Ensembl chr11:83,797,722...83,838,862
|
|
G |
Ube2q1 |
ubiquitin conjugating enzyme E2 Q1 |
increases expression |
EXP |
ochratoxin A results in increased expression of UBE2Q1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:175,198,793...175,209,152
Ensembl chr 2:175,198,873...175,207,942
|
|
G |
Ucp1 |
uncoupling protein 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of UCP1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr19:24,808,782...24,816,853
Ensembl chr19:24,808,783...24,816,852
|
|
G |
Ucp2 |
uncoupling protein 2 |
decreases expression multiple interactions increases expression |
EXP ISO |
ochratoxin A results in decreased expression of UCP2 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of UCP2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of UCP2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in increased expression of UCP2 mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of UCP2 mRNA ochratoxin A results in increased expression of UCP2 mRNA |
CTD |
PMID:17316727 PMID:19287073 PMID:22124623 PMID:34015425 |
|
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Ucp3 |
uncoupling protein 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of UCP3 mRNA |
CTD |
PMID:17316727 PMID:22124623 |
|
NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
|
|
G |
Ugdh |
UDP-glucose 6-dehydrogenase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of UGDH mRNA |
CTD |
PMID:32905824 |
|
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
increases expression |
ISO |
ochratoxin A results in increased expression of UGT1A6 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of UGT2B7 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
|
|
G |
Unc13d |
unc-13 homolog D |
increases expression |
EXP |
ochratoxin A results in increased expression of UNC13D mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:101,296,755...101,311,513
Ensembl chr10:101,296,776...101,311,687
|
|
G |
Upb1 |
beta-ureidopropionase 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of UPB1 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr20:13,217,252...13,243,590
Ensembl chr20:13,217,258...13,243,590
|
|
G |
Upf3b |
UPF3B, regulator of nonsense mediated mRNA decay |
decreases expression |
ISO |
ochratoxin A results in decreased expression of UPF3B mRNA |
CTD |
PMID:22124623 |
|
NCBI chr X:116,335,308...116,353,332
Ensembl chr X:116,335,308...116,353,236
|
|
G |
Uqcr11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
increases expression |
ISO |
ochratoxin A results in increased expression of UQCR11 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 7:9,305,042...9,309,753
Ensembl chr 7:9,305,058...9,309,750
|
|
G |
Uqcrh |
ubiquinol-cytochrome c reductase hinge protein |
increases expression |
ISO |
ochratoxin A results in increased expression of UQCRH mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 5:129,545,978...129,554,173
Ensembl chr 5:129,545,984...129,554,242
|
|
G |
Uqcrq |
ubiquinol-cytochrome c reductase, complex III subunit VII |
increases expression |
ISO |
ochratoxin A results in increased expression of UQCRQ mRNA |
CTD |
PMID:17316727 |
|
NCBI chr10:37,585,864...37,589,328
Ensembl chr10:37,586,888...37,589,169
|
|
G |
Uxt |
ubiquitously-expressed, prefoldin-like chaperone |
decreases expression |
EXP |
ochratoxin A results in decreased expression of UXT mRNA |
CTD |
PMID:18417182 |
|
NCBI chr X:1,126,110...1,138,670
Ensembl chr X:1,126,162...1,138,663
|
|
G |
Vars1 |
valyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of VARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr20:3,805,774...3,820,468
Ensembl chr20:3,805,776...3,820,298
|
|
G |
Vat1 |
vesicle amine transport 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of VAT1 protein |
CTD |
PMID:26861962 |
|
NCBI chr10:86,389,549...86,397,167
Ensembl chr10:86,389,545...86,397,224
|
|
G |
Vav3 |
vav guanine nucleotide exchange factor 3 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of VAV3 mRNA; ochratoxin A results in increased expression of VAV3 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 2:197,011,901...197,354,321
Ensembl chr 2:197,011,831...197,354,321
|
|
G |
Vcp |
valosin-containing protein |
increases expression |
ISO |
ochratoxin A results in increased expression of VCP protein |
CTD |
PMID:19445961 |
|
NCBI chr 5:57,210,167...57,229,571
Ensembl chr 5:57,210,168...57,229,571
|
|
G |
Vdac1 |
voltage-dependent anion channel 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of VDAC1 mRNA |
CTD |
PMID:34748853 |
|
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions affects expression decreases expression |
ISO |
EPAS1 protein inhibits the reaction [ochratoxin A results in decreased expression of VEGFA protein]; Oxygen deficiency inhibits the reaction [ochratoxin A results in decreased expression of VEGFA protein] ochratoxin A affects the expression of VEGFA mRNA [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of VEGFA mRNA; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of VEGFA protein ochratoxin A results in decreased expression of VEGFA mRNA |
CTD |
PMID:21554934 PMID:28710020 PMID:30876885 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
decreases expression increases expression multiple interactions |
ISO EXP |
ochratoxin A results in decreased expression of VIM protein ochratoxin A results in increased expression of VIM protein [ochratoxin A co-treated with Citrinin] results in decreased expression of VIM mRNA; [ochratoxin A co-treated with Citrinin] results in increased expression of VIM protein ochratoxin A results in increased expression of VIM; ochratoxin A results in increased expression of VIM mRNA; ochratoxin A results in increased expression of VIM protein |
CTD |
PMID:15994020 PMID:18308701 PMID:19445961 PMID:25218026 PMID:29673704 PMID:31369848 PMID:33543323 More...
|
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Vldlr |
very low density lipoprotein receptor |
decreases expression |
ISO |
ochratoxin A results in decreased expression of VLDLR mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920
|
|
G |
Vnn1 |
vanin 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of VNN1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
|
|
G |
Vom1r6 |
vomeronasal 1 receptor 6 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of VOM1R6 gene |
CTD |
PMID:26431795 |
|
NCBI chr 1:59,826,557...59,830,125
Ensembl chr 1:59,815,362...59,833,596
|
|
G |
Vps50 |
VPS50 subunit of EARP/GARPII complex |
decreases expression |
ISO |
ochratoxin A results in decreased expression of VPS50 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:31,484,424...31,585,617
Ensembl chr 4:31,484,463...31,585,617
|
|
G |
Wdr33 |
WD repeat domain 33 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of WDR33 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr18:23,432,233...23,535,460
Ensembl chr18:23,432,191...23,468,597
|
|
G |
Wdr46 |
WD repeat domain 46 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of WDR46 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr20:4,937,845...4,945,796
Ensembl chr20:4,937,847...4,946,535
|
|
G |
Wee1 |
WEE1 G2 checkpoint kinase |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of WEE1 mRNA ochratoxin A results in decreased expression of WEE1 mRNA |
CTD |
PMID:23358140 PMID:24243707 PMID:30763683 |
|
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
|
|
G |
Wipf1 |
WAS/WASL interacting protein family, member 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of WIPF1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:58,314,521...58,416,668
Ensembl chr 3:58,314,542...58,372,742
|
|
G |
Wnt1 |
Wnt family member 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of WNT1 mRNA |
CTD |
PMID:32617660 |
|
NCBI chr 7:129,938,604...129,942,651
Ensembl chr 7:129,938,604...129,942,651
|
|
G |
Wnt7b |
Wnt family member 7B |
increases expression |
ISO |
ochratoxin A results in increased expression of WNT7B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:116,634,817...116,679,459
Ensembl chr 7:116,634,814...116,679,581
|
|
G |
Wwp1 |
WW domain containing E3 ubiquitin protein ligase 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of WWP1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 5:33,092,379...33,185,887
Ensembl chr 5:33,098,494...33,186,046
|
|
G |
Xaf1 |
XIAP associated factor 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of XAF1 mRNA; ochratoxin A results in decreased expression of XAF1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770
|
|
G |
Xbp1 |
X-box binding protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of XBP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
G |
Xdh |
xanthine dehydrogenase |
increases expression decreases expression |
ISO |
ochratoxin A results in increased expression of XDH mRNA ochratoxin A results in decreased expression of XDH mRNA |
CTD |
PMID:17316727 PMID:30559759 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
G |
Xrcc5 |
X-ray repair cross complementing 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of XRCC5 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 9:73,955,216...74,044,020
Ensembl chr 9:73,955,216...74,044,018
|
|
G |
Xrcc6 |
X-ray repair cross complementing 6 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of XRCC6 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 7:113,542,992...113,563,762
Ensembl chr 7:113,543,057...113,563,762
|
|
G |
Yap1 |
Yes1 associated transcriptional regulator |
increases expression |
EXP |
ochratoxin A results in increased expression of YAP1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 8:5,095,705...5,166,808
Ensembl chr 8:5,095,722...5,167,010
|
|
G |
Yars1 |
tyrosyl-tRNA synthetase 1 |
increases methylation decreases expression |
ISO |
ochratoxin A results in increased methylation of YARS1 promoter ochratoxin A results in decreased expression of YARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:141,535,815...141,564,029
Ensembl chr 5:141,535,759...141,563,833
|
|
G |
Ywhab |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta |
decreases expression |
EXP |
ochratoxin A results in decreased expression of YWHAB protein |
CTD |
PMID:31369848 |
|
NCBI chr 3:152,659,663...152,682,105
Ensembl chr 3:152,659,651...152,682,105
|
|
G |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
decreases expression |
EXP |
ochratoxin A results in decreased expression of YWHAZ protein |
CTD |
PMID:31369848 |
|
NCBI chr 7:67,941,353...67,963,651
Ensembl chr 7:67,940,017...67,963,668
|
|
G |
Zbtb18 |
zinc finger and BTB domain containing 18 |
multiple interactions decreases acetylation decreases expression |
ISO |
[ochratoxin A results in decreased acetylation of ZBTB18 promoter] which results in decreased expression of ZBTB18 mRNA ochratoxin A results in decreased expression of ZBTB18 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr13:89,439,501...89,447,958
Ensembl chr13:89,439,420...89,448,862
|
|
G |
Zbtb4 |
zinc finger and BTB domain containing 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ZBTB4 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:54,480,698...54,501,492
Ensembl chr10:54,485,071...54,501,492
|
|
G |
Zfp148 |
zinc finger protein 148 |
increases expression |
ISO |
ochratoxin A results in increased expression of ZNF148 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr11:67,276,455...67,385,803
Ensembl chr11:67,281,707...67,385,772
|
|
G |
Zfp213 |
zinc finger protein 213 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of ZFP213 gene |
CTD |
PMID:26431795 |
|
NCBI chr10:12,592,368...12,599,296
Ensembl chr10:12,592,368...12,599,281
|
|
G |
Zfp518a |
zinc finger protein 518A |
multiple interactions decreases acetylation decreases expression |
ISO |
[ochratoxin A results in decreased acetylation of ZNF518A promoter] which results in decreased expression of ZNF518A mRNA ochratoxin A results in decreased expression of ZNF518A mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:239,719,305...239,744,978
Ensembl chr 1:239,719,505...239,744,979
|
|
G |
Zfp628 |
zinc finger protein 628 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ZNF628 mRNA; ochratoxin A results in decreased expression of ZNF628 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 1:68,913,600...68,921,186
Ensembl chr 1:68,910,401...68,921,243
|
|
G |
Zfp652 |
zinc finger protein 652 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ZNF652 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr10:80,626,555...80,706,397
Ensembl chr10:80,649,400...80,698,674
|
|
G |
Zmat3 |
zinc finger, matrin type 3 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of ZMAT3 mRNA ochratoxin A results in decreased expression of ZMAT3 mRNA |
CTD |
PMID:23358140 PMID:30559759 |
|
NCBI chr 2:115,106,046...115,136,888
Ensembl chr 2:115,106,966...115,136,863
|
|
G |
Zmym3 |
zinc finger MYM-type containing 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ZMYM3 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr X:66,528,585...66,544,234
Ensembl chr X:66,528,585...66,544,782
|
|
G |
Zzz3 |
zinc finger, ZZ-type containing 3 |
multiple interactions decreases acetylation decreases expression |
ISO |
[ochratoxin A results in decreased acetylation of ZZZ3 promoter] which results in decreased expression of ZZZ3 mRNA ochratoxin A results in decreased expression of ZZZ3 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 2:241,330,366...241,397,308
Ensembl chr 2:241,331,022...241,397,307
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases expression |
ISO |
secomilbemycin D results in decreased expression of ABCB1 protein |
CTD |
PMID:21458446 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|